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Abstract 
Type 2 diabetes is a major public health problem and its prevalence is increasing worldwide, 
especially among older people. Overweight and abdominal obesity are known risk factors for 
the disease, but few studies have analysed their longitudinal pattern. A high glycaemic index 
(GI), low dietary fibre and high dietary fats have also been linked to type 2 diabetes, but their 
combined effect has never been studied.  
Using data from the MRC National Survey of Health and Development this thesis aimed to 
examine adult life course (from age 26 to 53 years) body mass index (BMI), waist circumference 
(WC) and dietary patterns in relation to type 2 diabetes incidence between age 53 and 60-64 
years.  
At any stage of the adult life course BMI gain was associated with type 2 diabetes incidence. 
Early (26-36 years) and late (43-53 years) adulthood BMI gains were more important for men 
whereas late adulthood gains had stronger associations for women. The risk of type 2 diabetes 
increased with longer durations of overweight or obesity, probably because of the increasing 
accumulation of weight across the life course. Long-term WC change (36-53 years), 
independent of concomitant BMI change, was associated with increased risk of diabetes 
especially among women and people with an initially normal BMI. A high fat, high GI, low fibre 
dietary pattern was identified that was characterised by a high consumption of refined grains, 
processed meat, and animal fats, and a low intake of fruits, vegetables, low-fat dairy and 
wholegrain cereals. Higher scores for this dietary pattern at age 43 (only among women) and 53 
were associated with increased type 2 diabetes incidence, predominantly via pathways that 
were independent of BMI and WC. Long-term score change (36-53 years) was significantly 
associated with diabetes only among women. 
Early interventions to reduce weight and WC gain and improve dietary patterns would be 
effective public health strategies to prevent type 2 diabetes risk at older ages.  
  
4 
Acknowledgments 
I would like to thank my supervisors Marcus Richards, Mary Pierce and Gina Ambrosini for their 
invaluable advice and support throughout this PhD. This thesis would not have been possible 
without their feedback and encouragement. 
I would like to thank the team at the MRC Unit for Lifelong Health and Ageing for their 
assistance. Particular thanks go to Andrew Wills, Rebecca Hardy and Graciela Muniz-Terrera 
for sharing their statistical expertise.  For their suggestions and support with dietary data, I wish 
to thank members of the MRC Human Nutrition Research in Cambridge in particular Emily Fitt 
and Nida Ziauddeen for their collaboration in deriving glycaemic index values used in this 
thesis. I also thank the study members of the MRC National Survey of Health and Development, 
who contributed to this unique research by providing their time and information about their lives. 
I am very grateful to the MRC for providing financial support. 
I am extremely thankful to my family – especially my parents for supporting my education across 
my life – and my friends for their constant encouragement. In particular I would like to thank my 
friends and colleagues at UCL, Carolina Perez Ferrer, Jemima Stockton, Peijue Huangfu and 
Tuba Mazhari for their support and for making these years at room 404 so enjoyable. 
Finally I would like to thank my husband, David, for his unconditional belief in me and for giving 
me continuous motivation to succeed. This thesis is dedicated to our son Julian. 
 
  
5 
Contents 
Abstract ................................................................................................................................... 3 
Acknowledgments ................................................................................................................. 4 
List of Tables ........................................................................................................................ 11 
Table of Figures ................................................................................................................... 14 
Abbreviations ....................................................................................................................... 15 
1 Chapter 1: Introduction and literature review ........................................................ 16 
1.1 Prevalence and health burden of diabetes ................................................................. 16 
1.2 Definition and diagnosis of type 2 diabetes ................................................................ 16 
1.3 Aetiology of type 2 diabetes ........................................................................................ 17 
1.3.1 Factors affecting insulin resistance and -cell function ....................................... 18 
1.4 Type 2 diabetes risk factors ........................................................................................ 19 
1.4.1 Non-modifiable risk factors .................................................................................. 19 
1.4.2 Modifiable risk factors .......................................................................................... 19 
1.5 Body weight and abdominal obesity ............................................................................ 20 
1.5.1 Overweight and obesity ....................................................................................... 20 
1.5.2 Abdominal obesity ................................................................................................ 20 
1.5.3 Physiological mechanisms ................................................................................... 21 
1.6 Life course epidemiology of body weight, fat distribution and type 2 diabetes ........... 22 
1.6.1 Critical period model: birth weight and early growth ............................................ 23 
1.6.1.1 Physiological mechanisms ................................................................................... 23 
1.6.2 Accumulation of risk model: duration of obesity .................................................. 24 
1.6.3 Sensitive period model ......................................................................................... 25 
1.6.4 Changes in abdominal obesity ............................................................................. 26 
1.7 The Diabetes Prevention trials .................................................................................... 26 
1.8 Dietary factors and type 2 diabetes ............................................................................. 28 
1.8.1 Glycaemic index and glycaemic load ................................................................... 28 
1.8.2 Dietary fibre and whole grain foods ..................................................................... 30 
1.8.3 Dietary fat ............................................................................................................. 31 
1.8.4 Other dietary factors ............................................................................................ 33 
1.8.5 Limitations of studies investigating single dietary factors .................................... 34 
6 
1.9 Dietary patterns and type 2 diabetes .......................................................................... 34 
1.9.1 Methodologies used to derived dietary patterns .................................................. 35 
1.9.1.1 Theoretically defined dietary patterns: Diet quality scores .................................. 35 
1.9.1.2 Empirically defined dietary patterns: factor and cluster analyses ........................ 35 
1.9.1.3 Reduced rank regression (RRR) .......................................................................... 36 
1.9.2 Prospective studies of dietary patterns and incident type 2 diabetes .................. 37 
1.9.2.1 Studies using diet quality scores.......................................................................... 37 
1.9.2.2 Studies using factor or cluster analyses .............................................................. 38 
1.9.2.3 Studies using RRR ............................................................................................... 39 
1.10 Literature review summary and conclusions ............................................................... 41 
1.11 Overall aim and structure of the thesis ........................................................................ 42 
1.11.1 Research questions: ............................................................................................ 43 
1.12 Structure of the thesis ................................................................................................. 43 
2 Chapter 2. Methods ..................................................................................................... 45 
2.1 Introduction to the NSHD ............................................................................................ 45 
2.2 Response rate and representativeness of the study ................................................... 45 
2.3 Main outcome used in this thesis ................................................................................ 46 
2.3.1 Self-reported diabetes .......................................................................................... 47 
2.3.2 Diabetes diagnosed by fasting blood measures .................................................. 49 
2.3.3 Type of diabetes................................................................................................... 49 
2.3.4 Validation of diabetes ........................................................................................... 49 
2.3.5 Descriptive analyses of the outcome ................................................................... 53 
2.3.5.1 Diabetes prevalence ............................................................................................ 53 
2.3.5.2 Undiagnosed diabetes ......................................................................................... 53 
2.4 Exposure variables ...................................................................................................... 54 
2.4.1 BMI and waist circumference ............................................................................... 54 
2.4.2 Diet ....................................................................................................................... 55 
2.5 Confounding and mediating variables ......................................................................... 55 
2.5.1 Occupational social class ..................................................................................... 56 
2.5.2 Educational attainment ........................................................................................ 56 
2.5.3 Smoking ............................................................................................................... 56 
2.5.4 Physical activity .................................................................................................... 57 
2.6 Statistical analyses ...................................................................................................... 57 
7 
2.6.1 Descriptive analyses ............................................................................................ 57 
2.6.2 Multivariable analyses .......................................................................................... 57 
3 Chapter 3. BMI across the life course and type 2 diabetes ........................................ 58 
3.1 Introduction .................................................................................................................. 58 
3.1.1 Research question ............................................................................................... 59 
3.1.2 Objectives ............................................................................................................ 59 
3.1.3 Hypotheses .......................................................................................................... 60 
3.2 Methods ....................................................................................................................... 60 
3.2.1 Explanatory variables ........................................................................................... 60 
3.2.1.1 Missing data for BMI ............................................................................................ 60 
3.2.2 Outcome variable ................................................................................................. 60 
3.2.3 Potential confounding variables ........................................................................... 60 
3.3 Statistical analyses ...................................................................................................... 61 
3.3.1 Sample ................................................................................................................. 62 
3.4 Results ........................................................................................................................ 63 
3.4.1 Descriptive analyses of BMI ................................................................................. 63 
3.4.2 Investigation of potential confounders ................................................................. 63 
3.4.3 Adult overweight and obesity and type 2 diabetes .............................................. 70 
3.4.4 Duration of overweight and type 2 diabetes ........................................................ 70 
3.4.5 Sensitive periods of BMI gain and type 2 diabetes .............................................. 71 
3.5 Discussion ................................................................................................................... 78 
3.5.1 Main findings ........................................................................................................ 78 
3.5.2 Strengths .............................................................................................................. 81 
3.5.3 Limitations ............................................................................................................ 81 
3.5.4 Conclusions .......................................................................................................... 82 
4 Waist circumference across the life course and type 2 diabetes ................................ 84 
4.1 Introduction .................................................................................................................. 84 
4.1.1 Research question ............................................................................................... 85 
4.1.2 Objectives ............................................................................................................ 85 
4.1.3 Hypotheses .......................................................................................................... 86 
4.2 Methods ....................................................................................................................... 86 
4.2.1 Explanatory variables ........................................................................................... 86 
4.2.2 Outcome variables ............................................................................................... 86 
4.2.3 Potential confounding variables ........................................................................... 86 
8 
4.2.4 Statistical analyses .............................................................................................. 87 
4.2.5 Sample ................................................................................................................. 88 
4.3 Results ........................................................................................................................ 88 
4.3.1 Descriptive analyses of WC ................................................................................. 88 
4.3.2 Investigation of potential confounders ................................................................. 88 
4.3.3 Prospective associations between adult WC and type 2 diabetes ...................... 94 
4.3.4 Lifecourse change in WC and type 2 diabetes .................................................... 94 
4.3.5 Sensitive periods of WC change and type 2 diabetes ......................................... 95 
4.4 Discussion ................................................................................................................. 105 
4.4.1 Main findings ...................................................................................................... 105 
4.4.2 Strengths ............................................................................................................ 108 
4.4.3 Limitations .......................................................................................................... 108 
4.4.4 Conclusions ........................................................................................................ 109 
5 Chapter 5. Dietary fibre, dietary GI, dietary fat, SFA and type 2 diabetes ................ 110 
5.1 Introduction ................................................................................................................ 110 
5.1.1 Dietary fibre ........................................................................................................ 110 
5.1.2 Glycemic Index................................................................................................... 111 
5.1.3 Total and saturated fats ..................................................................................... 111 
5.1.4 Mechanisms of action: direct and indirect pathways ......................................... 112 
5.1.5 Previous findings from the MRC NSHD ............................................................. 112 
5.1.6 Research question ............................................................................................. 113 
5.1.7 Objectives .......................................................................................................... 113 
5.1.8 Hypotheses ........................................................................................................ 113 
5.2 Methods ..................................................................................................................... 114 
5.2.1 Explanatory variables ......................................................................................... 114 
5.2.2 Assignment of GI values .................................................................................... 114 
5.2.2.1 Missing data for dietary intake ........................................................................... 114 
5.2.3 Outcome variable ............................................................................................... 115 
5.2.4 Potential confounding variables ......................................................................... 115 
5.2.5 Statistical analyses ............................................................................................ 116 
5.2.6 Sample ............................................................................................................... 116 
5.3 Results ...................................................................................................................... 117 
5.3.1 Descriptive analyses .......................................................................................... 117 
5.3.2 Investigation of potential confounders ............................................................... 118 
5.3.3 Prospective associations between fibre, GI, dietary fats and type 2 diabetes .. 128 
5.3.3.1 Fibre density ....................................................................................................... 128 
9 
5.3.3.2 Dietary Glycaemic Index .................................................................................... 128 
5.3.3.3 Fat density .......................................................................................................... 128 
5.3.4 Investigation of interactions between dietary factors and BMI and WC ............ 129 
5.4 Discussion ................................................................................................................. 136 
5.4.1 Main findings ...................................................................................................... 136 
5.4.2 Strengths ............................................................................................................ 139 
5.4.3 Limitations .......................................................................................................... 139 
5.4.4 Conclusions ........................................................................................................ 140 
6 Chapter 6. Dietary patterns and type 2 diabetes ...................................................... 141 
6.1 Introduction ................................................................................................................ 141 
6.1.1 Research question ............................................................................................. 142 
6.1.2 Objectives .......................................................................................................... 142 
6.1.3 Hypotheses ........................................................................................................ 142 
6.2 Methods ..................................................................................................................... 143 
6.2.1 Explanatory variables ......................................................................................... 143 
6.2.2 Outcome variables ............................................................................................. 143 
6.2.3 Potential confounding variables ......................................................................... 143 
6.2.4 Statistical analyses ............................................................................................ 143 
6.2.4.1 Deriving dietary patterns .................................................................................... 143 
6.2.4.2 Descriptive and regression analyses ................................................................. 144 
6.2.5 Study population ................................................................................................ 145 
6.3 Results ...................................................................................................................... 145 
6.3.1 Descriptive analyses of dietary patterns ............................................................ 145 
6.3.2 Investigation of potential confounders/mediators .............................................. 146 
6.3.3 Prospective associations between dietary patterns and type 2 diabetes .......... 153 
6.3.4 Longitudinal changes in dietary pattern scores and type 2 diabetes ................. 153 
6.4 Discussion ................................................................................................................. 159 
6.4.1 Main findings ...................................................................................................... 159 
6.4.2 Strengths ............................................................................................................ 161 
6.4.3 Limitations .......................................................................................................... 162 
6.4.4 Conclusions ........................................................................................................ 163 
7 Chapter 7 - Discussion .............................................................................................. 164 
7.1 Research questions................................................................................................... 164 
7.2 Summary of main findings ......................................................................................... 164 
10 
7.3 Implications of findings .............................................................................................. 165 
7.4 Overall strengths and limitations ............................................................................... 167 
7.4.1 Strengths ............................................................................................................ 167 
7.4.2 Limitations .......................................................................................................... 168 
7.5 Policy implications ..................................................................................................... 169 
7.6 Future research ......................................................................................................... 170 
References ........................................................................................................................... 172 
Appendices .......................................................................................................................... 195 
 
  
11 
List of Tables 
Table 1. Summary of 2006 WHO diagnostic criteria for diabetes and intermediate 
hyperglycaemia ............................................................................................................... 17 
Table 2. Response rate in the MRC NSHD ........................................................................... 46 
Table 3. Questions on diabetes and hospital admission in postal questionnaires and nurse 
interviews from 1977 to 2006-10 .................................................................................... 48 
Table 4. Participants available for validation and GP response rate ..................................... 50 
Table 5. Proportion of GP-confirmed self-reported diabetes cases ....................................... 51 
Table 6. Prevalence of diabetes by gender and method of diagnosis ................................... 54 
Table 7. Summary of smoking variables used in this thesis .................................................. 56 
Table 8. BMI descriptive statistics by sex .............................................................................. 64 
Table 9. Correlations between BMI measures ....................................................................... 66 
Table 10. Associations between potential confounders and type 2 diabetes at age 53 to 60-64
 ........................................................................................................................................ 67 
Table 11. Associations between potential confounders and BMI at age 26, 36, 43 and 53 .. 68 
Table 12. Associations at each age between being overweight and obese and type 2 diabetes 
between age 53 and 60-64 among men ......................................................................... 72 
Table 13. Associations at each age between being overweight and obese and type 2 diabetes 
between age 53 and 60-64 among women .................................................................... 73 
Table 14. Associations between duration of overweight or obesity and type 2 diabetes incidence 
between age 53 and 60-64 ............................................................................................. 75 
Table 15. Associations between conditional BMI velocity and type 2 diabetes between age 53 
and 60-64 ........................................................................................................................ 77 
Table 16. Waist circumference descriptive statistics by sex .................................................. 89 
Table 17. Correlation between WC and BMI measures ........................................................ 91 
Table 18. Associations between potential confounders and WC at age 36, 43 and 53 ........ 92 
Table 19. Associations at each age between high risk and very high risk WC categories* and 
type 2 diabetes between age 53 and 60-64 among men relative to normal WC ........... 96 
Table 20. Associations at each age between high risk and very high risk WC categories* and 
type 2 diabetes between age 53 and 60-64 among women relative to normal WC ....... 97 
Table 21. Associations at each age between WC and type 2 diabetes between age 53 and 60-
64 among men by BMI categories .................................................................................. 98 
Table 22. Associations at each age between WC and type 2 diabetes between age 53 and 60-
64 among women by BMI categories ............................................................................. 99 
Table 23. Associations between lifecourse change in WC and type 2 diabetes between age 53 
and 60-64 ...................................................................................................................... 101 
Table 24. Associations between lifecourse change in WC and type 2 diabetes between age 53 
and 60-64 by categories of BMI .................................................................................... 102 
Table 25. Associations between conditional WC velocity at different age intervals and type 2 
diabetes between age 53 and 60-64 ............................................................................ 104 
12 
Table 26. Levels of confidence* used for the assignment of GI values in the NSHD dataset115 
Table 27.  Nutrient intakes and diabetes status (age 53 to 60-64) by quintiles of fibre density, 
GI, fat density and SFA density at age 36 .................................................................... 119 
Table 28.  Nutrient intakes and diabetes status (age 53 to 60-64) by quintiles of fibre density, 
GI, fat density and SFA at age 43 ................................................................................. 120 
Table 29.  Nutrient intakes and diabetes status (age 53 to 60-64) by quintiles of fibre density, 
GI, fat density and SFA at age 53 ................................................................................. 121 
Table 30.  Food groups correlated with fibre density, GI, fat density and SFA density ....... 124 
Table 31. Associations between potential confounders and mediators and selected dietary 
factors at age 36 ........................................................................................................... 125 
Table 32. Associations between potential confounders and mediators and selected dietary 
factors at age 43 ........................................................................................................... 126 
Table 33. Associations between potential confounders and mediators and selected dietary 
factors at age 53 ........................................................................................................... 127 
Table 34. Associations at each age between dietary fibre density intake and type 2 diabetes 
between age 53 and 60-64 ........................................................................................... 130 
Table 35. Associations at each age between average daily glycaemic index and type 2 diabetes 
between age 53 and 60-64 ........................................................................................... 131 
Table 36. Associations between total dietary fat density intake and type 2 diabetes at age 53 to 
60-64 by sex at each age ............................................................................................. 132 
Table 37. Associations between saturated fat density intake and type 2 diabetes at age 53 to 
60-64 by sex at each age ............................................................................................. 133 
Table 38. Associations between fibre density intake and type 2 diabetes at age 53 to 60-64 by 
BMI and WC at each age .............................................................................................. 134 
Table 39. Associations between glycaemic index and type 2 diabetes at age 53 to 60-64 by BMI 
and WC at each age ..................................................................................................... 135 
Table 40. Description of food groups included in the dietary pattern analyses ................... 147 
Table 41. Characteristics of the 3 RRR-derived exploratory dietary patterns at age 36, 43 and 
53 .................................................................................................................................. 148 
Table 42. Mean (SD) or median (IQR) nutrient intakes by quintile of high-fat, high-GI, low-fibre 
dietary pattern z-score .................................................................................................. 150 
Table 43. Associations between potential confounders/mediators and dietary patterns z-scores 
at age 36, 43 and 53 ..................................................................................................... 151 
Table 44. Associations at each age between a high fat, high GI, low fibre dietary pattern z-score 
and type 2 diabetes between age 53 and 60-64 .......................................................... 154 
Table 45. Associations between dietary pattern z-score at age 43 and type 2 diabetes at age 53 
to 60-64 by sex ............................................................................................................. 155 
Table 46. Mean change (95%CI) in dietary pattern z-score according to sex and type 2 diabetes 
diagnosed between age 53 and 60-64 ......................................................................... 156 
13 
Table 47. Associations between change in dietary pattern z-score and type 2 diabetes between 
age 53 and 60-64 .......................................................................................................... 158 
 
 
  
14 
Table of Figures 
Figure 1. Conceptual framework representing the effect of lifecourse body weight and diet on 
type 2 diabetes incidence in the NSHD .......................................................................... 43 
Figure 2. Differences in years between self-reported and GP-confirmed age at diagnosis plotted 
against the average difference. ...................................................................................... 52 
Figure 3. Percentage of people in the overweight and obesity categories* by age among: a) 
men and b) women. ........................................................................................................ 65 
Figure 4. Mean BMI from 26 to 53 years by age at onset of overweight for a) men and b) 
women. ........................................................................................................................... 74 
Figure 5. Mean BMI gain velocity per year for different periods of the adult life by sex and 
diabetes diagnosis at age 53-64. ...................................... Error! Bookmark not defined. 
Figure 6. Percentage of people in the high risk and very high risk WC category* by age and 
gender ............................................................................................................................. 90 
Figure 7. Mean WC at 36, 43 and 53 years by sex and type 2 diabetes diagnosis at age 53 to 
60-64 Note: Sample restricted to those with non-missing values for WC, type 2 diabetes 
and all covariates (N=2007) .............................................. Error! Bookmark not defined. 
Figure 8. Mean WC velocity (cm per year) at different periods by sex and type 2 diabetes 
diagnosis between 53 and 60-64 years. ....................................................................... 103 
Figure 9. Mean or median intakes by age and sex for a) fibre density b) GI c) fat density and d) 
Saturated fat density ..................................................................................................... 122 
Figure 10. Mean or median intakes by age and type 2 diabetes diagnosis (age 53 to 60-64) for 
a) fibre density b) GI c) fat density and d) SFA density ................................................ 123 
Figure 11. Factor loadings for the high-fat, high-GI, low-fibre dietary pattern at age 53 used in 
confirmatory dietary pattern analyses ........................................................................... 149 
Figure 12. Mean change in dietary pattern score (SD) by sex and type 2 diabetes diagnosis157 
 
  
15 
Abbreviations 
AHEI=Alternative Healthy Eating Index  
BMI-body mass index  
DASH=Adherence to the Dietary Approaches to Stop Hypertension 
EPIC=European Prospective Investigation into Cancer and Nutrition 
FFA=free fatty acids  
FFQ=food-frequency questionnaires  
FPG=fasting plasma glucose  
GI=glycaemic index 
GL=glycaemic load 
GP=general practitioner 
HbA1c=glycated haemoglobin  
HEI=Healthy Eating Index  
HOMA-IR=homeostasis model assessment of insulin resistance 
IDF=International Diabetes Federation 
IFG=impaired fasting glucose  
IGT=impaired glucose tolerance 
IR=insulin resistance 
MDS=Mediterranean Diet Score 
MUFA=monounsaturated fatty acids 
NSHD=MRC National Survey of Health and Development 
OGTT=oral glucose tolerance test 
PUFA=polyunsaturated fatty acids 
RRR=reduced rank regression 
SEP=socioeconomic position  
SFA=saturated fatty acids  
WC=waist circumference  
WHO=World Health Organization 
WHR=waist-to-hip ratio  
WHtR=waist-to-height ratio 
  
16 
1 Chapter 1: Introduction and literature review 
1.1 Prevalence and health burden of diabetes  
Diabetes is a major public health problem and its prevalence is rapidly increasing in low, middle 
and high-income countries. The International Diabetes Federation (IDF) (1) reported that 382 
million adult people worldwide had diabetes in 2013, corresponding to a prevalence of 8.3%, 
and that about 46% of all cases were undiagnosed. By 2035 this number is predicted to 
increase to an estimated 592 million people (1) The highest increase will be in the over 60 
category reflecting the trend towards an ageing society.  
According to 2012 Quality and Outcomes Framework reports (2) the number of people aged 17 
and over diagnosed with diabetes was 2,544,197 in England, 231,248 in Scotland, 167,537 in 
Wales and 75,628 in Northern Ireland. This corresponds to an average prevalence of diabetes 
in the UK of 4.6%. However, if undiagnosed cases of diabetes in the UK were taken into 
account, it is estimated that the current prevalence might be as high as 6.5% with a projected 
prevalence of 7.3% by 2035 (1). The prevalence of diabetes is higher among men, Asian and 
Black ethnic groups and increases with age. Among 55-75 year olds the point prevalence of 
diabetes in 2010 was estimated to be 14.3% (3). 
About 90% of all diabetes cases are type 2 diabetes. People with type 2 diabetes have a higher 
risk of developing conditions that can lead to increased mortality and reduced quality of life (4). 
Debilitating long-term complications include increased cardiovascular disease risk, retinopathy, 
nephropathy and neuropathy (4, 5). The management and treatment of diabetes complications 
is costly and difficult. Therefore primary prevention of type 2 diabetes is an important public 
health priority.  
1.2 Definition and diagnosis of type 2 diabetes 
In contrast to Type 1 diabetes, which is an autoimmune condition, Type 2 diabetes is a 
multifactorial metabolic disorder characterised by chronically elevated levels of glucose in the 
blood (hyperglycaemia) and disrupted metabolism of carbohydrate, fat and protein (6). The 
diagnosis of diabetes is based on blood glucose levels with or without symptoms. The latest 
criteria for the classification and diagnosis of diabetes have been published in 2006 following a 
joint consultation of the World Health Organization (WHO) and IDF (7). These criteria have been 
derived using epidemiological data on the distribution of plasma glucose in the population and 
on the prevalence of diabetes complications associated with raised glucose levels. 
The two methods recommended by WHO for diabetes diagnosis are the determination of fasting 
plasma glucose (FPG) and the oral glucose tolerance test (OGTT). The latter entails the 
measurement of plasma glucose two hours after the ingestion of 75g of glucose. A summary of 
current WHO/IDF criteria for diabetes and intermediate hyperglycaemia are shown in Table 1. In 
17 
2011 WHO published an addendum to its 2006 criteria acknowledging the conditional use of 
glycated haemoglobin (HbA1c) as a diagnostic test for diabetes (8). The recommended cut-
point for diabetes diagnosis is 6.5%. Diabetes can also be diagnosed by a random plasma 
glucose level of ≥11.1mmol/l (200mg/dl), if the patient presents with symptoms of 
hyperglycaemia, such as polydipsia, polyuria and unexplained weight loss (6). 
 
1.3 Aetiology of type 2 diabetes 
Insulin is a hormone produced by the islet -cells in the pancreas. It regulates the metabolism of 
carbohydrates, fat and protein in target tissues in the body (mainly skeletal muscles, liver and 
adipose tissue) and is key for maintaining normal levels of glucose in the blood. Insulin is 
secreted in response to raised blood glucose levels after the ingestion of food. Increased 
circulating levels of insulin stimulate uptake of glucose by target tissues where it is either stored 
as glycogen or used for fuel (6). Insulin also stimulates amino acid uptake for protein synthesis 
in muscles, and free fatty acids (FFA) uptake for triglyceride synthesis in adipose tissue. At the 
same time it suppresses levels of glucagon and other counter-regulatory hormones, which leads 
to reduced fat and protein breakdown and endogenous liver glucose production (6). In type 2 
diabetes these pathways are disrupted and physiological levels of blood glucose cannot be 
maintained. 
Because of the multifactorial nature of type 2 diabetes, the exact pathophysiology of this 
condition is still being elucidated. The disorder develops from the interplay of dysfunctions in 
insulin secretion and action on target tissues (9). A feedback mechanism exists between -cell 
insulin secretion and peripheral insulin action that maintains normal glucose tolerance (10). One 
of the earliest dysfunctions in the development of diabetes is insulin resistance (IR), which 
arises when the target tissues’ responses to physiological levels of insulin are disrupted or 
Table 1. Summary of 2006 WHO diagnostic criteria for diabetes and intermediate 
hyperglycaemia 
Diabetes 
 
Fasting plasma glucose  ≥7.0mmol/l (126mg/dl) or 
2–h plasma glucose* ≥11.1mmol/l (200mg/dl) 
Impaired Glucose tolerance (IGT)  
Fasting plasma glucose <7.0mmol/l (126mg/dl) and 
2–h plasma glucose** ≥7.8 and <11.1mmol/l (140mg/dl and 200mg/dl) 
Impaired fasting Glucose (IFG) 
 
Fasting plasma glucose  6.1-6.9mmol/l (110mg/dl-125mg/dl) and  
2–h plasma glucose** (if measured) <7.8mmol/l (140mg/dl) 
Adapted from WHO, 2006 (7); * Venous plasma glucose 2–h after ingestion of 75g oral 
glucose load; ** If 2–h plasma glucose is not measured, status is uncertain as diabetes or 
IGT cannot be excluded 
18 
delayed (10). To compensate for IR, -cells increase insulin secretion (hyperinsulinaemia). In 
some people the pancreas cannot compensate fully for the protracted decrease in insulin 
sensitivity and there is a progressive loss of -cell function, which leads to postprandial 
hyperglycaemia, impaired glucose tolerance (IGT) and eventually type 2 diabetes (11). Although 
the relative importance of IR and -cell dysfunction are unclear, there is evidence that both 
conditions are present early on in the development of diabetes (12).  
1.3.1 Factors affecting insulin resistance and -cell function 
Both genetic and environmental causes are important in the development of insulin resistance 
and -cell dysfunction. Type 2 diabetes has a strong hereditability with the risk significantly 
increased in people with a first-degree relative with diabetes (13, 14).  
Multiple environmental factors affect insulin resistance and secretion including age, exercise 
and fitness levels, smoking, dietary factors, obesity and visceral fat (12). Mounting evidence 
suggests that one of the primary links between lifestyle factors and diabetes is an imbalance in 
the delicate interaction between immune and metabolic responses. Inflammation has emerged 
in the last decade as a key feature of type 2 diabetes and other metabolic diseases (15, 16). 
The metabolic and immune systems are closely linked and mutually regulated. In normal 
conditions this interaction has evolutionary advantages, but can have adverse consequences 
under conditions of metabolic stress, such as over-nutrition and obesity (15). Prospective 
studies show that high levels of immune mediators and pro-inflammatory molecules are present 
many years before the development of type 2 diabetes (17, 18).  
Insulin exerts its action by binding to specific membrane receptors in target tissues and so 
activating a signal transduction pathway (8). Modifications or defects in any of the steps 
involved in this pathway could disrupt normal glucose uptake and lead to decreased tissue 
sensitivity to insulin (8). Although genetic factors could contribute to some of these defects, it is 
thought that elevated FFA and inflammatory mediators, mainly caused by environmental 
factors, such as obesity, visceral fat accumulation and unhealthy diets, are key factors in insulin 
signal disruption (11, 15, 16, 19).  
Individuals with type 2 diabetes have reduced -cell mass and impaired insulin secretory 
capacity (9). Factors that have been linked to the slow but constant loss of -cell function that 
precedes the development of diabetes include glucose toxicity and lipotoxicity (12, 19-21). 
Glucose toxicity refers to the metabolic stress caused by chronically elevated blood glucose 
levels over many years. This stress induces overproduction of reactive oxygen species, which 
can lead to oxidative damage of -cells (21). Glucose toxicity affects all body tissues, but can be 
especially damaging for the pancreatic islet cells because of their limited antioxidant capacity 
compared to other organs (21). Lipotoxicity refers to the detrimental effects of elevated FFA on 
the pancreas (20). Excessive levels of FFA can lead to accumulation of fat in the pancreas with 
consequent disruption of -cell function (11). It has been hypothesized that an underlying defect 
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is probably already present in genetically predisposed individuals and that glucose toxicity and 
lipotoxicity exacerbate -cell dysfunction (12, 17). 
1.4 Type 2 diabetes risk factors 
1.4.1 Non-modifiable risk factors 
As already mentioned genetic predisposition is a recognised risk factor for type 2 diabetes (13, 
14). Age (22) and ethnicity (23, 24) are also established risk factors for the disease. The risk of 
developing the type 2 (23) diabetes is higher among certain ethnic groups including African 
Americans (23) and South Asians (24) and increases with age (22).  
Social inequalities in health are well known as illustrated by the government-commissioned 
Marmot Review (25). In fact, the incidence of type 2 diabetes is influenced by socio-economic 
position (SEP), with persons from a lower SEP having a higher risk of developing the disease 
compared with persons from higher SEP (26-29). Different explanations might underlie the 
social gradient in type 2 diabetes. Lower education and income might limit knowledge about risk 
factors and reduce the material possibilities to act on these (29, 30). People from lower SEP 
might be more affected by psychosocial stress, which has been linked to diabetes (31).  
1.4.2 Modifiable risk factors 
Although the contribution of inherited factors is well established, the concomitant rise in obesity, 
sedentary lifestyle and type 2 diabetes in the last decades suggests a predominant role for 
environmental factors in the disease aetiology (32). Population studies have shown that the 
obesity pandemic brought about by a combination of lifestyle factors is a key contributor, 
particularly in middle and high-income countries, to the recent rise in metabolic disorders, 
including type 2 diabetes (33).  
The widespread adoption of a diet characterized by easily available, abundant and relatively 
inexpensive energy-dense foods, has led to energy overconsumption. At the same time 
changes in transport and work patterns have reduced opportunities for physical activity and 
energy expenditure. These factors are thought to have led to the current global obesity 
epidemic and a dramatic rise in type 2 diabetes (34). Ecological studies have shown that when 
people migrate to countries with a more Westernized diet and lifestyle their risk of developing 
type 2 diabetes increases (35, 36). In middle and high-income countries the prevalence of 
unhealthy lifestyle risk factors is socio-economically patterned. Obesity, physical inactivity and 
unhealthy diets are all more common among people with lower SEP and educational attainment 
(37-42). Furthermore evidence suggests that these risk factors tend to cluster in individuals and 
that clusters of unhealthy behaviours are more common among lower SEP groups (43, 44). For 
example, people eating unhealthy diets are also more likely to be inactive (43). 
As well as energy imbalance and lack of physical activity, an extensive body of literature reports 
a dose-response association between cigarette smoking and type 2 diabetes incidence. A 
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systematic review (45) of 25 studies reported an increased risk of 44% for active smokers 
compared to non-smokers. Smoking increases insulin resistance (46), inflammation (47) and 
might have direct toxic effects on pancreatic -cells (48). 
Some of these modifiable factors, namely obesity, abdominal adiposity and unhealthy dietary 
patterns, will be reviewed in more detail in the following sections.  
1.5 Body weight and abdominal obesity 
1.5.1 Overweight and obesity 
It is well established that being overweight, defined as a Body Mass Index (BMI) of 25-29.9 
kg/m
2
 or obese (BMI ≥ 30 kg/m
2
) increases the risk of developing type 2 diabetes as showed by 
many prospective studies (49-56). Furthermore, most intervention studies have demonstrated 
that weight loss decreases the progression to type 2 diabetes, at least in Western countries (57-
62). A recent time-trend analysis, based on a sample of 6,460 British men, calculated that 
among men 26% of the recent rise in type 2 diabetes in the UK could be attributed to BMI 
changes in the British male population (63). A meta-analysis of 31 follow-up studies on the 
association between BMI and type 2 diabetes incidence found a pooled relative risk (RR) of 
type 2 diabetes of 1.19 per unit increase in BMI (64). This association was only slightly affected 
by adjustments for age, physical activity, smoking and SEP in those studies that included these 
confounders. A subsequent meta-analysis (65) found a pooled incident rate ratio (IRR) of type 2 
diabetes for overweight of 2.40 (95%CI:2.12-2.72) for men and of 3.92 (95%CI:3.10-4.97) for 
women. Comparing obese people with normal weight subjects the IRR of type 2 diabetes were 
particularly large: 6.74 (95%CI:5.55-8.19] for men and 12.41 (95%CI:9.03–17.06) for women.  
1.5.2 Abdominal obesity 
Increasingly there is recognition that central rather than overall obesity might be more important 
in the pathogenesis of type 2 diabetes. Intra-abdominal visceral fat is more metabolically active 
than peripheral subcutaneous fat and is closely associated with insulin resistance (66). Although 
strongly associated with type 2 diabetes, BMI is a measure of overall obesity and gives no 
information about fat distribution. Measures of central obesity, mainly waist-to-hip ratio (WHR) 
and waist circumference (WC), have been used to predict metabolic risk related to visceral fat. 
Several studies have found that both measures are significant risk factors for type 2 diabetes, 
independently of BMI, in different ethnic groups (67-72). A meta-analysis of 32 studies (73) 
found similar pooled relative risks for incident diabetes for BMI (RR: 1.87, 95%CI: 1.67, 2.10), 
WC (1.87, 95% CI: 1.58, 2.20) and WHR (1.88, 95% CI: 1.61, 2.19). However, this analysis did 
not undertake statistical comparisons of these measures within the same study. When 
comparing the associations in the subset of studies with both BMI and WC or BMI and WHR, 
WC was moderately stronger while WHR was moderately weaker than BMI (73) .A subsequent 
meta-analysis (74) looking at the association between measures of abdominal obesity (WC, 
WHR, iliac circumference an intra-abdominal fat area) found a pooled odds ratio for type 2 
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diabetes (for all measures combined) of 2.14 (95%CI: 1.70-2.71) with most studies adjusting for 
BMI. In statistical comparisons between abdominal obesity measures, WC was slightly more 
predictive of type 2 diabetes than other measures.  
One limitation of these reviews is that they did not consider possible gender differences. Recent 
findings indicate that the relative importance of abdominal obesity might be greater for women 
than for men (75-78). Analyses of the Monitoring Trends and Determinants on Cardiovascular 
Diseases Augsburg cohort study (77) reported a HR for diabetes of 1.48 (95%CI: 0.85, 2.60) for 
men and 5.60 (95%CI: 1.86, 16.86) for women comparing the highest with the lowest quartile of 
WC after adjustment for age, education, smoking, BMI, alcohol intake, and physical activity. 
These strong associations were not observed for WHR in women. For men BMI, WC and WHR 
had similar HRs for type 2 diabetes. Similar findings and gender differences in risk were recently 
observed in the large European Prospective Investigation into Cancer and Nutrition (EPIC)-
InterAct Case-Cohort Study conducted among 26 countries in Europe (76) and the British 
Regional Heart Study (78). There might also be an additive effect of BMI and WC with the 
highest risk observed among men and women with a high WC and a high BMI compared with 
those having only one of these risk factors (77). However, the measurement of WC might be 
particularly informative among lower BMI groups (76, 79, 80). In the EPIC-InterAct (76) the risk 
of diabetes among overweight people with high WC was similar to obese people while the risk 
in overweight people with normal WC was comparable to people with a normal BMI. 
These meta-analyses have shown that WC is as good or a better predictor of type 2 diabetes 
than WHR (73, 74), therefore WC has been preferred in clinical and epidemiological settings, 
since WC is simpler to measure and interpret. Recently however, waist-to-height ratio (WHtR) 
has been proposed as a superior indicator of abdominal obesity and of risk of metabolic disease 
(81). The argument for adding height to WC is that shorter people have supposedly more 
abdominal fat than taller ones for the same WC measurement (82). Indeed WHtR has been 
found to have a stronger correlation with visceral abdominal fat than BMI, WHR or WC, 
although WC is significantly better than BMI and WHR (83, 84). However, a meta-analysis 
comparing the association of obesity indices with incident type 2 diabetes confirmed the 
superiority of WC and WHtR to BMI, but did not find any additional benefit in measuring height 
as well as WC (80). The pooled relative risks of type 2 diabetes were 1.62 (95%CI: 1.48, 1.78) 
for WHtR, 1.63 (95%CI: 1.49, 1.79) for WC and 1.55 (95%CI: 1.43, 1.69) for BMI. Therefore, 
although WHtR might be slightly better than WC in predicting diabetes, its superiority, and 
therefore clinical utility, has not been completely proved. 
1.5.3 Physiological mechanisms  
The connection between obesity and type 2 diabetes encompasses a complex interplay of 
mechanisms, which are still been elucidated. These mechanisms mainly involve pro-
inflammatory cytokines, disrupted fatty acid metabolism and cellular processes, such as 
mitochondrial dysfunction (85).  
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Increasingly, type 2 diabetes has been viewed as an autoinflammatory disease (86). It is now 
well-known that obesity is characterised by a state of low-level chronic inflammation, due to the 
pro-inflammatory molecules produced by adipocytes and immune cells within adipose tissue 
(15). Over-feeding, particularly excess free fatty acids and glucose, stresses adipose tissue 
leading to an abnormal production of cytokines and chemokines, such as tumour necrosis factor 
and interleukin-1β (86). In turn, the release of these inflammatory mediators in the circulation 
induces inflammation in other tissues, including islet β-cells. Increased tissue inflammation 
activates intracellular pathways that lead to the development of insulin resistance (87). 
Another important mechanism linking obesity to type 2 diabetes is the increase in circulating 
lipids (hyperlipidemia) typical in obesity. Increased ectopic fat deposition (the storage of 
triglycerides outside adipose tissue) in the liver and skeletal muscles can induce peripheral IR 
by interfering with cellular functions (88); while the toxic effect of free fatty acids on the 
pancreas can contribute to -cell dysfunction (19). Excess fat storage can also lead to larger 
adipocytes, which are more resistant to the effect of insulin (14). 
It is important to note that not all obese people develop type 2 diabetes. It is probable that an 
interaction between genetic and environmental cues might cause adipose tissue dysfunction, 
with associated adipocyte hypertrophy, heightened inflammatory reactions and consequent 
pathologic ectopic fat accumulation (89). 
As noted above, the negative effects of abdominal adiposity are mainly explained by visceral fat 
rather than subcutaneous fat. Visceral fat is mostly stored around the abdomen while 
subcutaneous fat is more common in peripheral fat accumulation. Visceral fat tends to increase 
with age and is more prominent in men and post-menopausal women (90). Compared with 
subcutaneous fat, visceral fat is more lipolytic, which means that stored lipids are broken down, 
and FFA are released in the circulation, more easily (91). FFA released by abdominal depots 
enter the liver directly, and thus are a major contributor to liver IR as well as systemic IR (11). In 
addition, the overproduction of cytokines and hormones released by adipose tissue is more 
pronounced in visceral obesity compared to peripheral obesity (90). 
The larger effect of abdominal fat on type 2 diabetes risk for women compared to men is not 
entirely clear. It is thought that hormonal differences affecting fat distribution might play a role in 
the sex difference of relative risk (92). Women have on average larger hips reflecting higher 
peripheral subcutaneous fat stores. It is possible that women with a more masculine body 
shape characterised by higher central adiposity, might have higher metabolic risk because of 
both the decreased protective effect of peripheral fat and the diabetogenic effect of abdominal 
fat (75). 
1.6 Life course epidemiology of body weight, fat distribution and type 2 
diabetes 
Life course epidemiology has been defined as the study of the long-term effects of biological or 
social exposures that act during early life, childhood, adolescence and adulthood on later health 
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or disease risk (93). Interest in the life course aetiology of chronic diseases has increased in the 
last decade. A range of models have been proposed to investigate how different factors affect 
later disease risk by interacting and accumulating over the life course. Three life-course models 
of growth and weight gain might be of particular relevance for future risk of type 2 diabetes (93). 
The first is the critical period model, underlying the concept of fetal programming of disease, 
which argues that impaired fetal growth during a certain window of time can impact irreversibly 
on birth weight and subsequently on diabetes risk (94). In an accumulation of risk model the 
duration of overweight or obesity is hypothesised to increase diabetes risk independently of the 
degree of obesity. The model of sensitive period hypothesises that the risk of diabetes might be 
higher if weight is rapidly gained during certain periods of the life course compared to others.  
1.6.1 Critical period model: birth weight and early growth 
The concept of foetal programming of disease refers to a process whereby events affecting the 
development of the fetus at certain critical periods can have later life repercussions on disease 
outcome (94). So far, the interest in foetal programming has mainly focused on the effect of 
malnutrition on birth weight, as a crude marker of foetal growth. It is now well established that 
low birth weight is associated with increased risk of type 2 diabetes in a wide range of 
populations (95, 96). In a recent systematic review of 31 studies including a total of 6090 
diabetes cases, Whincup et al (96) found a combined OR for type 2 diabetes of 0.80 (CI, 0.72-
0.89) per 1-kg increase in birth weight. This association was independent of socio-economic 
circumstances and adult BMI, both possible confounders. There was a strongly graded inverse 
relationship between birth weight and diabetes, particularly for birth weights lower than 3kg. For 
birth weights larger than 4kg there was a modest positive association between birth weight and 
type 2 diabetes, which might be a consequence of gestational diabetes-related macrosomia 
(97). This was particularly evident in native North Americans among whom the birth weight-type 
2 diabetes relationship was strongly U-shaped. The authors suggested that the high level of 
maternal diabetes among these populations was associated with high birth weight and 
subsequently diabetes.  
1.6.1.1 Physiological mechanisms 
According to the thrifty phenotype hypothesis proposed by Barker and colleagues (98) maternal 
malnutrition, which diminishes nutrients supply to the foetus, can trigger foetal metabolic 
adaptations in order to spare vital organs and increase the chances of survival in an 
environment with limited nutrient supply. These adaptations could lead to reduced β-cell mass 
growth and permanent changes in the metabolism of glucose (98). The evolutionary advantages 
of this adaptation have negative consequences when the individual grows up in an environment 
with abundant nutrient supply (98). As well as growth in utero, weight gain and growth in early 
life have been linked to diabetes risk (99). The normal body weight curve of infants is 
characterised by fast growth during the first year of life, followed by a slow-down for a few years 
and a second phase of rapid weight gain (100). The timing of this second phase, termed 
adiposity rebound has been linked to type 2 diabetes and adult obesity (100). Children with a 
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younger age at adiposity rebound, particularly if they were born small, have a higher risk of 
being glucose intolerant in adulthood (101). Using dual-energy X-ray absorptiometry, Taylor and 
colleagues showed that early adiposity rebound is characterized by rapid and larger gains in fat 
tissue compared to late adiposity rebound (102). Therefore this early rapid gain of adiposity 
might underlie a predisposition to higher glucose intolerance in adulthood. 
1.6.2 Accumulation of risk model: duration of obesity 
Although there is abundant evidence linking excess weight with type 2 diabetes, most studies 
have focused on the degree of obesity using only one BMI measurement to assess obesity 
status. However, the duration of obesity (or overweight) could be an important risk factor for 
type 2 diabetes independent of the degree of obesity, as it has been suggested by a few 
prospective studies (103-107). It has been hypothesised that being obese for longer might affect 
diabetes risk by way of progressively reducing insulin resistance and -cell function (104). 
However, the exact mechanism is not clear. In a population of Pima Indians the incidence of 
diabetes among people who had been obese ≥10 years was twice as high as that in people who 
had been obese <5 years, independently of current BMI (105). Data from the British Regional 
Heart Study (107) showed that, compared with normal weight category, men who had been 
severely overweight (BMI=28-29.9 kg/m
2
) for ≥5 years had a higher diabetes risk (4.74, 95%CI: 
2.99-7.51) than those who had been severely overweight for <5 years (2.68, 95%CI: 1.50-4.81). 
The risk associated with ≥5 years of obesity was even higher (8.04, 95%CI: 5.06-12.74 for 
obesity >5 years and 4.36. 95%CI: 1.33-14.28 for obesity <5 years). In this study however only 
the initial BMI was based on measured weight and height, while the follow-up values were self-
reported. In the Framingham Heart Study (103) the risk of type 2 diabetes for men increased by 
11% for each additional 2 years of obesity after adjustment for current BMI. In women the risk 
increased for duration of 5-14 years compared to less than 5 years but did not change further 
for longer durations. These studies only looked at adult-onset of obesity. Recent findings from 
the 1958 birth cohort showed that, compared to never being obese, long-term obesity from 
childhood was associated with more than 20-fold increased risk of elevated HbA1c at age 45 
years (106). Those who became obese in mid-adulthood had a three-fold increased risk. These 
associations were mostly explained by the higher BMI attained after a longer duration of being 
obese and were greatly weakened after adjustment for current BMI. Similar trends were found 
with longer durations of overweight, although the relative risks were smaller than for obesity 
duration. 
Recently two studies have evaluated the combined effect of degree and duration of excess 
body weight on type 2 diabetes, using a composite measurement in a similar way to how “pack-
years” is used to asses the cumulative exposure to cigarette smoking (108, 109). The first study 
(109) was conducted among adolescents and young adults (at the start of the study) with a 
mean follow-up of 25 years. Excess BMI-years, an index calculated by summing the differences 
between the reference BMI (25 for adults or 85th percentile for adolescents) and the observed 
BMI for each data collection year, was associated with increased type 2 diabetes risk. As an 
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example the authors reported that the odds of type 2 diabetes for a white 40 years old man with 
200 excess BMI-years was 2.94 (95%CI: 2.36-3.67) compared with a similar aged white man 
with 100 excess BMI-years. Using ROC curves, the model containing excess BMI-years was 
more predictive of type 2 diabetes risk than baseline BMI. For the same BMI-years the risk was 
higher for younger adults, which led the authors to suggest that prevention interventions might 
be more effective at a younger age. The second study (108) analysed a similar index of duration 
and degree of obesity, which the authors termed Cumulative Excess Weight, in a sample of 
adult people followed-up from their mid-thirties to mid-fifties. For each standard deviation 
increase in Cumulative Excess Weight the odds of type 2 diabetes was 1.99 (95%CI: 1.64-2.40) 
independent of other risk factors for diabetes, age and sex. However, once stratified by baseline 
BMI, the association was significant only in people with a normal BMI.  
Overall the evidence suggests that the duration, as well as the degree of obesity is important in 
type 2 diabetes risk. However, only a few prospective studies have investigated duration of 
overweight or obesity longer than 15 years (105, 106, 108, 109) while some used self-reported 
BMI measures (107, 109). Therefore more studies are needed on the cumulative effect of 
obesity particularly for longer durations and earlier onsets, given the increasingly younger age 
of obesity onset. 
1.6.3 Sensitive period model  
Accelerated gains in weight and BMI during childhood, particularly in children with low birth 
weight and early adiposity rebound, have been associated with higher glucose intolerance and 
increased risk of type 2 diabetes in adulthood (99, 101). In a Finnish study people who 
developed type 2 diabetes in adulthood had faster BMI growths between age 7 and 15 years 
(99). Bhargava et al (101) found similar results in an Indian population where for 1 standard 
deviation (SD) increase in BMI between age 2 and 12 years the odds ratio of developing 
diabetes was 1.26 (95%CI: 1.08-1.48) after adjustment for adult BMI.  
Many studies have found that weight gain in adult life (107, 110-115) increases the risk of type 2 
diabetes. For example, in the Health Professionals Follow-up study, the risk increased by 7.3% 
among adult men for each kilogram of weight gained (113). However, it is still not clear whether 
there are periods over the life-course when weight gain is particularly detrimental for diabetes 
risk and glucose tolerance. The majority of studies investigated weight gain at different periods 
over the adult life (110, 113-116); these studies mainly found that weight gain during early 
adulthood has a stronger impact on later type 2 diabetes risk than weight gain in middle or late 
adulthood. It has been suggested that people with a higher susceptibility to develop type 2 
diabetes, such as those with a specific genotype, might tend to gain weight early in adulthood 
(116). Alternatively, the stronger association of diabetes with BMI gains in earlier rather than in 
later adulthood might be explained by the longer exposure to cumulative excessive body weight 
(115). 
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A recent analysis of the 1958 birth cohort study (106) extended the investigation of sensitive 
periods of weight gain to encompass both childhood and adulthood. The authors analysed the 
association between BMI gain during multiple life-course periods (birth-7 years, 11-16 years 16-
23 years, 23-33 years, 33-45 years) and HbA1c levels adjusting for BMI at the beginning of 
each period. Weight gain at any period was associated with increased risk of hbA1c>7, 
particularly at age 23-33. When attained BMI was taken into account however, associations 
between weight gain during adulthood and hbA1c were mainly explained by attained BMI, while 
associations with weight gain from birth to age 7 were independent of attained BMI.  
Thus, although some evidence suggests that both early childhood and early adulthood weight 
gain might be more detrimental for future diabetes risk, further life course analyses are needed 
to confirm these findings. 
1.6.4 Changes in abdominal obesity 
Many studies have reported that abdominal fat is a strong predictor of incident diabetes (67-72). 
However, changes in WC and other measures of abdominal fat over the life course have not 
been studied extensively. In the Health Professionals Follow-up Study (113), changes over 9 
years of WC and waist to hip ratio were strongly associated with type 2 diabetes among older 
adult males. However, when controlling for weight change the association was weak (RR: 1.7, 
95%CI: 1.0, 2.8 comparing the highest with the lowest quintile) and only significant for 
substantial WC changes (>14cm). Anthropometric measurements were self-reported, which 
might have underestimated the results (117). In the Coronary Artery Risk Development in 
Young Adults Study 15-years changes in WC were associated with increased insulin resistance 
and diabetes incidence although no adjustment for BMI was attempted (118). The most recent 
study of WC changes and diabetes was an analysis of more than 35,000 men and women in the 
Danish Diet, Cancer and Health study (119). Although WC at baseline was a strong predictor of 
diabetes independently of BMI, 5-years changes in WC were only weakly associated with risk in 
women (HR: 1.09, 85%CI: 1.04, 1.15, per 5 cm change in WC) after adjustment for body weight 
and no association was found among men.  
The paucity of studies on longitudinal changes in abdominal obesity may reflect the fact that not 
all studies collected waist measurements until the importance of this risk factor for type 2 
diabetes was fully recognized. 
1.7 The Diabetes Prevention trials 
In the last decade a number of randomised controlled trials (57-62) have demonstrated that 
lifestyle interventions aimed at reducing weight, improving diet and increasing physical activity, 
can prevent or delay the development of type 2 diabetes in high risk subjects. Furthermore, 2 
trials (57, 60) showed that lifestyle interventions were more effective than the antidiabetic 
treatment metformin, a glucose-lowering drug, at reducing diabetes risk. There is also evidence 
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of the lasting benefits of lifestyle interventions even after the intervention has stopped (120-
122).  
One of the first diabetes prevention trials was the multi-clinic China Da Qing Diabetes 
Prevention Study (59), which randomised 577 IGT men and women to either a control, diet, 
exercise, or a diet with exercise group. All interventions were similarly effective with a diabetes 
risk reduction of up to 46% compared with the control group after 6 years of follow-up. 
Participants assigned to the diet group were prescribed a balanced macronutrient intake (55-
65% carbohydrates and 25-30% fat) and encouraged to consume more vegetables and reduce 
intake of simple sugar. Those overweight were also recommended to reduce their caloric intake. 
A subsequent trial, the Finnish Diabetes Prevention Study (62) randomised 522 high-risk 
subjects (middle age, overweight and with IGT) to either an intensive diet and exercise 
intervention or a control group. Participants in the intervention group were advised to lose 
weight, to limit their intake of total fat to <30% energy intake and saturated fat to <10% energy 
intake, and to increase their fibre intake to >15g/1,000 kcal. After a mean follow-up of 3.2 years, 
the intervention group had a reduced diabetes risk of 58% compared to the control group. The 
same risk reduction of 58% was also achieved in the United States-based Diabetes Prevention 
Program (57). This study is the largest diabetes prevention trial to date with over 3200 
participants randomised to receive a lifestyle intervention, metformin or placebo with an average 
follow-up of 2.8 years. The dietary intervention of this trial was particularly focused on fat 
reduction and calorie restriction with emphasis on overall healthy eating. 
Three further trials have been conducted among Asian populations. In a Japanese trial of 458 
men (58), the diet and exercise intervention was aimed specifically at reducing weight and 
included advice on fat and portion size reduction and emphasis on vegetables. After 6 years of 
follow-up the risk reduction for diabetes was 67% compared to the control group. In the Indian 
Diabetes Prevention Programme (60) the lifestyle intervention group, which received advise on 
diet and exercise, had a reduced risk of diabetes of 28% compared with the control group. 
Participants in the intervention group were recommended to balance their energy intake and 
expenditure, avoid simple sugars and refined carbohydrates, reduce total and saturated fat 
intake and increase consumption of fibre-rich foods (whole grains, fruits, vegetables and 
legumes). In a very recent trial (61) of 641 overweight Japanese men, lifestyle modification that 
included physical activity and dietary advice, reduced type 2 diabetes incidence by 41% in 
subjects with IGT, although it was not effective among IFG participants. The dietary intervention 
included recommendations to maintain fat intake at 20-25% of total energy intake and 
carbohydrate intake at 55-60% of total energy intake as well as increasing fibre intake.  
Although most interventions had positive effects on BMI and WC, there were wide variations 
among studies. In the Finnish Diabetes Prevention Study, the Diabetes Prevention Program and 
the Japanese trials the authors concluded that weight loss was the main driver of reduced 
diabetes incidence. However, the Diabetes Prevention Program and the Japanese studies were 
not designed to assess the independent effect of diet and exercise. Also, subsequent analyses 
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of the Finnish Diabetes Prevention Study found that composition of the diet was a predictor of 
lower diabetes incidence independently of BMI changes (123). In the China Da Qing Diabetes 
Prevention Study and the Indian Diabetes Prevention Programme weight loss was not 
substantial and not significantly different between control and intervention groups, suggesting 
that other mechanisms must have been important in reducing diabetes incidence (59, 60). In all 
Asian trials weight loss was not as high as in Western trials, suggesting that in Asian 
populations, which have a stronger genetic predisposition to type 2 diabetes, overall weight gain 
might not be as important as for Western populations. Differences in visceral fat are not properly 
captured by BMI or body weight. Thus changes in body composition might have been important. 
However, in the Indian Diabetes Prevention Programme changes in WC were also not 
significantly different between the control and the intervention groups.  
1.8 Dietary factors and type 2 diabetes 
Dietary factors are likely to play an important role in the prevention of type 2 diabetes both 
directly by affecting metabolic pathways and indirectly via body weight modulation. There is 
agreement that healthy eating advice is a key element of current preventive intervention 
strategies (124).  
One of the main challenges in the study of diet-disease associations is the measurement of 
habitual food consumption. The major difficulties involved are in the accurate estimation of the 
quantity of foods habitually consumed by individuals and in the estimation of nutritional and 
energy intakes based on self-reported food intakes (125). Different methods can be used to 
assess diet; these are usually categorised into those that record intake as it occurs, such as diet 
diaries either based on weighted or estimated records, and those based on recall of dietary 
intake, such as 24-hour recall and food-frequency questionnaires (FFQ). By far the most 
commonly used methods in nutritional epidemiology are recall methods, particularly FFQs, 
which are a relatively inexpensive and standardized way to obtain dietary information from a 
large sample. The disadvantages of FFQs however are the lack of detailed information and the 
large measurement error (126). In contrast, the dietary record method is more precise and is 
often considered as the gold standard. However, this method is more costly and therefore is 
seldom used in large studies; furthermore, it can be burdensome for study members, especially 
when weighted quantities are used, and therefore can lead to changes in their habitual eating 
behaviour (127). 
Despite the difficulty of assessing diet in the population a growing amount of data suggests a 
significant protective role for some dietary factors, especially low glycaemic index (GI) foods and 
dietary fibre and a detrimental role for foods high in total and saturated fat. 
1.8.1 Glycaemic index and glycaemic load 
The quantity and quality of carbohydrates in food have important metabolic effects. 
Carbohydrates that more rapidly increase insulin and glucose levels seem to have more 
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detrimental effects on metabolic health compared to slowly digested ones (128). The GI, 
introduced by Jenkins et al in 1981 (129), measures the magnitude of change in blood glucose 
levels (the glycaemic response) after the ingestion of different digestible carbohydrate-
containing foods. The GI is calculated by comparing, in the same individual, the post-prandial 
glycaemic response of a food to the glycaemic response after intake of the same amount of 
carbohydrate in a reference food, which is either glucose or white bread (129). The type of 
starch, level of gelatinisation, cooking methods and the amount of fibre, protein and fat affect 
digestion and the GI of foods (130). The glycaemic load (GL) is the product of the GI of a food 
and its carbohydrate content (131). 
After a high GI meal blood glucose levels increase rapidly and consequently induce a large 
insulin response. Hyperinsulinaemia triggers faster nutrient absorption, leading to a quicker late-
postprandial fall in blood glucose than would be observed with a slower release of insulin (132). 
The consequent hypoglycemia triggers an elevated counter-regulatory hormone response, 
which restores blood glucose levels by increasing endogenous glucose production (133). At the 
same time these hormones induce breakdown of stored fat increasing circulating levels of FFA 
(133), which as already mentioned can promote insulin resistance and -cell dysfunction. High 
GI-induced postprandial hyperglycaemia could also directly affect -cell functions because of 
the glucotoxic effect of excess glucose on pancreatic cells (132). Low-GI foods have positive 
effects on satiety leading to lower energy intake at a subsequent meal (134). A review of 
randomized trials reported that participants consuming a low GI diet lost an average of 1kg 
more compared to high GI diets or energy-restricted low-fat diets (134). Finally there is some 
evidence that high GI foods could lead to preferential visceral fat accumulation (135, 136). 
Most studies on GI and type 2 diabetes have shown a protective effect of low GI diets. In the 
Health Professionals Follow-up Study (137) the relative risk of type 2 diabetes was 1.37 
(95%CI: 1.02, 1.83) comparing the highest with lowest quintile of GI. A similar risk estimate for 
GI (RR: 1.37; 95%CI: 1.09, 1.71) and GL (RR= 1.47; 95%CI: 1.16-1.86) was found among 
middle-aged women in the Nurses Health Study (131). Similar results were confirmed in other 
large cohorts, particularly among American, Australian and Asian cohorts (138-144). The 
evidence is stronger for GI than for GL, with a few studies finding associations with GI but not 
for GL (141, 142). All these studies adjusted for major confounders, including social 
confounders, physical activity, smoking and BMI. However, a few studies showed only 
moderate or no effect for GI or GL and type 2 diabetes (145-147). The discrepancies in findings 
could be due to the use of different dietary questionnaires, most of which were not designed to 
capture dietary GI or GL. Other explanations include differences in the range of GI and GL 
across populations and different genetic responses to GI. Inconsistencies in assignment of GI 
values to different foods might have also contributed to these contradictions. Most of the data 
tables used to assign GI values are currently from the United States and Australia, where the 
interest in GI has been stronger. Few European and country-specific GI tables exist, which 
might explain the null results in a large European cohort (146). 
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Two meta-analyses have tried to address these discrepancies. A meta-analysis of nine 
prospective cohort studies (148) reported that both high GL and high GI diets increase the risk 
of type 2 diabetes with a relative risk of 1.27 (95 % CI 1.12, 1.45) and 1.40 (95 % CI 1.23, 1.59) 
respectively when comparing the highest versus the lowest quintiles. The meta-analysis was 
performed using adjusted models (including adjustment for age, sex, SEP, family history of 
diabetes, BMI, physical activity and dietary fiber). A subsequent meta-analysis (149) of 13 
studies confirmed the protective effect but reported lower risk estimates for GI (RR: 1.16; 
95%CI: 1.06, 1.26) or GL (RR:1.20; 95% CI: 1·11, 1·30). Furthermore, a Cochrane review of 11 
randomized trials on GI or GL diets among diabetic patients showed a reduction of 0.5% in 
HbA1c levels in subjects consuming a low GI diet. (150). Thus the evidence points to a role for 
GI in managing as well as preventing type 2 diabetes, although a few discrepancies remain, 
mainly due to the methodological challenges of assigning GI values. 
1.8.2 Dietary fibre 
Dietary fibre is the term for a complex mixture of substances with variable physiological and 
chemical properties. Generally dietary fibre has been defined as non-digestible carbohydrates, 
referring to carbohydrates that resist digestion in the small intestine and are partially fermented 
in the large intestine (151). They consist of non-starch polysaccharides, which are part of the 
plant cell wall, such as cellulose, hemicellulose and pectin, as well as other polysaccharides, 
such as gums and oligosaccharides (152). Based on physical and chemical properties, fibre can 
be subdivided into soluble fibre, which dissolves in water, and insoluble fibre. Some soluble (or 
viscous) fibres are able to form gels when dissolved in fluid (153). Dietary fibre is fermented by 
bacteria in the large intestine to a varying degree depending on the type of fibre. These varied 
characteristics of dietary fibre are involved in different physiological mechanisms, which confer 
distinctive health benefits. Dietary fibre is abundant in cereals, fruit and vegetables, which 
contain a mixture of different types of fibre.  
Several possible mechanisms have been proposed for the protective effect of dietary fibre. 
Fibre-rich foods have a lower GI, which results in lower glucose and insulin responses (129). 
Dietary fibre’s low energy density and large volume promote satiation leading to decreased 
energy intake (154). A review of 38 studies showed that dietary fibre also increased satiety 
between meals (155). The effect of dietary fibre on satiety is due to its mechanical stimulation of 
the intestine and its action on appetite-related intestinal hormones (156). Results from the large 
EPIC study found that fibre intake was associated with higher weight loss and WC changes 
(135).  
The anti-inflammatory properties of fibre have also been shown in molecular and human studies 
(157-159). Some types of dietary fibre are fermented by bacteria in the gut, resulting in the 
production of short chain fatty acids (159). These have anti-inflammatory effects that are 
modulated by a wide range of cellular mechanisms, including reduced expression and 
proliferation of inflammatory mediators (157). In the Finnish Diabetes Prevention Study dietary 
fibre intake lowered the levels of C-reactive protein and interleukin 6, two markers of 
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inflammation linked with type 2 diabetes, independently of changes in BMI (160). Improvement 
of first-phase insulin secretion in at-risk people has also been reported in a recent trial (161). 
High consumption of dietary fibre and whole grain foods, which are a rich source of fibre, has 
consistently been associated with decreased risk for type 2 diabetes in several prospective 
epidemiological studies (131, 137, 142, 145, 147, 162). In the Iowa Women's Health Study 
(145), the risk for type 2 diabetes was reduced by 22% in women consuming an average 26 g/d 
of dietary fibre. In the Nurses Health Study II (142) the risk reduction was particularly strong for 
cereal fibre with a RR of 0.64 (95% CI: 0.48, 0.86) comparing the highest with the lowest 
quintile of intake. Both these large studies reported effects independent of BMI as well as other 
social and health confounders. Similarly, in a Finnish cohort (163), fibre from cereal, was 
significantly associated with the risk of type 2 diabetes (RR: 0.36 (95% CI: 0.18, 0.70) 
independent of BMI, while total dietary fibre had a weaker association. A Cochrane systematic 
review reported significant risk reductions ranging between 0.37 (95%CI: 0.20-0.77) and 0.79 
(95%CI: 0.67-0.93) with high intake of cereal fibre (164). The difference in risk reductions was 
probably due to the difference range of confounders adjusted for in the various studies; while all 
studies adjusted for age, sex and BMI not all adjusted for physical activity, SEP and family 
history of diabetes.  
In the diabetes prevention trials increased fibre consumption was part of the dietary intervention 
that reduced diabetes incidence. Post-hoc analyses in the Finnish Diabetes Prevention Study 
(123) showed that increased fibre intake was associated with reduced type 2 diabetes risk and 
waist circumference independently of weight changes.  
Although prospective studies show that insoluble fibre, which is mainly found in cereals, are 
more protective than soluble fibre, found in fruit and vegetable as well as some cereals, 
intervention trials have mainly focused on the ability of soluble fibre to acutely reduce glycaemia 
and insulin responses (165). However, long-term beneficial effects on insulin sensitivity of both 
soluble and insoluble fibre have also been reported (166, 167). It is probable that a mixture of 
different types of fibre offers the most beneficial effect. 
1.8.3 Dietary fat 
Dietary fat is an important nutrient in the human diet. Dietary fats comprise triglycerides (fats 
and oils), phospholipids, and sterols (cholesterol). Triglyceride, which is broken down to fatty 
acids, is the most abundant type of fat in the diet. Depending on the presence or absence of 
double bonds on the carbon chain, fatty acids can be classified into saturated (no double bond), 
monounsaturated (one double bond) and polyunsaturated (two or more double bonds) fatty 
acids (168). The latter includes the essential fatty acids alpha-linolenic acid and linoleic acid, 
which cannot be synthesized from the body and are important in many cellular functions and 
their anti-inflammatory properties. Dietary fat is used as an energy source and storage in the 
body as well as for insulation and protection from external insults. It also facilitates absorption of 
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fat-soluble vitamins in the body as well as giving palatability and acting as a flavor carrier in 
foods (168). 
On average, cross-sectional (169-171) and prospective studies (172-174) have found that high 
fat diets, are associated with impaired glucose tolerance and the onset of type 2 diabetes. In 
some studies the association between total fat was independent of BMI (172, 173). Some 
studies however did not find an association between dietary fats and type 2 diabetes (51, 137). 
These discrepancies could be attributed to the variability of the dietary assessment method as 
well as the susceptibility of fat and high-energy foods to be underreported from obese people 
(175). Lately it has been shown that metabolic response to dietary fat intake is highly dependent 
on genetic susceptibility (176). In a recent analysis of the Data from an Epidemiological Study 
on the Insulin Resistance Syndrome (177) a high fat diet was a significant predictor of type 2 
diabetes, independent of BMI, only among certain genotype carriers. This genetic and 
nutritional interaction effect for dietary fat might explain why some studies did not find an 
association in the general population. 
Intervention studies aiming at preventing type 2 diabetes in at-risk individuals have 
demonstrated that a low-fat diet was successful at reducing body weight and type 2 diabetes 
(59, 121, 122, 178). In the Diabetes Prevention Program the largest dietary association with 
type 2 diabetes incidence was seen for total fat intake (178). Participants in the lifestyle 
intervention group of the Diabetes Prevention Program decreased their percent of calories from 
fat by 6% compared to 0.8% in the control groups. For every 5% reduction of percent calories 
from fat there was a reduced type 2 diabetes incidence of 25% during the follow-up period. 
However, the effect of dietary fat was mainly explained by its strong association with weight 
loss. In post-hoc analyses of the Finnish Diabetes Prevention Study dietary fat was a significant 
predictor of weight loss and reduced progression to type 2 diabetes (122). Comparing the 
highest quartile of fat intake with the lowest, the hazard ratio for type 2 diabetes incidence 
during 4.1 years of follow-up was 2.14 (95% CI: 1.16, 3.92) after adjustment for sex, 
intervention assignment, weight change and physical activity.  
The main link between total dietary fats and type 2 diabetes seems to be the promotion of 
excess body weight, as suggested by the literature. Fats are high in energy density and very 
palatable, leading to overconsumption (179). Prospective studies and intervention trials support 
the connection between lower dietary fat intake and weight loss (180-182). A systematic review 
of intervention trials confirmed that low-fat diets are associated with significant and sustained 
weight loss (183). There is also evidence that dietary fats can induce inflammatory cytokine 
production (184), which promote insulin resistance. It has been shown that following a single 
high-fat meal concentrations of inflammatory mediators were higher and levels of anti-
inflammatory adiponectin were lower (185).   
There is increasing evidence that the type of fatty acids consumed, as well as the quantity, 
might play an important role in -cell functionality and insulin sensitivity, particularly during the 
postprandial period (186). Consistently, observational studies have found that saturated fatty 
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acids (SFA) increase hyperinsulinaemia and risk of developing metabolic diseases, while 
unsaturated fats, particularly monounsaturated fatty acids (MUFA) and to a lesser extent 
polyunsaturated fatty acids (PUFA), improve insulin sensitivity and glycaemic control (187, 188). 
Intervention studies report that decreasing the proportion of SFA in the diet improves insulin 
sensitivity, glycaemic control, -cell function and insulin secretion (189-191). A recent 
systematic review of 9 randomized controlled trials with a duration ranging between 6 and 48 
months found that diets high in MUFA and low in SFA were more effective at reducing HbA1c in 
patients with abnormal glucose metabolism than diets low in MUFA (192).  
Different mechanisms can explain the metabolic effects of MUFA and SFA. Compared to 
MUFA, SFA are known to induce higher insulin secretion in the pancreatic  cells, with 
consequent postprandial hyperinsulinaemia (189). Evidence from animal studies has shown that 
SFA have the ability to disrupt insulin signaling pathways in skeletal muscles thus contributing 
to insulin resistance (193). On the other hand, MUFA do not interfere with signaling pathways. 
Another potential mechanism is the observation that some SFA preferentially facilitate visceral 
fat deposition (194). Finally, while SFA have been reported to increase markers of inflammation, 
MUFA seem to have anti-inflammatory effects (195). 
1.8.4 Other dietary factors 
Other dietary factors that are purported to reduce type 2 diabetes risk include antioxidants, 
phenolic compounds, magnesium and moderate alcohol intake (196, 197, 200). However, for 
any of these factors, more evidence, particularly from controlled trials, is needed to draw valid 
conclusions. Fruit and vegetables are one of the richest sources of dietary antioxidants. They 
are also low in energy density and high in insoluble fibre; therefore they may help prevent 
weight gain as well as reduce inflammatory responses and oxidative stress (196, 197). A recent 
systematic review of prospective cohort studies reported that green leafy vegetables, but not 
fruits or vegetables in general, were associated with a modest reduced risk of type 2 diabetes 
(198). However, the studies included in the review had a high level of heterogeneity, caused by 
differences in food classification and dietary assessment methods. Thus, the evidence on 
specific fruits and vegetables from available studies remains inconclusive. 
Evidence is emerging that moderate amount of alcohol could lower type 2 diabetes risk (199). 
Although the mechanisms are not completely understood, alcohol is known to improve insulin 
sensitivity through different pathways, including elevation of adiponectines and reduction of pro-
inflammatory compounds (200).  
A recent meta-analysis reported a U-shaped association between alcohol consumption and 
incidence of the disease (199). Compared to non-drinkers men who consumed moderate 
amounts of alcohol (22g/day) had a relative type 2 diabetes risk of 0.87 (95%CI: 0.76-1.00); the 
corresponding RR for women with a moderate alcohol intake (24g/day) was 0.60 (95%CI: 0.52–
0.69). Alcohol started to become deleterious at intakes above 60g/day for men and 50g/day for 
women, although there was more uncertainty regarding the deleterious effect of heavy alcohol 
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intake. Most of the studies included adjusted only for age and sex. Half of the studies adjusted 
for BMI and two adjusted for education. Moderate alcohol consumption is more common among 
people from high SEP (201), thus the lack of adjustment for SEP might have confounded the 
results.  
Phenolic compounds, of which coffee, tea and red wine are rich sources, have been reported to 
reduce postprandial glycaemia and improve insulin sensitivity (202).  A recent systematic review 
of observational studies reported that high intakes of tea and coffee were associated with 
decreased type 2 diabetes risk (203). The association was not affected by adjustment for age, 
family history of diabetes, BMI, SEP, smoking, alcohol and physical activity. However, small-
study bias might have overestimated the results. Also, very few studies adjusted for other 
dietary factors, thus residual confounding by dietary factors associated with tea or coffee 
consumption might still be possible.  
Magnesium deficiency could disrupt insulin-signaling pathways leading to decreased insulin 
sensitivity (204). A recent meta-analysis of cohort studies reported a modest diabetes risk 
reduction for high magnesium intakes, but this was significant only among overweight subjects 
(205). Few studies examining magnesium intake and type 2 diabetes risk adjusted for other 
dietary factors and specifically for dietary fibre, which is highly correlated with magnesium; thus 
confounding by other dietary factors is possible. 
Although moderate alcohol intake, high coffee and tea intake and magnesium consumption 
have increasingly been recognised as possible type 2 diabetes protective factors, more studies, 
especially large cohorts or randomised controlled trials are necessary to draw confident 
conclusions. 
1.8.5 Limitations of studies investigating single dietary factors 
The traditional approach to the study of the relation between diet and disease has been to focus 
on single nutrients and foods. However this approach has several limitations. For example, it 
does not account for the fact that foods and nutrients are not eaten in isolation, but rather in 
different combinations that can interact with each other (206). Many nutrients in the diet are 
strongly correlated, making it difficult to study their separate effects (207). Another limitation is 
that the effect of single nutrients might not be large enough to be detected, but the cumulative 
effect of multiple nutrients or foods can be significantly greater (208). 
1.9 Dietary patterns and type 2 diabetes  
Because of the limitations of a single nutrient approach, dietary pattern analyses have been 
introduced as an alternative method of studying associations between diet and chronic disease 
and have acquired increasing popularity in the past two decades. This method approaches diet 
in a more holistic way; thus it might better reflect the actual dietary habits in free-living people, 
where foods are consumed together (206). It also overcomes the problem of collinearity and 
interactions between nutrients since potential dietary confounders are incorporated into the 
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dietary pattern (209). Furthermore cumulative effects of certain combinations of foods might be 
stronger than the effects of single foods and nutrients (210). 
1.9.1 Methodologies used to derived dietary patterns 
Two main approaches have been used for the study of dietary patterns in nutritional 
epidemiology: theoretically and empirically derived dietary patterns. The first approach defines 
dietary patterns ’a priori’ using current knowledge of nutritional health (211). By contrast, the 
second approach uses statistical models to derive intake patterns from existing dietary data and 
involves mainly an ‘a posteriori’ interpretation. An emerging empirical method, called reduced 
rank regression, uses a combination of ‘a priori’ and ‘a posteriori’ methods (209). 
1.9.1.1 Theoretically defined dietary patterns: Diet quality scores 
Diet quality scores consist of foods or nutrients that are thought to be healthy and are quantified 
and grouped into an overall measure of diet quality (212). Dietary recommendations, guidelines 
and current knowledge of health have been used to create indexes and scores. A critical review 
identified 20 different scores of diet quality in the published literature, mostly based on 
variations of four main scores (212). Among these, the Healthy Eating Index (HEI) (213), the 
Mediterranean Diet Score (MDS) (212) and their variations have been most extensively 
investigated. The HEI is a score made up of 10 components based on the Dietary Guidelines for 
Americans. The MDS was created following considerable epidemiological interest in the health-
protective benefits of Mediterranean diets. Keys first popularized the term “Mediterranean diet” 
in the 1960s based on the food habits of some Mediterranean populations (214). The MDS and 
its variations include plenty of plant foods, such as vegetables, fruits, legumes, nuts and 
cereals, the use of olive oil (which contains a high proportion of MUFA) as the main source of 
fat, low intake of red meat and moderate wine consumption, preferably at meals (215). 
The strengths of diet quality scores are their simplicity and the good reproducibility (207). This 
method has also several limitations. For example, investigating the Mediterranean diet in a non-
Mediterranean population might not be useful as very few people will adhere to this dietary 
pattern. The validity and usefulness of dietary scores in predicting disease risk have also been 
questioned (212). Because they are not created to predict health outcomes but rather 
adherence to a certain guideline or recommendation, existing dietary scores might not be 
relevant for certain diseases. Furthermore there are major difficulties in devising diet quality 
indices. Subjectivity can be a problem, as the investigator has to make several decisions, for 
example regarding cut-offs of intakes and weighting of different foods included (207). 
1.9.1.2 Empirically defined dietary patterns: factor and cluster analyses 
Factor analysis is a multivariate statistical technique that identifies common patterns of food 
consumption from existing dietary data. Principal components analysis is the most common 
factor analysis method used in nutritional epidemiology. Principal components analysis is a 
multivariable technique that identifies latent constructs using correlations between data; from a 
large number of dietary variables a set of a few uncorrelated dietary patterns are created. Food 
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items, or groups, from questionnaires are aggregated based on the degree to which they 
correlate with one another. The resulting patterns are linear combinations of foods items that 
maximally explain the variance in the food intakes. A summary z-score for each pattern is then 
calculated for each individual calculating the degree to which their dietary intake reflected each 
dietary pattern. This score is a function of the contribution (loading) of each food to the pattern 
and the frequency with which is consumed by each individual. Z-scores can be used in 
regression analyses to investigate associations between dietary patterns and various outcomes, 
such as disease risk factors (206, 207). Cluster analysis is a multivariate statistical technique 
that aggregates individuals into mutually exclusive groups (clusters) with similar dietary intakes 
(206, 208). 
One drawback of these methods is that, like a priori methods, they are prone to subjectivity 
since the investigator has to make many choices during the dietary pattern analysis. For 
example, the investigator needs to decide whether to collapse and how to group the initial 
dietary data; how to quantify and treat the input variables; and which dietary pattern to 
investigate in risk modeling (211). Another limitation is that these methods are purely 
exploratory and like diet quality scores, not necessarily designed to derive dietary patterns that 
specifically predict diseases risk and therefore their mechanisms of action may be difficult to 
elucidate (207). 
1.9.1.3 Reduced rank regression (RRR) 
RRR is becoming a more frequently applied statistical method in the study of dietary patterns. 
RRR combines both exploratory and hypothesis-driven elements (210). This statistical method 
is technically similar to principal components analysis, but it uses two sets of data; one being 
the predictor variables i.e. food intakes, the second being a small number of response variables. 
The response variables are chosen on the basis that they are hypothesised to be intermediate 
variables on the pathway between food intake and the health outcome of interest. RRR-derived 
dietary patterns are linear functions of food intake that maximally explain the variation in the 
response variables (210). The response variables may be nutrients or biomarkers for which 
evidence exists of an association with the outcome of interest. There are some limitations to the 
use of biomarkers as response variables thus dietary nutrient intermediates might be more 
desirable. For example, most chronic diseases are caused by a complex interplay of biological 
pathways, making it difficult to select the most appropriate biomarkers (208). By examining 
dietary nutrient response variables, which are the product of food intake, there may be more 
certainty about dietary intakes that are important for the outcome – whereas for biomarkers this 
may be less clear unless the exact pathways between dietary intake and the biomarkers are 
known. Also, nutrient based dietary patterns are easier to interpret for giving public health 
advice compared to biomarkers. Furthermore, some biomarkers, such as blood lipids, may 
actually be a proxy for the disease of interest and therefore too close to the outcome and not 
suited as a real ‘intermediate’. 
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The greatest advantage of RRR is that it is more hypothesis-based than other exploratory 
empirical methods as it incorporates information on the biological pathways between foods and 
disease (209, 210). Thus, RRR offers potential to advance the knowledge on dietary patterns 
predictive of disease outcomes and the pathways through which they might act. A limitation of 
this method is that the response variables must be chosen carefully, particularly biomarkers, 
and require a-priori evidence. These variables must also be available for analysis. 
1.9.2 Prospective studies of dietary patterns and incident type 2 diabetes 
A number of prospective studies have investigated the association between dietary patterns and 
type 2 diabetes. The majority of these used either diet quality scores (216-224) or empirically 
derived dietary patterns (216, 223, 225-229) and only a few have adopted RRR (209, 230-232).  
1.9.2.1 Studies using diet quality scores 
Studies using different diet quality scores have reported protective dietary patterns. In the 
Nurses Health Study a high score on the Alternative Healthy Eating Index (AHEI), a variation of 
the original HEI, was associated with a type 2 diabetes relative risk of 0.64 (95%CI: 0.58-0.71) 
compared to a low score (218). The RR included adjustments for age, BMI, energy intake and 
physical activity. Further adjustment for WHR changed the RR to 0.76, suggesting a possible 
mediating role of central obesity. Adherence to the Dietary Approaches to Stop Hypertension 
(DASH) diet, an overall score that includes fruits, vegetables, low-fat dairy and whole grains, 
decreased diabetes risk among White adults in the Insulin Resistance Atherosclerosis Study 
(221). The RR after adjustment for age, sex, BMI, family history of diabetes, education, 
smoking, energy intake and energy expenditure was 0.31 (95%CI: 0.31-0.77) when comparing 
extreme tertiles. The DASH diet and the AHEI were also protective in the Health Professionals 
Follow-up Study (217). The multivariate HR for type 2 diabetes (adjusted for smoking, physical 
activity, family history of diabetes, BMI, and total energy) comparing quintiles of intake was 0.75 
(95%CI: 0.65–0.85) for the DASH diet and 0.77 (95%CI: 0.67–0.88) for the AHEI. However, 
both the DASH diet and the AHEI were not predictive of diabetes in the large EPIC-InterAct 
Study (219) although significant protective associations were found before adjustment for BMI 
and waist circumference, suggesting that these patterns were acting through their associations 
with body weight and fat. 
An increasing number of studies have analysed a Mediterranean dietary pattern as a possible 
diabetes-protective pattern. The Mediterranean dietary pattern contains a high proportion of 
MUFA to SFA, is low in energy density and high in fibre, all factors that have been shown to be 
protective in single nutrients studies. Key food groups which are part of the Mediterranean 
dietary pattern are fruit and vegetables, olive oil, pasta or bread, fish and beans. Prospective 
studies investigating this dietary pattern have been mainly conducted among Mediterranean 
populations. In a large study among Spanish populations higher adherence to the 
Mediterranean diet reduced diabetes risk by 83% (222). However, although the estimates were 
adjusted for a range of confounders, including BMI, education, physical activity and energy 
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intake, the overall number of cases was small (n=33). In the PREDIMED-Reus trial (224), a 4-
year randomized trial conducted among 418 Spanish people aged 55-80 years, individuals 
assigned to a Mediterranean diet with no energy restriction had a reduced incidence of type 2 
diabetes of 52% compared with those in the control group (assigned to a low-fat diet). Changes 
in weight and physical activity did not differ between the control and the intervention groups. 
Analyses of the large EPIC study reported that among European populations the relative risk of 
type 2 diabetes for people with high adherence to the Mediterranean diet compared with low 
adherence groups was 0.88 (95%CI: 0.79-0.97) (219), a smaller RR compared to studies 
restricted to Mediterranean populations.  
1.9.2.2 Studies using factor or cluster analyses 
Most studies using either factor or cluster analyses found relatively similar protective or 
unhealthy dietary patterns. In the Health Professionals Follow-up Study a ‘Western’ dietary 
pattern characterized by higher consumption of red and processed meat, French fries, high-fat 
dairy products, refined grains and sweets significantly increased the risk of type 2 diabetes 
(228). Similar patterns rich in high-fat dairy, meat or fried foods were predictive of type 2 
diabetes risk in a Finnish cohort (226) and in the Melbourne Collaborative Cohort Study (225). A 
‘healthy’ dietary pattern characterized by fruit, vegetables, wholemeal bread, low-fat dairy, and 
little alcohol significantly lowered the risk of type 2 diabetes in the Whitehall II Study (216). 
Similar patterns labeled ‘prudent’, rich in fruit and vegetable and/or whole grains were also 
protective in the Health Professionals Follow-up Study (228)  and Finnish cohort (226). In non-
White and multi-ethnic populations results were similar, although the patterns were 
characterized by somewhat different foods. A pattern made up of fruits, vegetables and soy-rich 
foods was protective in a Chinese population, while meat, sweetened and fried foods increased 
risk (229). However, a similarly characterised prudent dietary pattern was not associated with 
type 2 diabetes in a Japanese population after adjustment for multiple confounders (233). 
Interestingly, although fruits and vegetables feature in most protective patterns, in single foods 
analyses neither vegetables nor fruits were particularly protective. This supports the hypothesis 
that the effect of individual foods might be too small to be detected but their aggregate effect 
might be large enough to be significant. Indeed the associations between dietary patterns and 
type 2 diabetes in most studies were stronger than that for individual foods when analysed 
separately in the same cohort. 
The relative risks were comparable across studies in adjusted models (including adjustment for 
socio-economic class, education, BMI and family history in all models). For healthy and 
protective dietary patterns, in factor analysis studies the HR ranged between 0.84 and 0.72 
when comparing extreme quintiles or quartiles, while in cluster analyses the HRs were 0.77-
0.74 when comparing clusters of dietary patterns. Thus, the protective effects of dietary patterns 
seem relatively modest even when comparing extreme of intakes. This is not surprising, since 
factor and cluster analyses are purely exploratory methods and are not designed to identify 
disease-specific dietary patterns. 
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1.9.2.3 Studies using RRR 
One drawback of studies reviewed so far using factor or cluster analysis is that, even if a dietary 
pattern is identified that associates with disease, an explanation for its biological effect on type 2 
diabetes is difficult to find since this exploratory method does not seek to identify etiological 
pathways of food and disease. Studies using RRR can help overcome this problem as they 
incorporate a priori knowledge of diet and disease; by choosing hypothesis- based disease-
specific nutrient responses, dietary patterns obtained with RRR can better clarify the biological 
pathways linking foods type 2 diabetes. 
To date, few studies have adopted RRR to investigate dietary patterns predictive of incident 
type 2 diabetes (209, 230-232, 234). Hoffmann et al. (209) were the first investigators to apply 
RRR in nutritional epidemiology. In their initial model they derived dietary patterns that 
maximally explained variations in nutrients they presumed to be important for diabetes 
development using a nested case-control sample within the German EPIC cohort. These 
nutrients were fibre, alcohol, magnesium and a high ratio of PUFA to SFA. The relative risk 
reduction for the one protective dietary pattern derived, which was high in fibre but low in 
magnesium and had a moderate alcohol content was 0.64 (95%CI: 0.54-0.85) comparing 
extreme quintiles. The authors compared this dietary pattern with one they derived with principal 
components analysis and noted that the latter was not associated with type 2 diabetes although 
it explained more variation in the data.  This is not surprising since principal components 
analysis explains variation in food intake while RRR explains variation in the response 
variables. By choosing different sets of intermediate nutrients and using prospective data, RRR 
could be used as a tool to investigate the relative importance of different pathways.  
A recent cross-sectional analysis of Korean data (235) applied RRR but chose intermediate 
variables related to the quantity and quality of carbohydrates (total energy intake, total 
carbohydrate intake, percentage energy from carbohydrate and GI). The authors found that a 
rice-oriented pattern, characterised by high rice intake and low vegetables, fruit and dairy was 
associated with hypertriglyceridemia in men and low high-density lipoprotein-cholesterol in both 
men and women. 
To date, four studies have applied RRR using intermediate biomarkers of diabetes to identify 
dietary patterns associated with type 2 diabetes (230-232, 234). Schulze and colleagues (234) 
identified a dietary pattern related to inflammatory biomarkers such as IL-6 and CRP, 
characterized by high intake of sugary soft drinks, processed meat and refined grains and low 
intake of cruciferous and yellow vegetables, coffee and wine. The relative risk of type 2 diabetes 
comparing extreme quintiles for this pattern were 2.56 (95%CI: 2.10-3.10) in the Nurses’ Health 
Studies and 2.93 (95%CI: 2.18-3.92) in the Nurses’ Health Study II adjusting for age, BMI, 
physical activity and smoking. In the EPIC Postdam study RRR was used to identify a dietary 
pattern characterised by low levels of inflammatory biomarkers and HbA1c and high levels of 
HDL and adiponectin (230); the dietary pattern was high in fruit and low in processed meat, soft 
drinks, poultry, white bread and beer. The odds ratio for type 2 diabetes, comparing the highest 
40 
versus lowest quintile of this pattern, was 0.27 (CI: 0.13-0.64). In the Whitehall II study the 
homeostasis model assessment of insulin resistance (HOMA-IR), a measure of insulin 
resistance, was used as the intermediate response variable (232). The derived pattern, which 
was high in sugary and diet soft drinks, crisps, white bread, sausages and burgers and low in 
wholemeal bread and high-fibre cereals, was associated with increased risk of type 2 diabetes 
(HR for extreme quartiles 1.55; 95% CI: 1.13-2.15, adjusted for age, sex, ethnicity, SEP, 
smoking, alcohol, physical activity and BMI). However, the use of a marker of type 2 diabetes as 
response variable, such as the HOMA-IR, could be misleading since the derived pattern does 
not help explain how diet affects intermediate pathways to diabetes, but rather it describes 
foods associated with diabetes. In the Insulin Resistance Atherosclerosis Study (231) RRR was 
used to derive a dietary pattern high in red meat, fried potatoes, cheese, eggs and low-fibre 
cereals and bread and low in wine that maximally explained variations in markers of 
haemostasis and inflammation (plasminogen activator inhibitor-1 and fibrinogen). The OR for 
type 2 diabetes comparing extreme quintiles was 4.51 (95% CI: 1.60–12.69) after adjustment 
for age, sex, ethnicity, family history of diabetes, energy expenditure, smoking, energy intake 
and BMI. These results suggest that inflammatory responses could play a role in the diet-
diabetes association. However, it is not possible in these studies to ascertain whether 
inflammatory biomarkers are a cause or merely a marker of diabetes. Furthermore most of the 
studies using biomarkers have used too many response variables resulting in dietary patterns 
that are difficult to interpret in terms of their pathways. 
Recently, two studies have investigated the generalizability of RRR-derived dietary patterns to 
other populations. Imamura and colleagues (236) have used RRR-derived dietary patterns from 
the Nurses' Health Study (234), the EPIC-Postdam (230), and the Whitehall II Study (232) to 
generate three dietary pattern scores in the Framingham Offspring Study. Of these, only the 
Nurses Health Study-based score was associated with type 2 diabetes. However, a more recent 
study (219)  using the same three RRR-derived scores applied in a case-cohort selected from 
the multi-centre European EPIC-InterAct study found that all three dietary patterns were 
significantly associated with type 2 diabetes, even after adjustment for BMI and WC. Conversely 
in the same study both the AHEI and the DASH were not associated with diabetes after body 
weight adjustments. These results suggest that, although RRR-derived dietary patterns are 
generally more strongly predictive of diabetes than diet quality scores, they might not be 
generalizable to all populations. Reproducibility of pre-defined RRR-scores in other populations 
is complicated by the use of different dietary intake questionnaires in other cohorts reflecting 
consumption of different foods specific to certain populations. 
In summary, despite the heterogeneity of the methodologies used, the evidence suggests that 
dietary patterns high in whole grains, fruit and vegetables might decrease diabetes risk while 
dietary patterns high in red and processed foods, refined grains and sweets might increase the 
risk. However, so far the majority of dietary patterns studies have not investigated the pathways 
linking these foods choices with type 2 diabetes. Identifying the specific mechanisms and 
nutritional pathways that are important for type 2 diabetes is a key step in our understanding of 
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how diet affects disease risk and in devising specific nutritional recommendations. So far, only 
two studies have used RRR-derived patterns based on nutrients to examine nutritional 
pathways associated with type 2 diabetes and one of these was cross-sectional. The studies 
using biomarkers as response variables are potentially flawed because, as explained earlier, it 
is not possible to separate the biomarkers from the actual outcome. In particular, HOMA-IR and 
HbA1c are clinical markers, and therefore proxies for diabetes; thus studies adopting these as 
response variables do not explore biological pathways linking diet and diabetes.  
One limitation of much of the dietary pattern literature is the lack of life course investigations of 
dietary patterns in relation to type 2 diabetes. Virtually all studies have used only one dietary 
measurement at baseline and when repeated measurements were available these were not 
exploited to assess change in diet over time. Individual diet is likely to change with age and as 
consequence of developing life circumstances with important repercussions for the timing of 
disease development. Clearly the association between longitudinal changes in diet in relation to 
diabetes needs to be investigated. 
1.10 Literature review summary and conclusions 
As demonstrated by a range of epidemiological evidence lifestyle factors are major players in 
the development of type 2 diabetes. Being overweight or obese at any age increases the risk of 
type 2 diabetes. As well as overall obesity, the distribution of excess weight is an important risk 
factor for diabetes, particularly for women. Abdominal obesity measured in different ways has 
been associated with diabetes, independently of BMI. Among the various abdominal obesity 
indicators WC has been preferred due to its simplicity and high correlation with visceral intra-
abdominal fat. One limitation of much of the research in the field is the paucity of studies using 
longitudinal data to investigate life-course patterns of body weight or WC and type 2 diabetes. 
There is evidence that the duration of overweight and obesity, as well as the timing of weight 
gain, are important life-course risk factors for diabetes. However, most of the prospective 
studies that have investigated the cumulative effect of obesity and sensitive periods of weight 
gain had limited data across the life course. Very few studies have investigated changes of WC 
in relation diabetes and most have looked at only two time points.  
Notwithstanding the difficulties of assessing dietary intake, accumulated evidence suggests that 
certain dietary factors, such as low fibre intake, high GI foods and high total fat and SFA 
intakes, could increase the risk of type 2 diabetes. Plausible physiological mechanisms support 
the hypothesis that these factors have protective effects both independently and through their 
ability to protect from weight gain. However, their synergistic effect, which might be stronger 
than their individual ones, has not yet been analysed.  
In the last decade, dietary patterns have emerged as a method to describe the overall diet in a 
holistic way, which accounts for the cumulative and synergistic effects of nutrients in the diet. 
Two approaches have mainly been used. A theoretical approach uses current knowledge to 
create dietary scores; the empirical approach uses statistical models to derive dietary patterns 
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from existing dietary data. Dietary patterns high in added sugar, processed meat and refined 
grains appear to be detrimental for the development of diabetes. On the other hand, healthy and 
Mediterranean-style dietary patterns appear protective but these are not relevant to all 
populations, especially those in Northern countries. One limitation of the field is that the majority 
of dietary patterns used or created have been purely exploratory and as such, may be less 
disease-specific since they ignore the specific pathways between diet and disease. RRR has 
the advantage of allowing for the investigation of the biological pathways between foods and 
disease. However, most studies that have adopted this method to investigate diabetes have 
mainly examined RRR-derived dietary patterns based on biomarkers of inflammation or proxies 
for diabetes (HOMA-IR, HbA1c) and therefore do actually explore the pathways linking diet and 
diabetes. No study has used RRR to investigate dietary patterns characterised by dietary GI, 
fibre and fat intake, for which there is some evidence of an association with diabetes risk. A 
further limitation of most dietary patterns studies is the widespread use of FFQs to assess diet. 
In addition, there is a lack of studies investigating individual changes in diet over time in relation 
to diabetes incidence. 
Because of the gaps in the literature thus highlighted, this thesis proposes to expand the 
evidence on life-course patterns of obesity, fat distribution and dietary patterns in relation to 
type 2 diabetes incidence.  
1.11 Overall aim and structure of the thesis 
The overall aim of this thesis is to examine the life course associations between BMI, WC and 
dietary patterns in relation to the risk of type 2 diabetes.  
 First, it aims to describe the patterns of BMI and WC over the adult life course and their 
association with an increased risk of type 2 diabetes. Specifically it investigates 
accumulation models of weight gain and sensitive periods of BMI and WC gain over the 
adult life course in relation to type 2 diabetes incidence 
 Second, this work aims to identify dietary patterns associated with the risk of type 2 
diabetes and to investigate whether relationships between these dietary patterns and 
type 2 diabetes are mediated by body weight and waist circumference. Specifically, this 
thesis will use RRR to investigate the combined effect of dietary fibre, GI and dietary fat 
(as a dietary pattern) on type 2 diabetes incidence. Subsequent analyses will 
investigate changes in the derived dietary pattern over the adult life course in relation to 
diabetes 
 Social class, educational attainment, smoking and physical activity levels will be treated 
as confounders. BMI and WC will be treated as mediators in the association between 
diet and diabetes.  
The conceptual framework of this thesis is illustrated in Figure 1, with arrows indicating the 
hypothesised associations between the explanatory variables and type 2 diabetes. The 
following research questions will be asked: 
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1.11.1 Research questions: 
 Is the duration as well as level of obesity important for type 2 diabetes risk? Are there 
any periods over the adult life course when gaining weight is particularly detrimental for 
diabetes (Chapter 3) 
 Is waist circumference important independently of BMI or is there an interaction 
between BMI and WC? Are life-course changes in WC important for type 2 diabetes? 
Are there any periods over the adult life course when WC gain is particularly detrimental 
for diabetes (Chapter 4) 
 Are dietary fibre, the glycaemic index and dietary fat associated with type 2 diabetes? 
To what extent is this association mediated by BMI and WC? (Chapter 5) 
 Does the consumption throughout adult life of a dietary pattern characterised by high 
GI, low fibre and high fat predict type 2 diabetes risk in later life? To what extent is the 
effect of this dietary pattern mediated by BMI and WC? How do changes in this pattern 
affect diabetes risk independently of BMI and WC? (Chapter 6) 
 
Figure 1. Conceptual framework representing the effect of lifecourse body weight and 
diet on type 2 diabetes incidence in the NSHD 
Main explanatory variables are shown in the blue boxes, confounders in the white box and the 
outcome in the red box; arrows represent directions of associations. 
 
1.12 Structure of the thesis 
Details of the source of data used in this thesis, the MRC National Survey of Health and 
Development (NSHD) are given in Chapter 2 with detailed description of the outcome used. 
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This chapter also outlines the analytical strategies used in the thesis. Chapter 3 examines 
associations between life course patterns of BMI and type 2 diabetes. Chapter 4 expands from 
chapter 3 by investigating the lifecourse effect of WC (a measure of body fat distribution) and its 
interaction with BMI.  Chapter 5 and 6 investigate the effect of specific dietary factors (dietary 
fibre, GI and dietary fat) on type 2 diabetes both in isolation (chapter 5) and as a dietary pattern 
(chapter 6) and whether associations between diet and type 2 diabetes are mediated by the 
explanatory factors examined in Chapter 3 and 4 (BMI and WC). Chapter 7 draws the main 
findings of the thesis together and discusses the implications of this work, the overall strengths 
and weaknesses, and recommendations for future research.  
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2 Chapter 2. Methods 
2.1 Introduction to the NSHD 
The NSHD is the oldest birth cohort in Britain. It was initially established as a maternity study in 
1946 to investigate the costs of maternity services and the reasons for the falling fertility rate in 
Britain (237). The initial target sample consisted of all 16,695 births in the first week of March 
1946 that occurred in England, Wales and Scotland. Out of this sample, 13,687 mothers were 
interveiwed for the maternity study. The follow-up study (the NSHD) sample included 5362 
births (2,547 women, 2815 men) selected from the maternity survey. This sample comprised all 
births from non-manual and agricultural workers’ wives and 1 in 4 births to wives of manual 
workers. Births from non-married women and multiple births were excluded. The reason for the 
sampling strategy was to limit costs and to maintain a socially-representative sample that was 
easy to track in future years (238). 
Between birth and the latest data collection at age 60-64 years, the sample has been followed-
up 23 times (Table 2). In the first 16 years data was collected 11 times. Subsequently, contact 
has been less frequent. Data collections consisted of a mixture of postal questionnaires and 
interviews administered by health visitors, teachers, school and research nurses. At age 60-64 
clinical assessments in a clinical research facility were introduced. The research and policy 
focus of the study has changed and developed over the years. Initially it was concerned with the 
impact of social class differences on maternal and child health. In the childhood years the focus 
shifted to educational attainment and in early adulthood to the occupational results of education. 
From age 36 onward the focus has been primarily on health and pathways to healthy ageing.  
The abundance of detailed data, which in most cases were collected by trained professionals 
rather than being self-reported, makes this study ideally suited to investigate life course patterns 
of BMI, weight change, waist circumference and dietary patterns, adjusting for a broad range of 
confounders. 
2.2 Response rate and representativeness of the study 
 As with all longitudinal studies loss to follow-up due to death, migration and refusal has affected 
the NSHD sample size. However, the response rate throughout the study has been good (Table 
2) (238). Response rate was lowest in early adulthood but it increased in the later years when 
research was strongly refocused on health and home visits were offered to those unable to 
travel to a clinical research facility. At the latest data collection in 2006-10, out of the sample 
available for contact at age 60 years (all those alive, residents in the UK and not permanent 
refusals) 2,661 (84.1%) provided some information (either a visit or a postal questionnaire). 
Females, non-smokers and those with higher educational attainment, higher adult social class, 
46 
higher childhood and adult cognition and fewer health problems at age 53 were more likely to 
provide some data at age 60-64 (239).  
Despite some differential attrition by social and health characteristics the NSHD at age 60-64 
has remained broadly representative of the white British population born in the early post-war 
years. When compared with age and ethnically relevant data from the 2010 Office for National 
Statistics Integrated Household Survey and the 2001 England Census, the NSHD had a similar 
sex and social class profile, and smoking rates were similar (239). However in the NSHD a 
slightly higher proportion was employed and a lower proportion had limiting illnesses. Similarly, 
at the previous data collections at age 43 and 53 the NSHD sample was comparable to the 
1991 census population, although those from higher social classes and the never married 
tended to be over-represented (237, 238).  
 
 
2.3 Main outcome used in this thesis 
The main outcome measure used in this thesis was incident type 2 diabetes between 53 and 
60-64 years. Diabetes diagnosis was ascertained only by self-reported information at age 53, 
while at age 60-64 it was ascertained by both self-reported information and by analyses of 
Table 2. Response rate in the MRC NSHD 
Year 
Age of study 
member 
Respondent 
Sample 
successfully 
contacted 
% of target  
sample* 
1946 8 weeks Mother 5,362 (100) 
1948 2 Mother 4,698 (94) 
1950 4 Mother 4,700 (96) 
1952 6 Mother and cohort member 4,603 (95) 
1953 7 Mother and cohort member 4,480 (93) 
1954 8 Mother and cohort member 4,435 (92) 
1955 9 Mother and cohort member 4,181 (87) 
1956 10 Cohort member 4,077 (85) 
1957 11 Mother and cohort member 4,281 (89) 
1959 13 Cohort member 4,127 (86) 
1961 15 Mother and cohort member 4,247 (89) 
1965 19 Cohort member 3,561 (75) 
1966 20 Cohort member 3,899 (83) 
1968 22 Cohort member 3,885 (84) 
1969 23 Cohort member 3,026 (67) 
1971 25 Cohort member 3,307 (74) 
1972 26 Cohort member 3,750 (85) 
1977 31 Cohort member 3,340 (78) 
1982 36 Cohort member 3,322 (86) 
1989 43 Cohort member 3,262 (87) 
1999 
2006-10 
53 
60-64 
Cohort member 
Cohort member 
3,035 
2,661 
(83) 
(84) 
* Target sample excludes deaths, persons living abroad or untraced, and permanent refusals. 
Adapted from Wadsworth et al, 2003 (238) 
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fasting blood glucose and HbA1c. One hundred cases of prevalent diabetes at age 53 were 
excluded from the analyses. Only cases of type 2 diabetes diagnosed between age 53 (1999) 
and age 60-64 (2006-10) were included, which in total were 257. Of these, 130 were self-
reported and a further 127 were identified solely by blood measures at age 60-64.  
2.3.1 Self-reported diabetes 
Self -reported diabetes was determined in two ways: firstly, in response to a direct question and 
secondly from all relevant medical information that study members reported (Table 3). Study 
members were asked whether they had diabetes at ages 36, 43, 53 and between 60 and 64 
years. At age 36 study members were asked: “Do you have diabetes all or most of the time?” At 
age 43, 53 and 60-64 the questionnaire included a question on doctor-diagnosed diabetes since 
the last contact (“In the last ten years have you had diabetes?  Has a doctor said you had this 
problem?”). Hospital attendances, doctor diagnoses of diabetes, dates of diagnoses, and 
medications were reported at nurse interviews at 36, 43 and 53 years and on a postal 
questionnaire at 31 years.  Relevant data of those with any report of diabetes or record of anti-
diabetic medication was reviewed by a GP with a special interest in diabetes. The validity of 
self-reported diabetes was assessed using GP records. Results from this validation study are 
reported below. 
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Table 3. Questions on diabetes and hospital admission in postal questionnaires and nurse interviews from 1977 to 2006-10 
 
Questionnaire year 
Questions 1977 1982 1989 1999 2006-10 
In-patient 
hospital 
admissions 
Have you been a hospital 
inpatient since the last 
admission you told us about? 
Reason for admission? 
Have you been a patient in 
hospital for at least one night 
since the last time you told about 
being a patient in hospital? 
Reason for admission 
Have you been a patient in 
hospital for at least one night since 
the last time you told us about? 
Reason for admission 
Since we last saw you have 
you been admitted to hospital 
as an in-patient? Why were 
you admitted to hospital as an 
in-patient on this occasion?  
Since 1999 have you been 
admitted to hospital as an in-
patient? Why? 
Out-patient 
hospital 
admissions 
Have you attended an outpatient 
or other clinic since? Reason for 
attendance 
 Since you were 36 years old have 
you been to a hospital outpatient 
or day care department for 
consultation or treatment? Reason 
for consultation or type of 
treatment 
Since we last saw you have 
you spent a day at a hospital 
for treatment or surgery and 
then come home at the end of 
the day? What was the illness 
or condition that was being 
treated? 
Since 1999 have you been to 
hospital for treatment or surgery 
and then come home again on 
the same day? Why? 
Doctor visits Have you seen a doctor since 
this time last year?  Why did you 
go? What did the doctor say was 
wrong with you? 
    
Medication Do you regularly take any 
medicine, pills or tablets (or 
have regular injections)? What 
do you take it for? 
 Are you regularly taking any 
medicines or tablets prescribed by 
a doctor? 
Do you now regularly take any 
prescribed medicines? 
Do you regularly take any 
medicines, tablets, tonics or pills 
prescribed by a doctor?  
Diabetes 
status 
  Do you have any of the following 
all or most of the times? (nurse 
reads list aloud. List includes 
diabetes 
Have you ever had diabetes? How 
often have you consulted a doctor 
or other health professional about 
this in the last year?  
In the last ten years (that is 
since you were 43 years old,) 
have you had diabetes? Has a 
doctor said you had this 
problem?  
Since 1999 have you been told 
that you have diabetes?  
Diabetes type    What kind of diabetes have 
you had. Was it: 
o Insulin-dependent  
o Non-insulin dependent or 
o High blood sugar or 
o Some other kind of diabetes? 
 
Age at 
diagnosis 
  How old were you when you had 
this problem the first time?  
How old were you then? How old were you when you 
were first told that you had 
diabetes? 
Diabetes 
treatment 
    Have you taken any prescribed 
medicines or tablets for this in the 
last year? 
  Is your diabetes controlled by: 
o Diet alone  
o Tablets 
o Insulin injections 
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2.3.2 Diabetes diagnosed by fasting blood measures 
Levels of fasting blood glucose and HbA1c measures were analysed from 50-ml blood samples 
collected between 2006 and 2011 in 5 clinical research facilities (240). The sample was 
collected in the morning, mostly between 08.00 and 09.00 hours, by a trained research nurse 
after the study member had fasted overnight since 22.00. A diagnosis of diabetes was 
established if fasting plasma glucose was equal or greater than 7mmol/L or HbA1c was equal or 
greater than 6.5% (48 mmol⁄mol). This diagnosis was based on the 2006 WHO diagnostic 
criteria (7) and the updated 2011 WHO guideline for use of HbA1c as a diagnostic tool (8)  
2.3.3 Type of diabetes 
Individuals only ever treated with diet or oral hypoglycaemic agents, or who had insulin added 
more than 2 years after diagnosis, were classified as having Type 2 diabetes (n=230). All were 
aged 30 years or more at diagnosis. Study members who had taken insulin since time of 
diagnosis were classified as having Type 1 diabetes. All the latter were under 29 years at 
diagnosis (n=13, of which 8 men and 5 women).  
2.3.4 Validation of diabetes  
To evaluate the accuracy of self-reported diabetes and age at diagnosis in the NSHD a 
validation study was conducted at the beginning of the PhD. Details and results of the study 
have been exhibited at the poster session of the 2011 Diabetes UK Conference in London and 
recently published in Primary Care Diabetes (241). To validate self-reported diabetes cases 
these were compared with general practitioners (GP)-confirmed cases. GP are an optimal 
source of information on disease status in the UK as nearly all British citizens are registered 
with a GP practice. Moreover, during the last decade diabetes care in the UK has moved into 
general practice.  
The validation study was conducted using all self-reported diabetes cases up to the latest data 
collection. Of the 230 study members who reported a diagnosis of diabetes 184 (80%) were 
seen at the latest follow-up, when 172 (75%) gave permission to contact their GP. A validation 
questionnaire was developed and sent to the GPs, of which 157 returned completed 
questionnaires (91.2%). The questionnaire consisted of items on diabetes status and type, date 
of diagnosis, how the diagnosis was established and which type of treatment patients were 
currently receiving (diet, oral hypoglycaemic agents, insulin or other). Table 4 shows the follow-
up process for the validation of self-reported questionnaires and the overall GP response rate. 
The validity of self-reported diabetes was assessed by calculating the percentage of self-
reported diabetes cases that were confirmed to have diabetes by their GP, i.e. the positive 
predictive value (PPV) with GP confirmation as the gold standard (PPV= b/a x100 where a= 
number self-reported and b= those confirmed by GP). The difference between self-reported and 
GP-confirmed age at diagnosis was analysed with a Bland-Altman plot (242); the mean 
difference, 95% CI and limits of agreements were calculated.  
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Table 4. Participants available for validation and GP response rate 
 No. % 
Total self-reported diabetes 1977-2008  230  
Died 19  
Withdrew 9  
Lost to follow up 15  
Emigrated  2  
Seen at the latest follow-up 184  
Refused consent to contact their GP 7  
Died after follow-up 5  
Available for validation study 172 74.7 
    1st questionnaire sent to GPs 172  
    GPs telephoned 27  
    Study members telephoned 11  
    Questionnaire resent to GPs 24  
    Questionnaire sent to new GPs 11  
    Questionnaires returned (GP response rate) 157 91.2 
GP= general practitioner 
   
Of the 157 study members who reported a diagnosis of diabetes 149 were confirmed by their 
GP (PPV=94.9%) (Table 5). Results were very similar when the analyses were performed using 
only responses to a direct question on diabetes diagnosis (PPV=95.4%). Information on the test 
used to diagnose diabetes was available for 121 participants. The most common diagnostic 
tests were FPG (n=68, 56.2%) and OGT (n=15, 12.4%). The date of diagnosis was reported by 
148 GPs. The mean age at diagnosis was 55.5 years (±SD 7.3). Information on self-reported 
age at diagnosis was available for 102 study members. Of these, 37 (36.2%) reported the same 
age in years at diagnosis as their GP. Figure 2 plots the differences between self-reported and 
GP-reported age at diagnosis against the average difference. The average difference was 0.6 
years (95% CI 0.2-1.1). The 95% limits of agreements were 5.1/-3.7years. Information on 
treatment was reported by 148 GPs. The combination of diet and oral hypoglycaemic agents 
was the most common treatment prescribed (37.1%) followed by oral hypoglycaemic agents 
alone (31%) and diet alone (15.5%). Twenty four (16.2%) study members were treated with 
insulin.   
This study showed that self-reported diabetes in the NSHD was generally confirmed by GP 
records and could be used as a valid measure of diabetes diagnosis. These results were similar 
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to previous diabetes validation studies that used family doctors as the gold standard (243-246). 
However, none of these studies have been conducted among the general British population. It 
has been suggested that the high agreement of self-reported diabetes might be partly due to the 
well-defined diagnostic criteria of this disease and to the fact that it often requires treatment 
once diagnosed (243, 246). This study found that the self-reported age at diagnosis was on 
average 0.2-1.1 years earlier than the age reported by the GP. This result is similar to previous 
studies, which indicated that patients tend to overestimate the duration of their condition (247, 
248).  
 
 
  
Table 5. Proportion of GP-confirmed self-reported diabetes cases 
  Total GP-confirmed (N) PPV (95% CI) 
Self-reported diabetes  
(from responses to a 
direct question and from 
medication information) 
157 149 94.9% (90.2-97.7) 
Self-reported diabetes  
(from responses to a 
direct question only) 
153 146 95.4% (90.8-98.1) 
 PPV= positive predictive value; CI=confidence interval 
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Figure 2. Differences in years between self-reported and GP-confirmed age at diagnosis 
plotted against the average difference.  
Horizontal lines denote the mean difference (0.6 years), and the upper (5.1 years) and lower  
(-3.7 years) limits of agreement (mean difference ± 1.96 SD of the differences).  
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2.3.5 Descriptive analyses of the outcome 
2.3.5.1 Diabetes prevalence 
Table 6 shows the prevalence of diabetes among the NSHD study sample by year, gender and 
method of diagnosis. The overall prevalence of diabetes (including type 1 and 2, diagnosed and 
undiagnosed) increased with age, ranging between 0.6% at age 36 to 11.8% at age 64, and 
tended to be higher for men, although it was statistically higher only at age 60-64. This 
prevalence is similar to the age-standardized prevalence of total (undiagnosed and diagnosed) 
diabetes found by other surveys in the UK, which ranged between 3.2% and 7.1% for the 
European ethnic group and included people aged 20 to 74 years (3, 249-252). As in the NSHD 
diabetes prevalence was higher for men than women and increased significantly with age. 
Recent estimates of the Association of Public Health Observatories Diabetes Prevalence Model 
(3), which used the Health Survey England 2004 and 2006 data applied to people aged 
16 years and older in Primary Care Trusts, suggest a point estimate for 2011 of total diabetes 
prevalence ranging from 5.5 to 10.9%. 
In the Health Survey for England 2009 (250) the prevalence of doctor-diagnosed diabetes 
among the 55-64 years old was 10.5% for men and 6.3% for women. This is comparable to self-
reported diabetes between age 53 and 60-64 among the NSHD (8.6% for men and 6.3% for 
women). The lower proportion of diabetes among men in the NHSD compared to the Health 
Survey for England might reflect the slightly lower male representativeness in the NSHD, 
especially from lower-social classes. Also the Health Survey for England includes a sample of 
the current multi-ethnic English population, which is barely represented in the NSHD, since this 
study was initiated before the major post-war immigration waves to the UK.  
2.3.5.2 Undiagnosed diabetes 
Undiagnosed diabetes was defined as a fasting blood glucose level equal or greater than 7 
mmol/L or an HbA1c of 6.5% (48 mmol ⁄mol) or greater in the absence of self-reported doctor-
diagnosed diabetes. The prevalence of undiagnosed diabetes in the NSHD at age 53 was 2.5%, 
accounting for 44.6% of all cases of diabetes. Undiagnosed diabetes prevalence was 5.9% in 
2006-10 accounting for 40.7% of all diabetes cases. At age 60-64, undiagnosed diabetes was 
substantially higher in men (7.5%) compared to women (4.4%). These figures are lower than 
those produced by the IDF (1), which estimates that about 50% of all cases of diabetes 
worldwide are undiagnosed. 
The NSHD estimates of undiagnosed diabetes are also comparable, although higher than those 
found by other population-based estimates (3, 253). For example, the APHO Diabetes 
Prevalence Model (3) estimated that undiagnosed diabetes among people aged 16 years and 
older in England accounted for 30.2% of diabetes cases in 2011 using an HbA1c of 6.5% or 
greater and 36.5% using fasting plasma glucose of 7 mmol/l or greater. The English 
Longitudinal Study of Ageing (253), based on an older (55-75 years) White population, reported 
that 18.5% of cases of diabetes were undiagnosed. Similarly to the NSHD, men in the English 
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Longitudinal Study of Ageing had a significantly higher prevalence of undiagnosed diabetes 
than women (2.6% compared to 0.8%). Fasting plasma glucose of 7 mmol/l or greater was used 
to detect undiagnosed diabetes in the English Longitudinal Study of Ageing. It is probable that 
the higher estimates in the NSHD are due to the combined use of HbA1c and FBG as 
diagnostic tools.  
 
Table 6. Prevalence of diabetes by gender and method of diagnosis 
 
2.4 Exposure variables 
2.4.1 BMI and waist circumference 
Anthropometric data in the NSHD were collected at different times of the life course. In this 
thesis BMI at ages 26, 36, 43 and 53 were used. BMI was calculated from weight (in kilograms) 
divided by height (in meters) squared. Height and weight were measured using standard 
protocols at all ages except at age 26, when they were self-reported. Overweight was calculated 
as a BMI  25 - 29.9 kg/m
2
 and obesity as a BMI ≥ 30 kg/m
2
.  
 Diabetes prevalence n/N (%)  New cases 
of diabetes 
Age Total Males Females P*  
36      
(Self-reported) 20/ 3322 (0.6) 13/1656 (0.7) 7/1666 (0.4) 0.17 20 
43      
(Self-reported) 36/3254 (1.1) 22/1632 (1.3) 14/1622 (0.8) 0.13 21 
53       
Self-reported 83/2987 (2.8) 44/1467 (3) 39/1520 (2.6) 0.23 59 
Blood measure 
(HbA1c >=6.5) 
67/2582 (2.5) 29/1293 (2.2) 38/1289 (2.9) 0.26 67 
Total  150/2987 (5.0) 73/1467 (4.9) 77/1520 (5.0) 0.68 126 
60-64      
Self-reported 185/2439 (7.5) 102/1173 (8.6) 83/1266 (6.5) 0.04 130 
Blood measure 
(HbA1c>=6.5 or 
FBG>=7mmol/L) 
127/2133 (5.9) 78/1033 (7.5) 49/1100 (4.4) <0.01 127 
Total  312/2642 (11.8) 180/1279 (14.0) 132/1363 (9.6) <0.001 257 
FBG= Fasting Blood Glucose; *P value for test of sex difference using Chi-square test 
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WC was measured by a trained research nurse at age 36, 43 and 53 according to a 
standardised protocol. With the study member standing straight and looking ahead, a nurse 
applied the measuring tape at the mid-point between the costal margin and the iliac crest and in 
line with the mid-axilla. WC was measured twice to the nearest 1 mm. In this thesis an average 
of the two measures will be used. Descriptive statistics for BMI and WC are presented in 
Appendix 1. 
2.4.2 Diet 
Dietary data at age 36, 43 and 53 were collected by a research nurse at home visits. The nurse 
asked study members to complete a 5-day food diary detailing all foods and drinks consumed 
over the next 5 days and to return it by post (254). Survey members were given guidance on 
household measures and photographs of portion sizes to aid completion. Nutrient intakes were 
calculated using in-house programs based on updated versions of the McCance and 
Widdowson's The composition of Foods. Survey members with at least 3-days food records 
were included, but if food records were provided for more days, these were included in the 
analyses. The response rate for diet diaries was different than that for the main study. The 
number of study members completing diet diaries for at least 3 days was 2441 at age 36, 3187 
at age 43 and 1776 at age 53, corresponding to a response rate of 63%, 85% and 48% 
respectively. The response rates for the main study at age 36, 43 and 53 were 86%, 87% and 
83%. Descriptive statistics of the key dietary factors used as exposure variables are presented 
in Appendix 1.  
2.5 Confounding and mediating variables 
Occupational social class, educational attainment, smoking and physical activity were identified 
as factors that may confound any associations between the explanatory variables (BMI, WC 
and diet) and type 2 diabetes. These variables were chosen a-priori on the basis of existing 
evidence. Specific justification for inclusion of each variable is given in chapters 3 to 6. A 
confounder is a factor associated with both exposure and outcome, but not on the hypothesised 
causal pathway (255). Failure to adequately control for the effects of confounders can bias the 
associations between exposure and outcome. Descriptive statistics of all confounder variables 
are presented in Appendix 2. 
BMI and WC will be treated as mediating variables in the association between dietary factors 
(chapter 5) or dietary patterns (chapter 6) and type 2 diabetes. A mediator is defined as a 
variable that is associated with both the exposure and the outcome and is on the causal 
pathway (255). In this thesis it is hypothesized that BMI and WC partially explain how diet 
affects type 2 diabetes. The extent to which the relationship between diet and the outcome acts 
through these mediators is investigated in chapters 5 and 6.   
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2.5.1 Occupational social class  
Lifetime occupational social class was based on the head of the household’s occupational 
social class at age 15-53. Occupational social classes were defined according to the UK 
Registrar-General’s Classification of social classes, which were introduced in 1913 and 
renamed in 1990 as Social Class based on Occupation (256). The six social classes used in 
this thesis are: I professional, II managerial and technical, IIINM skilled non-manual, IIIM skilled 
manual, IV partly-skilled manual, V unskilled manual, the first three being non-manual and the 
last three manual. 
2.5.2 Educational attainment 
The highest level of educational qualification achieved by age 26 was grouped into 8 categories 
(from none attempted to higher degree) using the Burnham scale (Department of Education and 
Science, 1972) and regrouped into 4 categories for this thesis (none attempted, vocational, 
advanced secondary and higher education). 
2.5.3 Smoking  
Information on cigarette smoking was obtained in the NSHD at seven data collections (at ages 
20, 25, 31, 36, 43, 53 and 60-64). Up to age 31, information was collected by postal 
questionnaire; from age 36 onwards a research nurse collected smoking information by 
interviews at home visits. People who provided an affirmative response to being a current 
cigarette smoker were classified as ‘smokers’ regardless of the number of cigarettes smoked. 
Those who replied negatively were classified as ‘non-smokers’. Smoking history variables were 
created to account for the effect of past smoking habits. A lifetime smoking trajectory up to age 
53 variable was created that comprised those who provided data for at least three waves (n = 
3387) and for whom missing data are not sequential. Table 7 gives a summary of the smoking 
variables used in this thesis as confounders. 
 
 
Table 7. Summary of smoking variables used in this thesis 
Variable Categories 
Smoking history up to age 36, 43 and 53 Current smoker 
 Ex-smoker 
Never smoker 
Lifetime smoking trajectory up to age 53 Never smoker 
 Predominantly non-smoker 
 Predominantly smoker 
 Lifelong smoker 
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2.5.4 Physical activity 
Information on physical activity in the NSHD was collected at different times during the life 
course. In this thesis physical activity at age 36, 43 and 53 were used as confounder variables. 
At age 36 self-reported physical activity was collected using the Minnesota leisure time physical 
activity questionnaire, which included a checklist of 25 recreational activities and sports during 
the previous month. At age 43 an open-ended questionnaire was used to assess sports and 
vigorous leisure activities. At age 53 years study members were asked one question about 
whether they had taken part in any sport or vigorous activity or if they had undertaken any 
physical activity in the previous month.  
2.6 Statistical analyses 
Different statistical methods will be used in this thesis depending on the specific research 
questions in each chapter. To avoid repetition the following methods, which are used throughout 
the thesis are described below. Statistical analyses were conducted using Stata 12 (Statacorp, 
College Station, TX, USA) and SAS 9.0. Dietary patterns were derived using RRR; details of 
this methodology are given in chapter 6. 
2.6.1 Descriptive analyses 
Descriptive analyses of the outcome and the different explanatory variables were conducted 
prior to multivariable analyses. Descriptive statistics included means and standard deviations for 
continuous variables and frequencies and percentages for categorical variables. Chi-square 
test, analysis of variance (for categorical variables) and analysis of variance (for linear 
variables) were conducted to assess statistical differences according to specific variables or 
population groups.  
2.6.2 Multivariable analyses 
The main statistical method used to examine associations between explanatory and outcome 
variables in this thesis is multiple logistic regression. First the relationship between potential 
confounding variables and both the exposure and type 2 diabetes will be investigated in each 
chapter. Then multiple logistic regression models will be constructed to examine associations 
between the explanatory variables and the outcome, with sequential adjustments made for 
potential confounders and mediators.  
For the analysis of duration of overweight or obesity and type 2 diabetes a Cox proportional 
hazard model will be employed. This technique was chosen because, unlike logistic regression, 
survival analyses can handle time to event and duration data. Details of this methodology are 
given in chapter 3.  
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3 Chapter 3. BMI across the life course and type 2 diabetes 
3.1 Introduction 
A substantial body of evidence has highlighted the role of excess body weight as the single 
most important lifestyle risk factor in the pathogenesis of type 2 diabetes. Several studies have 
found strong associations between adult BMI measured at one point in time and later risk of 
type 2 diabetes (49-56, 63). There is a linear increase in risk with higher BMI across the whole 
range of BMI values, with a suggested pooled RR for type 2 diabetes of 1.19 per unit increase 
in BMI (64). The degree of overweight is a critical factor for type 2 diabetes risk. Although 
overweight people (BMI 25-29.9 kg/m
2
) are at higher type 2 diabetes risk compared to those in 
the normal BMI category the risk for the disease is particularly high for obese people (BMI ≥ 30 
kg/m
2
) (65, 75-77). 
Studies suggest that obesity has a greater influence on type 2 diabetes risk in women 
compared to men. For example, in the Monitoring Trends and Determinants on Cardiovascular 
Diseases Augsburg survey (77), the adjusted HRs for type 2 diabetes for the 3 highest quartiles 
of BMI compared to those in the lowest were 1.37, 2.08, 4.15 among men and 3.77, 4.95, 10.58 
among women. Similar differences in risk estimates were reported in the Spanish EPIC (75) 
(adjusted HRs for type 2 diabetes in the highest quartile of BMI compared to the lowest: 2.57 in 
men and 4.14 in women) and across several European countries in the EPIC-InterAct Study 
(76), (unadjusted HRs for those obese compared to normal BMI: 7.58 in men and 11.6 in 
women). The reasons for this sex difference are not completely understood. However, it is likely 
that endogenous sex hormones, such as testosterone and sex hormone–binding globulin, which 
are involved in fat accumulation and distribution, have a key role in modulating type 2 diabetes 
risk differently in men and women (75). 
Despite the abundance of evidence on the role of BMI as a risk factor for type 2 diabetes and 
the increasing interest in life course models of disease, comparatively fewer studies have 
focused on the longitudinal patterns of excess body weight and their association with type 2 
diabetes risk. As outlined in chapter 1, three relevant life course models have been particularly 
studied in the literature. These are the critical period model, encompassing the foetal 
programming of disease, the accumulation model and the sensitive period model. Most of the 
studies have focused on the foetal programming of disease model and it is now recognised that 
low birth weight, a crude marker of foetal growth, is associated with increased risk of type 2 
diabetes in adult life (95, 96). Less is known about the accumulation and sensitive period of 
weight gain models in relation to type 2 diabetes.  
Overall the evidence (103-109) suggests that the duration as well as the degree of overweight 
or obesity might be an important risk factor for type 2 diabetes. Increasingly, obesity and 
overweight are becoming more prominent among younger people, underscoring the importance 
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of elucidating the long-term effects of longer durations of overweight. However, only a handful of 
prospective studies have investigated duration of overweight or obesity longer than 15 years 
(105, 106, 108, 109). Furthermore, some studies only used self-reported BMI measures (107, 
109), which are known to be inaccurate when compared to objectively measured BMI (257). In 
particular, height tends to be overestimated in men while body weight tends to be 
underestimated in women, leading to lower BMI estimates. Furthermore, underreporting of BMI 
and weight is more common among certain groups, such as women and obese people (258). 
Therefore, more studies are needed on the cumulative effect of obesity particularly for earlier 
onsets, given the increasingly younger age of obesity onset. 
Faster gains in weight and BMI during childhood, especially in association with low birth weight 
and early adiposity rebound, have been found to increase type 2 diabetes risk (99, 101). 
Several studies have also found that weight gain either in early, middle or late adulthood 
increases the risk of type 2 diabetes (107, 110-115). However, only a few studies have 
investigated whether weight change during different periods of the life course modulate the risk 
for diabetes differently (106, 110, 113-116). The studies conducted among adult populations 
have mainly found that weight gain during early adulthood has a stronger impact on later type 2 
diabetes risk than weight gain in middle or late adulthood.  
Most of the studies on sensitive periods of BMI gain were limited by a retrospective design (110, 
115, 116) or the use of self-reported measures of weight and height (110, 115, 116, 259). Thus, 
although a few studies suggest that weight gains in early adulthood are particularly detrimental 
for type 2 diabetes, more high-quality studies, using prospectively measured weight and height 
during a sufficiently longer period of the adult life course, are needed to confirm these results. 
In view of the limited prospective evidence on the accumulation and sensitive period models of 
body weight and type 2 diabetes, this chapter will investigate longitudinal patterns of weight gain 
in adult life and their relation with later type 2 diabetes. First, associations will be presented for 
the effect of BMI on diabetes at different time points from age 26 to age 53 years. 
Subsequently, the chapter will assess the effect of duration of overweight or obesity and the role 
of BMI change at different periods of the adult life course on later diabetes risk.  
3.1.1 Research question 
The main research question of this chapter is how longitudinal patterns of BMI throughout adult 
life affect type 2 diabetes risk in later life. 
3.1.2 Objectives 
1. To analyse the association between BMI measured at different time points in the adult 
life (age 26, 36, 43 and 53 years) and type 2 diabetes incidence 
2. To assess the effect of the duration of overweight or obesity on subsequent type 2 
diabetes incidence 
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3. To investigate whether BMI gain at different periods of the adult life (26 to 36, 36 to 43 
and 43 to 53 years) has a different impact on later risk of type 2 diabetes incidence 
3.1.3 Hypotheses 
1. BMI measured at all available time points between age 26 and 53 years is associated 
with type 2 diabetes diagnosed between age 53 and 64 years and this association is 
stronger for women than for men 
2. Earlier onsets of overweight or obesity are associated with a greater risk of type 2 
diabetes compared with later onsets during the adult life course 
3. The positive association between weight gain and type 2 diabetes will be stronger in 
early adulthood (26 to 36 years) than in middle (36 to 43 years) or later adulthood (43 to 
53 years) 
3.2 Methods 
3.2.1 Explanatory variables  
The main explanatory variables used in this chapter are BMI measures at age 26, 36, 43 and 
53. Overweight was calculated as a BMI  25 - 29.9 kg/m
2
 and obesity as a BMI ≥ 30 kg/m
2
. 
Height and weight were measured using standard protocols at all ages except at age 26, when 
they were self-reported. 
3.2.1.1 Missing data for BMI 
In Appendix 3 and 4 individuals with missing BMI data (those whose anthropometric 
measurements, i.e. height and weight, were not collected) were compared with those who had 
BMI information at each age; at all ages those with non-missing data were more likely to be 
female and to be more educated and less likely to be in manual employment and to be 
smokers. At age 43 those with non-missing data were also less likely to have a raised WC and 
to be inactive at the previous data collection (age 36). At all ages there was no difference in BMI 
category (using data from the previous data collection) and type 2 diabetes diagnosis when 
comparing missing and non-missing individuals for BMI. 
3.2.2 Outcome variable 
The outcome used in this chapter is the main outcome of this thesis, type 2 diabetes diagnosed 
between age 53 and 60-64 years. This was described in more detail in Chapter 2.  
3.2.3 Potential confounding variables 
Measures of SEP were considered as potential confounders, since both type 2 diabetes (26-29) 
and excess body weight (34, 38, 42, 260, 261) are more prevalent among people from lower 
social classes. Two measures of SEP were chosen: lifetime social class based on the head of 
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the household’s occupational social class at age 15-53 years and highest level of educational 
qualification achieved by age 26 years.  
Two lifestyle behaviours were considered potential confounders. Physical inactivity is an 
established risk factor for type 2 diabetes (262-265). Overweight people are more likely to be 
physically inactive since these two risk factors are strongly correlated (266, 267). The weight 
stigma experienced by obese people might decrease their motivation to exercise, resulting in 
lower levels of physical activity (268). 
Smoking has also been recognised as a risk factor for type 2 diabetes (45). On the other hand it 
is known that on average smokers tend to be leaner than non-smokers (269), although smokers 
have a more metabolically detrimental fat profile than non-smokers (270). Smoking cessation is 
also associated with weight gain through increased energy intake, reduced resting metabolic 
rate and increased lipoprotein lipase activity (271). 
Waist circumference was considered a mediator. As detailed in chapter 1, visceral abdominal 
fat is a strong risk factor for type 2 diabetes; although both BMI and waist circumference 
independently increase diabetes risk, overall obesity and abdominal obesity are strongly 
correlated and the effect of BMI on diabetes is, to some extent, explained by excess abdominal 
fat. Measures of WC were available at age 36, 43 and 53. 
For the analyses presented in this chapter, self-reported measures of leisure time physical 
activity at 36, 43 and 53 years were used as potential confounders. A categorical variable of 
smoking history was used as a measure of cumulative smoking damage. 
More detailed descriptions of the potential confounding measures used in this chapter were 
given in Chapter 2. 
3.3 Statistical analyses 
Mean and SD of BMI and percentages of overweight and obesity from age 26 to age 53 were 
presented by sex. All subsequent analyses were stratified by sex on a priori grounds based on 
evidence from the literature and to test the hypothesis that the effect of BMI on type 2 diabetes 
is stronger for women than for men. Associations of potential confounders with BMI at age 26, 
36, 43 and 53 and the outcome were examined using linear regression or bivariate analyses. 
Multivariable logistic regression was used to examine prospective associations between BMI at 
26, 36, 43 and 53 years of age and type 2 diabetes between age 53 and 64 years. These 
models provide a crude suggestion of the periods during which BMI is more strongly associated 
with the outcome. 
To investigate the cumulative impact of overweight and obesity a variable was derived defining 
the age at onset of overweight. Using data from 2,277 study members for whom information of 
BMI was available at 26, 36, 43 and 53 years the variable included five categories: never 
overweight, onset of overweight at age 26, onset of overweight at age 36, onset of overweight 
at age 43 and onset of overweight at age 53. This categorisation assumes that those who 
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became overweight remained overweight. This assumption was justified by the fact that very 
few people lost weight. Of those first overweight at age 26, 82%, 91%, 95%, were still 
overweight or obese at age 36, 43 and 53 respectively; of those first overweight at age 36, 86% 
and 94% were still overweight or obese at age 43 and 53 respectively; of those first overweight 
at age 43, 89% were still overweight or obese at age 53. Cox’s proportional hazards models 
were used to estimate the association between duration of overweight or obesity until age 53 
and incidence of type 2 diabetes diagnosed after age 53. Follow-up was in years from birth until 
the diabetes diagnosis or the first of the following events: death, emigration or last completed 
questionnaire. The assumption of proportional hazards was examined using Kaplan-Meier 
curves and found to be valid.  
BMI change per year was calculated by subtracting a later BMI measure by the earlier measure 
(e.g. BMI at 36 minus BMI at 26) and by dividing this change score by the number of years 
between measures. These BMI velocities were plotted (272) graphically to allow visual 
inspection.  
A conditional model of change (272) was used to examine whether there are sensitive periods 
for adult BMI gain. BMI change scores for each period were calculated for each sex conditional 
on earlier BMI. These change scores were obtained by regressing each BMI measure on the 
earlier measures and saving the residuals. To allow comparison between the two periods the 
residuals were standardized (mean=0 and SD=1).  
These residuals represent the change in BMI above or below what is expected given an earlier 
BMI measure and therefore can be interpreted as BMI velocities. Because residuals are 
uncorrelated with each other all BMI velocity scores for different periods were fitted in the same 
model with the outcome; the coefficients for each period were then compared using Wald tests. 
For all analyses (prospective and longitudinal) associations were first presented unadjusted 
(Model 1). A series of models were then constructed to sequentially adjust for socio-economic 
status and educational attainment (Model 2), smoking history and exercise (Model 3) and 
abdominal circumference (Model 4). In analyses of onset of overweight, a further model 
adjusting for current BMI (Model 5) was included to determine to what extent the impact of 
duration of overweight on diabetes is mediated by attained BMI. 
3.3.1 Sample 
All analyses were restricted to those with data for type 2 diabetes diagnosed between age 53 
and 60-64, for BMI at age 26, 36, 43 and 53 and for all confounders (SEP, education, smoking, 
WC). The final number for prospective analyses of BMI and sensitive periods of BMI gain and 
type 2 diabetes was 1860. For analyses of duration of overweight and type 2 diabetes the final 
number was 2130. 
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3.4 Results 
3.4.1 Descriptive analyses of BMI 
Descriptive statistics of BMI at age 26, 36, 43 and 53 for those included in the prospective and 
longitudinal analyses of BMI and type 2 diabetes are shown in Table 8 and Figure 3. BMI 
increased with age for both men and women. Up to age 43 men had a higher mean BMI than 
women; however, while overweight was more prevalent among men at all ages, obesity was 
more common among women from age 36. There was a particularly sharp increase in mean 
BMI between age 43 and 53, especially for women, for whom obesity prevalence doubled in 10 
years. By age 53 more than 70% of males and 60% of women were either overweight or obese. 
Table 9 shows correlations between BMI measures from age 26 to age 53. Overall, correlations 
were similar for men and women. All measures were highly positively correlated with each 
other. Correlations were stronger for consecutive measures and weaker for those farther apart.  
3.4.2 Investigation of potential confounders 
Sex, educational attainment by age 26, lifetime smoking trajectory and WC at age 36, 43 and 
53, were all associated with type 2 diabetes diagnosed between age 53 and 60-64 (Table 10). 
However, lifetime social class, based on occupational class of the head of household between 
age 15-53 was not. People who developed type 2 diabetes between age 53 and 60-64 were 
more likely to be inactive, but the associations were weak. 
People from a lower SEP, especially those in manual employment, and with lower educational 
attainments had higher BMI at all ages (Table 11). Waist circumference was significantly 
associated with BMI. Those in the highest tertile of WC at age 36, 43 and 53 had the highest 
BMI at all ages. Less active people at age 36, 43 and 53 had significantly higher BMI than more 
active people. Smoking history was significantly associated with BMI only at age 53, when, 
compared to never smokers, current smokers had a lower BMI and ex-smokers had a higher 
BMI. 
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Table 8. BMI descriptive statistics by sex 
 Men Women  
 N=882 N=978  
 n % n % P value* 
BMI at age 26      
BMI (Mean ± SD) 23.2 (2.7) 22.3 (3.1) <0.001 
BMI categories:      
Overweight      
(BMI 25 – 29.9 kg/m
2
) 197 22.3 131 13.4  
Obese      <0.001 
(BMI 30 kg/m
2
) 20 2.2 17 1.7  
      
BMI at age 36      
BMI (Mean ± SD) 24.6 (3.1) 23.3 (3.6) <0.001 
BMI categories:      
Overweight 335 37.9 180 18.4  
(BMI 25 – 29.9 kg/m
2
)      
Obese  42 4.7 54 5.5 <0.001 
(BMI 30 kg/m
2
)      
      
BMI at age 43      
BMI (Mean ± SD) 25.6 (3.2) 24.9 (4.4) <0.001 
BMI categories:      
Overweight 394 44.6 248 25.3  
(BMI 25 – 29.9 kg/m
2
)      
Obese  88 9.9 125 12.7 <0.001 
(BMI 30 kg/m
2
)      
      
BMI at age 53      
BMI (Mean ± SD) 27.3 (3.8) 27.3 (5.2) 0.84 
BMI categories:      
Overweight  447 50.6 359 36.7  
(BMI 25 – 29.9 kg/m
2
)      
Obese  183 20.7 248 25.3  <0.001 
(BMI 30 kg/m
2
)      
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53, type 2 
diabetes and all covariates; *P value from  test of sex difference using t-test for BMI as continuous 
variable and chi-squared test for categories of BMI. BMI=Body Mass Index 
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Figure 3. Percentage of people in the overweight and obesity categories* by age among: 
a) men and b) women. 
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53, type 
2 diabetes and all covariates. * Overweight = BMI  25 - 29.9 kg/m2; obesity = BMI ≥ 30 kg/m2.
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Table 9. Correlations between BMI measures 
 
a) Males (n=882) 
  
BMI at 36 0.76   
BMI at 43 0.72 0.86  
BMI at 53 0.63 0.76 0.84 
 BMI at 26 BMI at 36 BMI at 43 
a) Females (n=978)   
BMI at 36 0.74   
BMI at 43 0.70 0.86  
BMI at 53 0.61 0.77 0.85 
 BMI at 26 BMI at 36 BMI at 43 
Note: Analyses restricted to those with non-missing data for BMI at age 26, 36, 43 
and 53, type 2 diabetes and all covariates 
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Table 10. Associations between potential confounders and type 2 diabetes at age 
53 to 60-64 
 No diabetes Diabetes 
 n % n  % 
Male 1127 47.2 152 58.6 
              P-value (chi-squared test) <0.001    
Lifetime socioeconomic position     
I    professional 171 7.2 18 7 
II   intermediate 894 37.8 95 36.9 
III  skilled (Non-Manual) 563 23.8 50 19.8 
III  skilled (Manual) 390 16.5 51 19.8 
IV   partly skilled 256 10.8 31 12.6 
V    unskilled 87 3.6 12 4.6 
P-value (trend) 0.22    
Education attained by age 26     
None attempted 746 33.3 101 40.8 
Intermediate 631 28.2 67 27.1 
Highest  857 38.3 79 31.9 
P-value (trend) 0.01    
Waist circumference (WC) (cm)      
WC at age 36 (Mean ± SD)  N=2375 
P-value (t-test) 
81.8 
<0.001 
(11.7) 
 
88.7 
 
(11.8) 
 
WC at age 43 (Mean ± SD)  N=2240 
P-value (t-test) 
83.1 
<0.001 
(11.9) 
 
92.5 
 
(12.3) 
 
WC at age 53 (Mean ± SD)  N=2429 90.0 (12.5) 101.2 (13) 
P-value (t-test) <0.001    
Lifetime smoking trajectory     
Never smoker 688 30.9 59 24.5 
Predominantly non-smoker 787 35.4 79 32.9 
Predominantly smoker 458 20.6 53 22.0 
Lifelong smoker 289 13.0 49 20.4 
P-value (trend) <0.01    
Exercise at age 36     
Inactive 746 34.6 95 41.6 
Less active 575 26.6 58 25.4 
Most active 834 38.7 75 32.8 
P-value (trend) 0.03    
Exercise at age 43     
Inactive 1107 49.5 124 53.4 
Less active 534 23.9 61 26.2 
Most active 592 26.5 47 20.2 
P-value (trend) 0.08    
Exercise at age 53     
Inactive 1000 45.3 121 51.7 
Less active 415 18.8 45 19.2 
Most active 789 35.8 68 29.0 
P-value (trend) 0.03    
Note: analyses restricted to those with non-missing data for type 2 diabetes; maximum available sample size 
used with each indicator. Educational attainment was categorised as none (none attempted), intermediate (GCE 
'O' level or Burnam C or lower) or highest (GCE A level or Burnam B or higher); activity at each age was coded 
as inactive (no participation), moderately active (participated one to four times) and most active (participated five 
or more times), in the previous month (36 years), per month (43 years) and in the previous 4 weeks (53 years). 
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Table 11. Associations between potential confounders and BMI at age 26, 36, 43 and 53 
      
 n 26 year 36 year 43 year 53 years 
Lifetime socioeconomic position      
I    professional 162 22.6 (2.6) 23.8 (2.8) 24.8 (3.2) 26.7 (3.8) 
II   intermediate 831 22.4 (2.6) 23.6 (3.1) 25.0 (3.5) 27.0 (4.3) 
III  skilled (Non-Manual) 537 22.3 (2.8) 23.4 (3.6) 24.9 (4.1) 27.3 (5.1) 
III  skilled (Manual) 392 23.9 (3.0) 25.3 (3.5) 26.3 (3.8) 27.8 (4.3) 
IV   partly skilled 256 23.3 (4.1) 24.5 (4.6) 26.2 (5.4) 28.2 (6.0) 
V    unskilled 96 23.7 (3.7) 24.9 (4.3) 26.2 (4.7) 28.2 (5.6) 
P-value  (trend)  <0.001 <0.001 <0.001 <0.001 
Education attained by age 26      
None attempted 764 23.4 (3.3) 24.8 (4.0) 26.1 (4.6) 28.1 (4.9) 
Intermediate 626 22.8 (3.1) 23.9 (3.6) 25.4 (4.1) 27.5 (5.0) 
Highest  814 
22.3 (2.6) 23.4 (3.1) 24.7 (3.6) 26.6 (4.3) 
P-value (trend)  <0.001 <0.001 <0.001 <0.001 
Waist circumference age 36       
Lowest tertile  708 21.3 (2.2) 21.7 (2.1)   
Middle tertile 634 22.6 (2.4) 23.7 (2.5)   
Highest tertile 588 24.9 (3.5) 27.2 (3.8)   
P-value (trend)  <0.001 <0.001   
Waist circumference age 43      
Lowest tertile  798 21.2 (2.1) 21.6 (2.2) 22.6 (2.4)  
Middle tertile 743 22.5 (2.3) 23.7 (2.5) 24.9 (2.8)  
Highest tertile 725 25.0 (3.4) 27.1 (3.8) 28.9 (4.3)  
P-value (trend)  <0.001 <0.001 <0.001  
Waist circumference age 53      
Lowest tertile  763 21.2 (2.1) 21.6 (2.1) 22.6 (2.4) 23.8 (2.5) 
Middle tertile 764 22.6 (2.4) 23.7 (2.6) 24.9 (2.7) 26.9 (3.0) 
Highest tertile 747 24.8 (3.4) 26.9 (3.8) 28.8 (4.3) 31.6 (4.8) 
P-value (trend)  <0.001 <0.001 <0.001 <0.001 
Smoking history up to 36 years      
Current smoker 676 23.0 (3.1) 24.0 (3.8)   
Ex smoker 901 22.8 (3.0) 24.2 (3.5)   
Never smoker 698 22.7 (2.9) 23.9 (3.5)   
P-value (ANOVA)  0.27 0.10   
Smoking history up to 43 years      
Current smoker 621   25.2 (3.9)  
Ex smoker 965   25.6 (4.2)  
Never smoker 687   25.3 (4.1)  
P-value (ANOVA)    0.17  
Smoking history up to 53 years      
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Current smoker 494    26.6 (4.4) 
Ex smoker 1103    27.8 (4.8) 
Never smoker 680    27.3 (4.7) 
P-value (ANOVA)     <0.001 
Exercise at age 43      
Inactive 987   25.8 (4.6) 27.9 (5.2) 
Less active 453   25.2 (3.7) 27.7 (4.5) 
Most active 493   24.6 (3.2) 26.5 (3.9) 
P-value (trend)    0.02 <0.001 
Exercise at age 53      
Inactive 913    28.0 (5.4) 
Less active 359    26.9 (4.1) 
Most active 659    26.7 (4.0) 
P-value (trend)     <0.001 
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53; maximum 
available sample size used with each indicator; educational attainment was categorised as none (none 
attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or Burnam B or 
higher); activity at each age was coded as inactive (no participation), moderately active (participated one 
to four times) and most active (participated five or more times), in the previous month (36 years), per 
month (43 years) and in the previous 4 weeks (53 years); p value for trend using Wilcoxon rank-sum test   
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3.4.3 Adult overweight and obesity and type 2 diabetes 
Prospective associations between being overweight or obese at ages 26, 36, 43, 53 and type 2 
diabetes diagnosed between 53 and 60-64 years are shown in Table 12 for men and Table 13 
for women. For both sexes, overweight people at all ages were about twice more likely to have 
type 2 diabetes in later adulthood. These associations were not appreciably changed by 
adjustment for SEP, education, smoking and physical activity (Model 2 and 3). After further 
adjustment for WC however, the associations were considerably weakened particularly for 
women, for whom only associations at age 26 remained significant (OR=1.96, 95% CI, 1.07, 
3.58, p=0.02) (Model 4). 
In men (Table 12) obesity at all ages, except at age 26 (when it was rare), was significantly 
associated with later type 2 diabetes risk. There was a trend for obesity to become a stronger 
risk factor for type 2 diabetes with increasing age, with ORs ranging from 1.83 (95% CI, 0.51, 
6.53) at age 26 to 9.30 (95% CI, 4.40, 19.63) at age 53. Adjustment for social confounders did 
not change the risk estimates (Model 2), but after further adjustment for physical activity and 
smoking the associations were slightly strengthened (Model 3). Further adjustment for WC 
(Model 4) weakened all associations but these remained significant for age 36 (OR=2.98, 95% 
CI, 1.01, 8.78), age 43 (OR=3.31, 95% CI, 1.25, 8.79) and particularly for age 53 (OR=7.39, 
95% CI 2.70, 20.25).  
In women (Table 13) associations between obesity and type 2 diabetes were of similar 
magnitude than those for men, except for age 26 when it was higher (OR=4.33, 95% CI, 1.36, 
13.74). As for men associations were stronger with increasing age, but unlike men adjustment 
for smoking and physical activity did not strengthen the associations (Model 3). After further 
adjustment for WC all associations were considerably weakened to a higher degree than for 
men, and were no longer significant (Model 4). The OR of type 2 diabetes for obese women at 
age 53 was particularly weakened and changed from 8.61 (95% CI, 4.20, 17.64) in Model 3 to 
1.94 (95% CI, 0.73, 5.17) in Model 4. 
3.4.4 Duration of overweight and type 2 diabetes 
Figure 4 shows mean BMI from age 26 to age 53 in men and women by categories of age at 
onset of overweight. In summary for all categories mean BMI increased with age in both men 
and women; those who never became overweight maintained a low BMI ranging from 20.9 
kg/m
2
 at age 26 to 22.8 kg/m
2
 at age 53 in men and from 20.4 kg/m
2
 to 22.6 kg/m
2
 in women; 
those who became overweight at a younger age had on average a higher BMI at all ages, with 
the highest value at age 53; women had sharper increases in BMI in mid to late adulthood and 
reached highest BMI values at age 53; for example men overweight since age 26 reached an 
average BMI of 30.9 kg/m
2 
by age 53 compared to a BMI of 33.3 kg/m
2 
for women overweight 
since age 26. In short, earlier onset of overweight was associated with higher mean lifetime 
BMI. 
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Duration of overweight was associated with incident type 2 diabetes, with longer durations 
having higher HRs for diabetes, a trend that was particularly evident among women (Table 14). 
Among men, compared with people who had never been overweight, those overweight since 
age 26 had a 5-fold increased risk of type 2 diabetes, whereas those with late adulthood onsets 
were only twice as likely to develop the disease. Women with an early adulthood onset had a 
10-fold increased risk of type 2 diabetes versus a 4-fold increased risk for a late adulthood 
onset. Adjustment for education, socio-economic position, exercise and smoking did not change 
the associations in men and slightly attenuated the associations among women. Adjustment for 
average waist circumference between age 36 and 53 (Model 4) attenuated the risk effects and 
further adjustment for BMI (Model 5) at age 53 substantially reduced all associations. 
3.4.5 Sensitive periods of BMI gain and type 2 diabetes 
Figure 5 shows the mean BMI gain velocity by sex and type 2 diabetes outcome diagnosed 
between 53 and 64 years. Men who remained free of diabetes had a slow and constant BMI 
gain velocity whereas men who developed the disease had higher BMI gain velocities in early 
and late adulthood. The pattern of BMI gain velocity was similar between women with diabetes 
and women without the disease: faster in later years, especially between age 43 and 53 
compared to early adulthood. However, for diabetic women at all ages BMI velocity was 
substantially higher. 
Among men, conditional on baseline BMI and independent of BMI change on previous periods, 
for 1 SD BMI gain between 26-36 years there was a 54% increased risk of type 2 diabetes in 
later years (Table 15). The corresponding risk estimates for the periods 36-43 years and 43-53 
years were 13% and 59%. Early and late BMI gains were more strongly associated with 
diabetes than gains in mid-adulthood (difference in OR between early and mid-adulthood=0.41, 
p=0.04; difference in OR between late and mid-adulthood=0.46, p=0.03). Among women gains 
in BMI during each period of the adult life course were associated with diabetes. Gains between 
age 43 and 53 had the highest OR for diabetes (1.85, 95 % CI: 1.46, 2.34) compared with 
previous life periods (1.43, 95% CI: 1.14, 1.79 for 26-36 years; 1.36, 95% CI: 1.08, 1.71 for 36-
43 years), although there was no statistically significant difference between periods (p>0.05). 
Adjustments for SEP, education, physical activity and lifetime smoking did not affect the 
associations considerably for either men or women (Model 2 and 3). 
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Table 12. Associations at each age between being overweight and obese and type 2 diabetes between age 53 and 60-64 among men 
 Model 1  Model 2  Model 3  Model 4  
 Unadjusted 
 
Adjusted for SEP 
and education 
 As Model 2 + 
physical activity and 
smoking history, 
 As Model 3 + WC  
N=882 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
26 years         
Overweight 2.13 (1.36, 3.35) <0.01 2.18 (1.37, 3.45) <0.01 2.23 (1.40, 3.56) <0.01 1.53 (0.91, 2.58) 0.10 
Obese 1.74 (0.49, 6.13) 0.38 1.83 (0.51, 6.53) 0.34 1.87 (0.52, 6.73) 0.33 0.84 (0.21, 3.40) 0.81 
36 years         
Overweight 2.27 (1.45, 3.55) <0.001 2.27 (1.44, 3.59) <0.01 2.29 (1.44, 3.64) <0.001 1.79 (1.02, 3.13) 0.04 
Obese 4.48 (2.08, 9.64) <0.001 4.61 (2.11, 10.05) <0.01 5.28 (2.39, 11.67) <0.001 2.98 (1.01, 8.78) 0.04 
43 years         
Overweight 2.32 (1.40, 3.86) <0.01 2.35 (1.41, 3.92) <0.01 2.24 (1.34, 3.77) 0.01 1.62 (0.88, 3.00) 0.12 
Obese 5.87 (3.14, 10.97) <0.001 5.97 (3.15, 11.31) <0.001 6.66 (3.45, 12.86) <0.001 3.31 (1.25, 8.79) 0.01 
53 years         
Overweight 2.87 (1.37, 5.99) <0.01 2.86 (1.36, 5.93) <0.01 2.87 (1.36, 6.04) <0.01 2.46 (1.10, 5.47) 0.02 
Obese 9.33 (4.43, 19.62) <0.001 9.30 (4.40, 19.63) <0.001 10.46 (4.89, 22.38) <0.001 7.39 (2.70, 20.25) <0.001 
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53, type 2 diabetes and all covariates; BMI=Body Mass Index; WC=waist 
circumference; overweight= BMI  25 - 29.9 kg/m
2
; obese= BMI  30 kg/m
2
; for all associations the reference category was BMI <25 kg/m
2
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Table 13. Associations at each age between being overweight and obese and type 2 diabetes between age 53 and 60-64 among women 
 Model 1 
 
Model 2  Model 3  Model 4  
 Unadjusted 
 
Adjusted for SEP 
and education 
 As Model 2 + 
physical activity 
and smoking 
history, 
 As Model 3 + WC  
N=978 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
26 years         
Overweight 3.00 (1.77, 5.08) <0.001 2.81 (1.64, 4.32) <0.001 2.77 (1.60, 4.80) <0.01 1.96 (1.07, 3.58) 0.02 
Obese 4.33 (1.36, 13.74) 0.01 3.54 (1.08, 11.57) 0.13 3.45 (1.02, 11.61) 0.04 1.63 (0.43, 6.13) 0.46 
36 years         
Overweight 1.77 (1.02, 3.06) 0.04 1.70 (0.98, 2.96) 0.05 1.70 (0.97, 2.97) 0.06 1.23 (0.67, 2.27) 0.49 
Obese 4.49 (2.26, 8.94) <0.001 3.98 (1.96, 8.08) <0.01 3.63 (1.75, 7.52) <0.001 1.63 (0.64, 4.15) 0.30 
43 years         
Overweight 2.31 (1.31, 4.04) <0.01 2.22 (1.26, 3.91) <0.01 2.16 (1.22, 3.82) 0.01 1.32 (0.69, 3.50) 0.38 
Obese 6.22 (3.54, 10.92) <0.001 5.89 (3.29, 10.41) <0.001 5.72 (3.18, 10.29) <0.001 1.67 (0.66, 4.24) 0.27 
53 years         
Overweight 2.47 (1.15, 5.26) 0.01 2.44 (1.14, 5.23) 0.02 2.51 (1.17, 5.37) 0.01 1.50 (0.67, 3.32) 0.31 
Obese 8.88 (4.40, 17.93) <0.001 8.56 (4.21, 17.39) <0.001 8.61 (4.20, 17.64) <0.001 1.94 (0.73, 5.17) 0.18 
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53, type 2 diabetes and all covariates; BMI=Body Mass Index; WC=waist 
circumference; overweight= BMI  25 - 29.9 kg/m
2
; obese= BMI  30 kg/m
2
; for all associations the reference category was BMI <25 kg/m
2
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Figure 4. Mean BMI from 26 to 53 years by age at onset of overweight for a) men and b) 
women.  
Note: Sample restricted to those included in Cox’s proportional hazards models of duration of 
overweight and type 2 diabetes 
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Table 14. Associations between duration of overweight or obesity and type 2 diabetes incidence between age 53 and 60-64 
  Model 1  Model 2  Model 3  Model 4  Model 5  
  Unadjusted 
 
Adjusted for SEP 
and education 
 As Model 2 + 
physical activity 
and smoking 
history 
 As Model 3 + 
WC* 
 As Model 4 + 
adjusted for 
BMI at age 
53 
 
N=2130 
 
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) 
 
P value HR (95% CI) P value 
Age first overweight 
Men n (%)           
Never  256 (24.8) Reference  Reference  Reference  Reference  Reference  
26 years 248 (24.0) 4.97 (2.40, 10.29) <0.001 5.20 (2.37, 11.37) <0.001 5.18 (2.48, 10.79) <0.001 3.32 (1.41, 7.77) <0.01 1.47 (0.58, 3.75) 0.41 
36 years 227 (22.0) 3.57 (1.67, 7.62) <0.01 3.59 (1.59, 8.11) <0.01 3.54 (1.65, 7.61) <0.01 2.53 (1.10, 5.78) 0.02 1.44 (0.60, 3.44) 0.40 
43 years 144 (13.9) 2.60 (1.11, 6.10) 0.02 2.68 (1.07, 6.70) 0.03 2.71 (1.15, 6.35) 0.02 2.25 (0.94, 5.37) 0.06 1.29 (0.52, 3.18) 0.57 
53 years 158 (15.3) 2.15 (0.90, 5.11) 0.08 2.39 (0.96, 5.98) 0.06 2.27 (0.95, 5.42) 0.06 2.01 (0.83, 4.82) 0.1?1 1.36 (0.56, 3.32) 0.475 
Women n (%)           
Never 388 (35.4) Reference  Reference  Reference  Reference  Reference  
26 years 166 (15.1) 9.61 (4.36, 21.16) <0.001 8.76 (3.94, 19.49) <0.001 8.54 (3.81, 19.14) <0.001 5.80 (2.42, 13.86) <0.001 2.04 (0.72, 5.74) 0.17 
36 years 136 (12.4) 5.07 (2.10, 12.24) <0.001 4.89 (2.02, 11.85) <0.001 4.73 (1.95, 11.50) <0.01 3.57 (1.42, 8.92) <0.01 1.56 (0.56, 4.27) 0.38 
43 years 157 (14.3) 5.03 (2.13, 11.87) <0.010 4.91 (2.08, 11.59) <0.001 4.88 (2.05, 11.55) <0.001 4.48 (1.89, 10.64) <0.01 2.26 (0.90, 5.68) 0.08 
53 years 250 (22.8) 3.76 (1.64, 8.59) 0.01 3.74 (1.63, 8.55) 0.01 3.72 (1.62, 8.55) <0.01 3.48 (1.51, 8.09) <0.01 2.21 (0.94, 5.21) 0.06 
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53, type 2 diabetes and all covariates; WC=waist circumference Overweight (including obesity) = 
BMI  25 kg/m
2
; * Average waist circumference between age 36-53 
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Figure 5. Mean BMI gain velocity per year for different periods of the adult life 
by sex and diabetes diagnosis at age 53-64 
Note: Sample restricted to those included in logistic regression models of sensitive periods of 
BMI gain and type 2 diabetes 
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Table 15. Associations between conditional BMI velocity and type 2 diabetes between age 53 and 60-64 
 Model 1 
 
Model 2  Model 3  
 Unadjusted 
 
Adjusted for SEP 
and education 
 As Model 2 + 
adjusted for 
physical activity and 
smoking history 
 
 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Period of change        
Men, n=883       
26-36 years 1.54 (1.24, 1.91) <0.001 1.52 (1.22, 1.89) <0.001 1.56 (1.25, 1.95) <0.001 
36-43 years 1.13 (0.91, 1.39) 0.24
a
 1.12 (0.91, 1.39) 0.24 1.15 (0.93, 1.43) 0.24 
43-53 years 1.59 (1.28, 1.97) <0.001
b
 1.58 (1.27, 1.96) <0.001
b 1.67 (1.33, 2.08) <0.001b 
Women, n= 977       
26-36 years 1.43 (1.14, 1.79) <0.01 1.41 (1.13, 1.77) <0.01 1.40 (1.11, 1.76) <0.01 
36-43 years 1.36 (1.08, 1.71) <0.01 1.36 (1.08, 1.71) <0.01 1.38 (1.09, 1.74) <0.01 
43-53 years 1.85 (1.46, 2.34) <0.001 1.85 (1.46, 2.34) <0.001 1.84 (1.45, 2.35) <0.001 
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53, type 2 diabetes and all covariates. BMI=Body 
Mass Index; OR of type 2 diabetes for a 1 SD increase in BMI in each interval conditional on previous BMI; 
Letter (a): Significantly different from 26-36; Letter (b): Significantly different from 36-43; P for difference between periods estimated with 
Wald’s test 
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3.5 Discussion 
3.5.1 Main findings 
The main findings of this chapter are that for both genders, at any stage of the adult life course, 
overweight and obesity, as well as BMI gains, are associated with later risk of type 2 diabetes. 
Early and late adulthood BMI gains were more important for men whereas gains in late 
adulthood had stronger associations for women. 
As well as the level of overweight, this chapter found that the duration of overweight or obesity 
is a significant risk factor for type 2 diabetes incidence, probably because of the increasing 
accumulation of weight across the life course, with higher attained BMI with longer durations of 
overweight. 
1
st
 objective: To analyse the association between BMI measured at different time points in the 
adult life (age 26, 36, 43 and 53 years) and type 2 diabetes incidence 
It was hypothesised that BMI at any point of the adult lifecourse would be associated with type 2 
diabetes and that this association would be stronger for women. In support of the first 
hypothesis, overweight and especially obese people had higher risks of later type 2 diabetes. 
This was true for all ages except for obesity at age 26 in men. This might reflect a lack of power 
because of the few obese men at this age (n=20) or it might be due to misclassification since 
BMI at age 26 was self-reported. These findings are in agreement with the many studies (49-56, 
63) that reported that being overweight, and particularly obese, at any age during adult life is 
strongly associated with later type 2 diabetes. The associations were not affected by adjustment 
for SEP and education, suggesting that the effect of overweight and obesity was unlikely to be 
confounded by these factors. However adjustment for physical activity and smoking slightly 
strengthened the associations in men but not in women. This is probably due to the BMI-
lowering effect of smoking, thus acting as an effect-suppressor. Since there were more smokers 
among men, the confounding effect of smoking was more evident for men. Adjustment for WC 
removed most of the associations for women while associations at age 36, 43 and especially 53 
remained significant for men. These results suggest that WC is a more important risk for women 
than for men, a fact that has been acknowledged in other studies (64, 65, 75-77).  
In disagreement with the first hypothesis and in contrast with other studies (64, 65, 75-77) that 
found stronger associations for women, there was no difference in risk estimates between men 
and women. Specifically in the NSHD cohort the odds of diabetes among obese women were 
lower than those reported by other studies. Unlike younger samples, the NSHD is a relatively 
lean cohort with low levels of obesity until middle age particularly among women, whose obesity 
prevalence had a dramatic increase only between age 43 and 53 (see Figure 3). The difference 
between men and women might be only evident in this cohort in later adulthood, when women 
gain most of their weight. Most other studies that showed a differential effect of obesity by sex 
included a population sample with a range of ages, usually between mid and late adulthood. It is 
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possible that the different age at BMI calculation might have produced different risk estimates 
compared with those found in the NSHD, since older women tend to be larger.  
The results showed that in both men and women obesity was a more important risk factor for 
type 2 diabetes at older ages. This might reflect a true differential effect depending on when 
weight was gained (a sensitive period model) or it might be due to a continuous weight gain 
over the years leading to a higher BMI at a later age (an accumulation model). To answer this 
question the sensitive and accumulation models hypotheses were tested in section 3.3.4 and 
3.3.5 and findings are explained below.  
2
nd
 objective: To assess the effect of the duration of overweight or obesity on subsequent type 
2 diabetes incidence. 
It was hypothesised that earlier onsets of overweight or obesity would be associated with a 
greater risk of type 2 diabetes compared with later onsets during the adult life course. The 
results in this chapter support the second hypothesis and are in agreement with previous 
studies, which found that duration of overweight is an important risk factor for type 2 diabetes 
(103-109). This chapter expands on previous studies that investigated shorter durations (105, 
106, 108, 109) or only used self-reported measures of BMI (110, 115, 116, 259). Compared with 
people who had never been overweight, those with the longer duration of overweight (equal or 
more than 27 years) had the highest diabetes incidence; whereas those with the shorter 
duration (1-10 years) had the lowest incidence.  
The associations were not confounded by SEP, education, physical activity and smoking, since 
adjusting for these variables had a minimal effect on the HRs. Adjustment for attained BMI at 
age 53 significantly weakened and removed most associations. This suggests that most of the 
association between age at onset of overweight and type 2 diabetes could be explained by 
attained BMI, since those with longer durations reached a higher BMI at age 53, as shown in 
figure 3. Because in this cohort very few individuals moved from the overweight and obese 
categories to the normal weight one and many gained weight over the years, it was not possible 
to single out any additional risk caused by protracted adult exposure to overweight from the 
association caused by accumulation of BMI. Power and Thomas (106) found that current BMI 
significantly reduced, but did not completely eliminate, the association between age at onset of 
obesity and diabetes, suggesting that accumulation of BMI was the predominant explanation, 
but that a small effect of duration per se was possible. In a study of Pima Native Americans 
(105) longer duration of obesity remained significantly associated with diabetes even after 
adjustment for current BMI. However, it is difficult to compare the NSHD sample with this 
ethnically different population with an extremely high prevalence of obesity and diabetes. 
At any age at onset of overweight women had higher HRs for type 2 diabetes compared with 
men with the same age at onset, particularly for onset at age 26. Although the interaction term 
for sex and age at onset was not significant, these differences might suggest that duration of 
overweight could be slightly more important for women. Women with longer durations had a 
higher BMI at age 53 compared with men with the same duration. Thus the stronger effect of 
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duration of overweight on type 2 diabetes for women could be explained by their higher BMI 
reached at age 53. 
3
rd
 objective: To investigate whether BMI gain at different periods of the adult life (26 to 36, 36 
to 43 and 43 to 53 years) has a different impact on later risk of type 2 diabetes incidence. 
It was hypothesised that weight gain at any adult lifecourse period would be associated with 
type 2 diabetes and that this association between would be stronger in early adulthood (26 to 36 
years) than in middle (36 to 43 years) or later adulthood (43 to 53 years). In partial agreement 
with the third hypothesis, BMI gains at any period of the adult life were significantly correlated 
with later type 2 diabetes incidence for women, but only BMI gains during early and late 
adulthood increased diabetes risk for men. The findings in this chapter also partly support the 
hypothesis that early-adulthood BMI gains are more important for later type 2 diabetes than 
middle and late adulthood BMI gains. In men, independently of baseline weight and previous 
periods of BMI change, BMI changes between 26-36 and 43-53 years were significantly more 
strongly associated with later diabetes risk when compared to changes between 36-43 years. 
These differences persisted after adjustment for SEP, education, smoking, physical activity for 
the period 43-53 but not 26-36 years. In women there was no statistical difference between 
periods of BMI change; however BMI gain in the period 43-53 years had a higher OR for type 2 
diabetes compared with the previous periods. Adjustment for SEP, education, smoking and 
physical activity hardly changed these associations. These findings suggest that, compared to 
women, early adulthood is a particularly sensitive period for later diabetic risk among men 
possibly due to the susceptibility of young men to gain weight during these years. However late 
BMI gains remain a more important period of weight gain, maybe due to the increased 
susceptibility to develop metabolic complications in later years. Women seem to have a more 
gradual weight gain during early to mid-adulthood and more substantial BMI gains during late-
adulthood; this spike in weight gain could be explained by changes in lifestyle or by the 
hormonal and physiological changes accompanied by the peri-menopausal years.  
These findings are in partial agreement with previous studies, which found that BMI gains 
during early adulthood were more strongly correlated with later type 2 diabetes than changes in 
mid-adulthood independently of earlier weight (106, 113-116) but in disagreement with the three 
studies that included weight change in later adulthood (113-115) and found a more pronounced 
association with type 2 diabetes for weight gains in early than later life. However, the periods 
analysed by previous studies are difficult to compare to the present findings. One study 
compared weight change from age 21 to age 40-75 with 10-years weight change from age 40-
75 (113); another study looked at BMI gains from age 25 to 40 versus changes from age 40 to 
55 (115); the third study analysed BMI change from 20 years to the baseline examination 
(average age of 50 years) with change from baseline to 5 years afterwards (114). The results 
from this chapter add to the previous literature by providing a more detailed characterisation of 
sensitive periods of adult BMI gain. Whereas previous studies only compared two periods, this 
chapter compared three periods of change. In an attempt to compare the results in this chapter 
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with previous studies, the findings from Table 15 were repeated comparing the period 26 to 43 
years with 43 to 53 years using the same methodology employed for analyses presented in 
table 15 (Appendix 5). The results showed that changes in BMI in the later period were slightly 
more strongly correlated with type 2 diabetes than BMI changes in the earlier period for both 
men and women, although these differences did not reach statistical significance (p<0.05). Thus 
it seems that the greater effect observed for early compared with later BMI gains in other 
studies could be mainly driven by changes in the early adulthood years (25 to 36 years) in men.  
3.5.2 Strengths 
A strength of these analyses is that they used repeated measures of BMI throughout adult life at 
regular intervals. Most previous studies only used two or three repeated measures to test for 
sensitive periods of BMI and duration of overweight; in this chapter the richness of the data 
could be exploited to investigate longer trajectories of overweight and more detailed 
characterization of BMI history in relation to type 2 diabetes. A further strength is that, unlike 
other studies, heights and weights were measured using a standardized protocol at 36, 43 and 
53. Measures at 26 were self-reported, but were reported at that age rather than being recalled 
later. 
The analytical strategy used had a number of strengths. First models were constructed to 
account for a range of confounders and mediators that have not always been included in other 
studies. Second, to enable comparison of BMI gains across intervals of varying length, periods 
of BMI change were converted into velocities using the residual method, which enabled formal 
comparison of velocities within the same model. 
3.5.3 Limitations 
Although BMI was obtained by weight and height measured by a trained professional at ages 
36, 43 and 53, BMI at age 26 was derived from self-reported weight and height and this could 
be a potential source of measurement error. However, self-reported height and weight among 
younger adults have been found to provide a reliable estimate of measured values, while recall 
bias could be a problem for older adults (273). Nevertheless, differential misreporting might 
have introduced some bias in the estimated BMI change between age 26 and 36, since in 
general weight tends to be underreported particularly from overweight individuals (257). 
In this chapter complete case analyses were conducted with only study participants with data 
for all BMI measures and type 2 diabetes status as well as for all covariates included in the 
analyses. However, the final sample size in all analyses was large enough to find significant 
associations and comparable to previous longitudinal studies therefore loss of power was 
unlikely to be an issue. 
In addition to contributing to loss of power, the use of complete case analyses in this chapter 
might have resulted in bias. However, as shown in Appendix 6 those with non-missing data for 
all covariates were remarkably similar to those in the maximum sample available for each 
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covariate and type 2 diabetes. In particular, there was no difference in mean BMI at all ages 
between the maximum sample available and the sample included in the analyses, suggesting 
that the use of complete cases was unlikely to have substantially impacted on the results. 
Similarly, Appendix 3 and 4 show that those with missing data on BMI were not different from 
those without missing with respect to BMI category and type 2 diabetes status. However, those 
with non-missing data were healthier (i.e. less likely to smoke and be inactive) and more 
educated, suggesting results might not be generalizable to all populations. 
Another potential source of bias was loss to follow-up in the NSHD sample. Some loss to follow 
up is inevitable in every longitudinal study and the NSHD has maintained good response rates 
throughout the study, which are comparable with other cohorts. 
A limitation of this chapter is that longitudinal analyses were restricted to adult life. The NSHD 
sample was a very lean cohort up to age 20-26 compared with younger cohorts thus limiting 
generalisability. Because there were few overweight and obese children, it was not possible to 
investigate longer trajectories that encompassed both childhood and later adulthood. 
A limitation of the analyses of duration of overweight and type 2 diabetes is the assumption that 
individuals first overweight at one age remained overweight at the following data collection. 
Although fluctuation in weight between data collections cannot be ruled out, the assumption was 
reasonable considering the small number of people who moved from the overweight to the 
normal weight category.  
A possible problem might arise with the use of change measures because of the risk of 
regression to the mean. However, the effect of regression to the mean is greater with increasing 
measurement error and when measures used for change scores are poorly correlated (274). 
BMI values in the NSHD were measured by trained professionals according to standard 
protocols, and were highly correlated, especially those consecutive in time; thus, the effect of 
regression to the mean was likely to be small. 
3.5.4 Conclusions 
This chapter has shown that at any age BMI gains, as well as overweight and obesity per se, 
are positively associated with later type 2 diabetes. For men, early and late adulthood BMI gains 
are more strongly associated with the disease than gains in mid adulthood, whereas for women 
late adulthood BMI gains are more important for type 2 diabetes.  
Longer durations of overweight are significantly associated with type 2 diabetes and this 
associated is mainly explained by attained BMI. These findings suggest that due to 
accumulation of weight throughout the adult life course, interventions in earlier life to prevent 
increasing BMI gains with age might be more successful to tackle type 2 diabetes than 
interventions in mid- to late adulthood. This might be particularly important for men who tend to 
gain weight earlier in life compared to women.  
83 
Although analyses presented in this chapter acknowledge the importance of BMI as a key risk 
factor for diabetes, BMI cannot measure body fat distribution, which as discussed in chapter 1 
might better predict metabolic risk. Chapter 4 builds on the work done in this chapter by 
investigating associations between WC and type 2 diabetes and its interaction with BMI. 
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4 Waist circumference across the life course and type 2 diabetes 
4.1 Introduction 
As illustrated in chapter 3, obesity at any time during the adult life course is a strong predictor of 
future risk of type 2 diabetes. However, there is growing acknowledgment that central, rather 
than overall obesity, is particularly detrimental for diabetes. This is because, as outlined in 
Chapter 1, excess visceral intra-abdominal adipose tissue is a key factor in the pathogenesis of 
metabolic disorders (66). While BMI is an indicator of generalized obesity, WC has been found 
to closely associate with localised central fatness and visceral fat (83, 84). WC measures are 
simple to obtain and interpret and are preferred to other abdominal obesity indicators in clinical 
and public health settings.  
WC is strongly associated with type 2 diabetes risk independently of BMI (67-72); systematic 
reviews have also found that the relative risk of diabetes is higher with WC than with BMI (80, 
275) especially among women (76). However, evidence from large samples suggests that WC 
is better interpreted in the context of BMI (75, 276, 277); although BMI and WC are highly 
correlated at the population level, at the individual level, for a given BMI there is a wide variation 
in WC measures (278). At the same BMI level those with a larger waist have a higher metabolic 
risk. This was well documented in the International Day for the Evaluation of Abdominal Obesity 
(276), a 63-country study involving more than 160,000 people: WC had a graded relationship 
with type 2 diabetes at all levels of BMI and the risk was increased even among those with a 
normal BMI (<25 kg/m
2
) but an elevated WC. Similarly, in the EPIC InterAct study (76), among 
overweight people, WC identified a sub-group of individuals with a larger waist, whose diabetes 
risk was similar to that of people in the obese category.  
Although the absolute risk of type 2 diabetes is higher for men at any BMI and waist category, it 
has been reported that the relative effect of WC on diabetes is stronger for women than for men 
(75-78). This might be particularly evident after adjustment for BMI, suggesting that WC might 
be a better indicator of excess abdominal fat and metabolic abnormalities among women once 
the effect of overall obesity is removed.  
Although there is strong evidence of an association between WC measured at one point in time 
and type 2 diabetes, it is less clear whether changes in WC, controlling for initial abdominal 
fatness, are also important for diabetes risk. This is mainly because few longitudinal studies 
have repeated WC measures, and most rely on self-reported values.  
In the Coronary Artery Risk Development in Young Adults study (118) a steady gain in WC over 
15 years was associated with increasing insulin resistance after adjustment for confounders. 
There was an interaction between initial WC and change in WC, such that the association of 
WC change with insulin resistance was stronger for those who had a lower initial WC. This 
study was limited to young people and did not test sex differences. Increases in WC were also 
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associated with progression to type 2 diabetes in people with IFG in the Data from an 
Epidemiological Study on the Insulin Resistance Syndrome cohort (79). In this study there was 
an interaction between WC changes and initial BMI: the effect of WC change was larger for 
people within the normal BMI category (<25 kg/m
2
) than for those with a BMI equal or higher 
than 25 kg/m
2
. Only two studies investigated whether WC changes are predictive of type 2 
diabetes independently of changes in total body weight (113, 119). In the Health Professionals 
Follow UP study (113) the risk of diabetes increased with higher WC changes over 10 years 
among middle-age and older adults; however, only the highest quintile of WC gain (>14.6 cm) 
remained significantly associated with diabetes after adjustment for concurrent weight change. 
Conversely, in a subsequent Danish study (119) 5-year WC changes were not associated with 
later diabetes risk in men but were weakly associated among women after adjustment for BMI 
change. 
These findings suggest that the effect of WC change on type 2 diabetes might be different 
according to initial levels of overall and abdominal fatness and that these might be more 
pronounced among women. There is also some suggestion that WC changes act independently 
of weight change, but only for substantial increases in WC. However, only two studies (113, 
119) included adjustment for weight change and both studies used self-reported anthropometric 
measures at least at one point. Furthermore only one study investigated men and women 
separately (119). To the author’s knowledge, no study has investigated whether there are 
sensitive periods when WC gains are more detrimental for future type 2 diabetes risk.  
Because of the limited available evidence on life course abdominal obesity in relation to 
metabolic conditions, this chapter will analyse how change in WC over the adult life course 
influences type 2 diabetes risk and whether changes are independent of concurrent BMI 
change. Subgroup analyses will also be performed to confirm any differential effect according to 
sex and to categories of initial BMI. Finally sensitive periods of WC gain (36-43 years and 43-53 
years) will be investigated. 
4.1.1 Research question 
The main research question of this chapter is how WC throughout the adult life course affects 
type 2 diabetes risk in later life. 
4.1.2 Objectives 
1. To analyse the association between WC measured at different time points in the adult 
life (age 36, 43 and 53 years) and incident type 2 diabetes 
2. To assess whether the effect of WC on type 2 diabetes risk is different according to 
different levels of BMI 
3. To investigate whether WC changes during the adult life-course are associated with 
later risk of type 2 diabetes independently of initial WC and of concurrent BMI changes  
4. To assess whether the effect of lifecourse WC change on type 2 diabetes risk is 
different according to levels of initial BMI 
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5. To investigate whether WC gain at different periods of the adult life (36 to 43 and 43 to 
53 years) has a different impact on later risk of type 2 diabetes 
4.1.3 Hypotheses 
1. WC at age 36, 43 and 53 years is associated with type 2 diabetes diagnosed between 
age 53 and 64 years independently of BMI and this association is stronger for women 
than men 
2. The relative risk of type 2 diabetes for a raised WC will differ according to BMI 
categories. In particular risk will be higher for normal weight people than for overweight 
and obese individuals 
3. Increases in WC over the lifecourse are associated with type 2 diabetes risk 
independently of BMI changes and this association will be stronger for women 
4. The association between WC increases and diabetes will be stronger for people with an 
initial lower BMI 
4.2 Methods 
4.2.1 Explanatory variables  
The main explanatory variables used in this chapter are WC measures at age 36, 43 and 53. As 
well as using WC as a continuous variable, in this chapter categories of WC were defined 
according to the National Institute for Health and Care Excellence (NICE) cut-offs for increased 
risk of type 2 diabetes (279). A WC of 94-102 cm in men and 80-88 cm in women was defined 
as high risk WC; a WC of >102 cm for men and >88 cm for women was defined as very high 
risk WC. These cut-offs are based on the IDF consensus worldwide definition of metabolic 
syndrome (280).  
4.2.2 Outcome variables 
The outcome used in this chapter is the main outcome of this thesis, the risk of type 2 diabetes 
diagnosed between age 53 and 60-64 years. This is described in more detail in Chapter 2.  
4.2.3 Potential confounding variables 
Level of education and of socio-economic position (SEP) were considered as potential 
confounders since, as mentioned in previous chapters, type 2 diabetes (31-35) is more 
prevalent among people from lower social classes and with lower educational attainment. 
Studies have also reported an inverse relationship between education (281) and WC as well as 
an association between low socio-economic status (282) and abdominal obesity, in particular 
among women. 
Lifetime social class based on the head of the household’s occupational social class at age 15-
53 years was used as a measure of SEP and highest level of educational qualification achieved 
by age 26 years was used to adjust for education. 
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Lack of physical activity is a risk factor for obesity, both general and abdominal (266, 267). 
Although smoking cessation is associated with weight gain (267), there is a dose-response 
relationship between the amount of cigarettes smoked, as well as the length of smoking, and 
abdominal and visceral fat (270). 
BMI was used both as a confounder and as an effect modifier, to test the hypotheses that WC 
acts independently of BMI and that the effect of WC might be different according to BMI 
categories. 
For the analyses presented in this chapter, self-reported measures of leisure time physical 
activity at 36, 43 and 53 years were used as potential confounders. Three categorical variables 
of smoking history up to 36, 43 or 53 were used as measures of cumulative smoking damage. 
BMI was included at age 36, 43 and 53. 
More detailed descriptions of the potential confounding measures used in this chapter were 
given in Chapter 2. 
4.2.4 Statistical analyses 
Mean and SD of WC and proportions of people with a large (at increased risk of type 2 
diabetes) and very large (at greatly increased risk of type 2 diabetes) waist circumference 
between age 36 and age 53 are presented by sex. All subsequent analyses were stratified by 
sex on a priori grounds based on evidence from the literature and to test the hypothesis that the 
effect of WC on type 2 diabetes is stronger for women than for men. Associations of potential 
confounders with WC at age 36, 43 and 53 and the outcome were examined using linear 
regression or bivariate analyses. 
Multivariable logistic regression was used to examine prospective associations between low risk 
(<94 cm for men and <80 cm for women), high risk (94-102 cm in men and 80-88 cm in women) 
and very high risk (>102 cm for men and >88 cm for women) categories of WC at 36, 43 and 53 
years of age and type 2 diabetes between age 53 and 64 years. An interaction between WC 
and BMI categories was formally tested and analyses were subsequently stratified by 
categories of BMI. 
To investigate life-course changes in WC a conditional change approach (277) was adopted. To 
analyse the effect of long-term WC changes on the outcome, changes in WC (cm) from age 36 
to 53 (calculated by subtracting WC at 53 minus WC at 36) were regressed on type 2 diabetes 
conditional on WC at age 36.  
A conditional model of change (272) was used to examine whether there are sensitive periods 
for adult WC gain in a similar manner as in chapter 3. WC change scores for the periods 36–43 
and 43–53 years were calculated for each sex conditional on earlier WC using the residual 
method, which has been described in chapter 3. As in the previous chapter the residuals were 
fitted in the same model with the outcome and compared using Wald tests. 
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For all analyses associations were first presented unadjusted (Model 1). A series of models 
were then constructed to sequentially adjust for socio-economic status and educational 
attainment (Model 2), smoking history and exercise (Model 3) and either BMI for prospective 
models or change in BMI analyses of WC change (Model 4). 
4.2.5 Sample 
All analyses were restricted to those with data for type 2 diabetes diagnosed between age 53 
and 60-64 and all covariates included in fully adjusted models (SEP, education, smoking, 
physical activity, BMI). For prospective associations of WC at each age the available number 
differed by year and was 2242 for WC at age 36, 2290 for WC at age 43 and 2269 for WC at 
age 53. The final number for longitudinal analyses of change in WC and sensitive periods of 
WC change and type 2 diabetes was 2007. 
4.3 Results 
4.3.1 Descriptive analyses of WC 
Descriptive statistics of WC at age 36, 43 and 53 for those included in the prospective analyses 
of WC and type 2 diabetes are shown in Table 16 and Figure 6. WC increased with age for both 
men and women, in particular from age 43 to 53. At any age men were more likely to be in the 
“high risk” WC category (men 94-102cm, women 80-88cm), while women were more likely to 
be in the “very high risk” WC category (men >102cm, women >88cm). Between age 43 and 53 
there was a sharp increase in proportion in the “very high risk” WC category especially among 
women, the prevalence of which more than doubled in 10 years. By age 53 more than 62% of 
males and 63% of women had a WC that put them at increased risk of type 2 diabetes. 
Table 17 shows correlations between WC measures from age 36 to age 53. Correlations 
between WC at age 36 and 43 and between WC at age 36 and 53 were stronger for men than 
for women, while correlations between WC at age 43 and 53 were similar for men and women. 
All measures were positively correlated with each other. Correlations were stronger for 
consecutive measures and weaker for those farther apart.  
At all ages there was a strong positive correlation between WC and BMI among men; for 
women the correlation was strong at age 43 and 53 and slightly weaker at age 36 
4.3.2 Investigation of potential confounders 
On average, people in manual employment and with the lowest educational attainment tended 
to have a larger WC at all ages (Table 18). WC was significantly positively associated with BMI 
categories, in a clear dose-response way. At age 36 and 43 both current and ex smokers had 
significantly larger WC than never smokers, while at age 53 ex smokers had the highest WC 
compared to the other categories. Less active people at all ages had a significantly higher WC 
than more active people, with a stronger trend at age 43 and 53.  
89 
 
 
Table 16. Waist circumference descriptive statistics by sex 
 Men Women  
 n % n % 
P 
value* 
WC at age 36 (N=2242)      
WC (Mean ± SD) 89.1 (8.9) 76.3 (10.8) <0.001 
WC categories:      
Low  
 (Men <94cm, women <80cm) 
763 71.3 831 70.7  
High 
 (Men 94-102cm, women 80-88cm) 
231 21.6 176 14.9 <0.001 
Very high 
 (Men >102cm, women >88cm) 
75 7.0 168 14.3  
WC at age 43 (N=2290)      
WC (Mean ± SD) 91.4 (9.5) 77.2 (10.5) <0.001 
WC categories:      
Low  
 (Men <94cm, women <80 cm) 
685 62.6 828 69  
High 
 (Men 94-102cm, women 80-88cm) 
271 24.7 210 17.5 <0.001 
Very high 
 (Men >102cm, women >88cm) 
138 12.6 162 13.5  
WC at age 53 (N=2269)      
WC (Mean ± SD) 97.4 (10.5) 85.3 (12.4) <0.001 
WC categories:      
Low  
 (Men <94cm, women <80cm) 
407 37.2 442 36.9  
High 
 (Men 94cm, women 80cm) 
346 32.0 332 27.7 <0.001 
Very high 
 (Men >102cm, women >88cm) 
326 30.2 423 35.2  
Note: analyses restricted to those with non-missing data for type 2 diabetes and all covariates; 
WC=waist circumference; categories of WC were defined according to the National Institute for 
Health and Care Excellence (NICE) cut-offs for increased risk of type 2 diabetes (279) 
*P value from test of sex difference using t-test for WC as continuous variable and chi-squared 
test for categories of WC.  
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Figure 6. Percentage of people in the high risk and very high risk WC category* by age 
and gender  
Note: analyses restricted to those with non-missing data for WC, type 2 diabetes and all covariates for 
each age. Men: at age 36 N=1068, at age 43 N=1092, at age 53 N=1075. Women: at age 36 N=1174, 
at age 43 N=1198, at age 53 N=1194. 
* High risk category = Men: WC of 94-102 cm; women: WC of 80-88 cm. Very high risk category = Men: 
WC >102 cm; women: WC > 88 cm. Categories of WC were defined according to the National Institute 
for Health and Care Excellence (NICE) cut-offs for increased risk of type 2 diabetes (279). 
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Table 17. Correlation between WC and BMI measures 
 
a) Males (n=947) 
     
WC at 43 0.74      
WC at 53 0.69 0.77     
BMI at 36 0.70 0.70 0.65    
BMI at 43 0.70 0.83 0.72 0.84   
BMI at 53 0.65 0.72 0.86 0.75 0.83  
 WC at 36  WC at 43 WC at 53 BMI at 36 BMI at 43  
a) Females (n=1060)      
WC at 43 0.60      
WC at 43 0.56 0.79     
BMI at 36 0.69 0.76 0.68    
BMI at 43 0.58 0.83 0.75 0.86   
BMI at 53 0.53 0.76 0.88 0.77 0.85  
 WC at 36  WC at 43 WC at 53 BMI at 36 BMI at 43  
Note: BMI = Body Mass Index. Analyses restricted to those with non-missing data for WC and BMI at age 
36, 43 and 53, type 2 diabetes and all covariates 
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Table 18. Associations between potential confounders and WC at age 36, 43 and 53 
 
WC (cm)  
at 36 year 
WC (cm)  
at 43 year 
WC (cm)  
at 53 years 
 n Mean (SD) n Mean (SD) n Mean (SD) 
Socioeconomic position       
I    professional 218 85.9 (9.5) 223 87.9 (10.3) 207 94.6 (11.0) 
II   intermediate 1159 82.8 (11.5) 1147 84.2 (12.0) 1067 91.2 (12.7) 
III  skilled (Non-Manual) 757 78.9 (12.4) 723 80.5 (12.4) 664 88.1 (13.7) 
III  skilled (Manual) 602 88.2 (11.2) 581 89.9 (11.4) 518 96.0 (12.0) 
IV   partly skilled 207 83.5 (13.0) 382 84.5 (13.4) 357 91.5 (14.3) 
V    unskilled 144 82.6 (13.1) 145 85.7 (14.8) 123 91.5 (14.3) 
P-value  (trend)  0.01  <0.01  0.15 
Education attained by age 26       
None attempted 1196 84.5 (12.7) 1128 86.6 (13.2) 1028 93.5 (13.6) 
Intermediate 879 81.0 (12.1) 851 82.6 (12.2) 773 89.8 (13.3) 
Highest  1061 83.0 (11.5) 1053 84.5 (12.0) 985 91.2 (12.7) 
P-value (trend)  <0.001  <0.001  <0.001 
BMI category age 36        
Normal (<25 kg/m
2
)  2129 77.8 (9.4)     
Overweight (25 -29.9 kg/m
2
) 929 90.7 (8.8)     
Obese (30 kg/m
2
) 215 103.2 (11.4)     
P-value (trend)  <0.001     
BMI category age 43       
Normal (<25 kg/m
2
)    1684 77.4 (8.8)   
Overweight (25 -29.9 kg/m
2
)   1130 90.1 (9.0)   
Obese (30 kg/m
2
)   395 101.4 (12.3)   
P-value (trend)    <0.001   
BMI category age 53       
Normal (<25 kg/m
2
)      975 80.8 (8.7) 
Overweight (25 -29.9 kg/m
2
)     1254 92.1 (8.9) 
Obese (30 kg/m
2
)     714 105.7 (11.1) 
P-value (trend)      <0.001 
Smoking history*       
Never smoker 966 81.8 (12.1) 933 83.3 (12.5) 868 90.2 (13.3) 
Ex smoker 1214 84.3 (12.1) 1316  85.6 (12.7) 1403 93.0 (13.4) 
Current smoker 1119 83.2 (12.3) 967 85.0 (12.4) 690 90.7 (12.6) 
P-value (ANOVA)  <0.001  <0.001  <0.001 
Exercise at age 36       
Inactive 1210 84.1 (13.4) 1070 85.4 (13.2) 974 92.5 (14.1) 
Less active 832 82.8 (11.9) 747 84.7 (12.8) 679 91.6 (13.0) 
Most active 1250 82.6 (11.2) 1136 84.2 (12.0) 1021 90.9 (12.4) 
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P-value (trend)  <0.01  0.03  <0.01 
Exercise at age 43       
Inactive   1673 85.7 (13.2) 1431 92.7 (13.7) 
Less active   749 84.4 (12.1) 646 91.0 (12.5) 
Most active   800 83.2 (11.5) 708 89.9 (12.2) 
P-value (trend)    <0.001  <0.001 
Exercise at age 53       
Inactive 1456     93.2 (13.8) 
Less active 516     90.8 (12.2) 
Most active 988     89.8 (12.7) 
P-value (trend)      <0.001 
Note: maximum available sample size used with each indicator; educational attainment was categorised as 
none (none attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or 
Burnam B or higher); activity at each age was coded as inactive (no participation), moderately active 
(participated one to four times) and most active (participated five or more times), in the previous month (36 
years), per month (43 years) and in the previous 4 weeks (53 years);BMI = Body Mass Index; p value for 
trend using regression; * Smoking history up to age 36 using for WC at age 36, smoking history up to age 43 
using for WC at age 43, smoking history up to age 53 using for WC at age 53.  
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4.3.3 Prospective associations between adult WC and type 2 diabetes 
Prospective associations between categories of WC at ages 36, 43, 53 and type 2 diabetes 
diagnosed between 53 and 60-64 years are shown in Table 19 for men and Table 20 for 
women. At all ages, men within the high risk category (WC = 94-102 cm) had more than double 
the risk of type 2 diabetes compared with those within the normal WC range. Men in the very 
high risk category (WC> 102 cm) had a five-fold increased risk.  
Among women the risk for type 2 diabetes increased with higher WC categories, especially for 
the highest category, and this trend was stronger at older ages. Women within the very high risk 
category (WC> 88 cm) had a five-fold increased risk at age 43 and 14 times higher risk at age 
53 compared to those in the normal WC.  
For both sexes, adjustment for SEP, education, smoking and physical activity (Model 2 and 3) 
made little difference to risk estimates. After further adjustment for BMI however, the 
associations were considerably weakened particularly for men, for whom the associations with 
WC were no longer significant except for the very high risk category at age 43 (Model 4). 
Among women adjustment for BMI did not eliminate the associations between WC and type 2 
diabetes apart from age 36, although the associations for the highest category were greatly 
weakened (Model 4).  
Tests for trend showed that the risk of type 2 diabetes increased linearly across categories of 
WC, although after adjustment for BMI associations were not linear among men. In men for 
each 5 cm of WC the odds of type 2 diabetes increased by 28%, 41% and 39% at age 36, 43 
and 53 after adjustment for SEP, education, physical activity and smoking (Table 21, Model 3). 
The corresponding relative increase among women was 24%, 37%, 42% at age 36, 43 and 53. 
Inclusion of an interaction term between WC and BMI categories in these models showed a 
significant interaction (p<0.05) at age 36 and 43 for men and a weak interaction (p>0.05) at age 
53 for women, therefore analyses were stratified by BMI categories. The association between 
WC and type 2 diabetes was strong for men in the normal BMI category, particularly at age 43; 
there was also some evidence of an association between WC (at 36 years) and type 2 diabetes 
among overweight men, whereas among obese men, at all ages there was no evidence of an 
effect of WC on the odds of diabetes (Table 21). Similarly, obese women had smaller ORs for 
diabetes for each extra 5cm of WC compared with overweight and, particularly, normal weight 
women (Table 22). This differential effect increased with age and was higher at age 53 (normal 
BMI: OR=1.89 (95%CI: 1.26, 2.84); overweight: OR=1.40 (95%CI: 1.04, 1.88); obese: OR=1.29 
(95%CI: 1.12, 1.49). 
4.3.4 Lifecourse change in WC and type 2 diabetes 
Figure 7 shows the mean WC between age 36 and 53 by sex and type 2 diabetes. As before, at 
all ages those with diabetes diagnosed between age 53 and 60-64 had a higher WC compared 
to those without diabetes, with the difference being larger among women (Figure 7).  
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Table 23 shows the association between lifecourse change in WC and type 2 diabetes. For 
every 5-cm gain in WC between age 36 and 53 the risk of type 2 diabetes increased by 34% 
among men and 44% among women. Adjustments for SEP, education, physical activity and 
lifetime smoking did not affect the associations noticeably (Model 2 and 3). After further 
adjustment for BMI change between age 36 and 53 associations among women were 
weakened but were not eliminated, while among men the associations were significantly 
reduced.  
In models with categories of WC change (tertiles), the risk of diabetes for the highest tertile of 
change was considerably larger among women (OR: 6.28, 95%CI: 3.21, 12.27) then men (OR: 
2.71, 95%CI: 1.62, 4.53) after adjustment for lifestyle and social covariates (Model 3). After 
adjustment for BMI change the associations were weakened, but the highest tertile of WC 
change remained significant for both men (OR: 1.89, 95%CI:1.01, 3.53) and women (OR: 2.73, 
95%CI: 1.22, 6.11). 
When associations were stratified by baseline BMI categories (Table 24) WC change was 
associated with later diabetes only for men and women with a BMI <30kg/m
2
 (normal or 
overweight). The size of the association was larger for normal weight women whereas, normal 
weight and overweight men had similar risk estimates. In fully-adjusted models (Model 4) the 
associations remained significant only among women with a normal BMI. 
4.3.5 Sensitive periods of WC change and type 2 diabetes 
Figure 8 shows the mean WC velocity for the periods 36-43 and 43-53 years, by sex and type 2 
diabetes. For both men and women at both age intervals those with diabetes had higher WC 
velocities compared to non-diabetics. The difference in WC velocity between diabetic and non-
diabetic was larger among women especially between age 36 and 43. From figure 8 it can be 
seen that although WC velocity was larger at a later age, the difference between those who 
remained free of diabetes and those who developed it was slightly larger at 36-43 years (0.21 
cm/y for men and 0.44.cm/y for women) than 43-53 years (0.13 cm/y for men and 0.36 cm/y for 
women). 
For each period of the adult life course, conditional on previous WC, an increase in WC was 
associated with higher odds of type 2 diabetes in later life (Table 25). For both men and women 
the association between WC gain from 36-43 and type 2 diabetes was slightly larger than the 
association between 43-53 years however this was not statistically significant. Among men the 
odds of diabetes in fully-adjusted models (Model 3) were 1.62 (95%CI: 1.23, 2.14) per SD 
increase in WC velocity between 36-43 years and 1.48 (95%CI: 1.16, 1.88) for the period 43-53 
years. The corresponding ORs in women were 1.77 (95%CI: 1.42, 2.21) and 1.66 (95%CI: 1.36, 
2.09).  
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Table 19. Associations at each age between high risk and very high risk WC categories* and type 2 diabetes between age 53 and 60-64 
among men relative to normal WC 
 Model 1  Model 2  Model 3  Model 4  
 Unadjusted 
 
As Model 1 + SEP and 
education 
As Model 2 + physical activity, 
smoking history, 
As Model 3 + BMI  
 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
36 years (N=1068)         
High risk WC  1.63 (1.07, 2.60) 0.02 1.63 (1.04, 2.55) 0.03 1.59 (1.01, 2.50) 0.04 0.93 (0.56, 1.55) 0.80 
Very high risk WC 3.40 (1.91, 6.06) <0.001 3.33 (1.86, 5.98) <0.001 3.20 (1.77, 5.70) <0.001 0.88 (0.39, 1.99) 0.77 
P for linear trend <0.001  <0.001  <0.001  0.75  
43 years (N=1092)         
High risk WC 2.32 (1.48, 3.65) <0.001 2.29 (1.45, 3.60) <0.001 2.33 (1.47, 3.70) <0.001 1.57 (0.92, 2.67) 0.09 
Very high risk WC 5.65 (3.51, 9.08) <0.001 5.57 (3.45, 9.01) <0.001 5.81 (3.55, 9.49) <0.001 2.58 (1.23, 5.43) 0.01 
P for linear trend <0.001  <0.001  <0.001  0.01  
53 years (N=1075)         
High risk WC 2.09 (1.18, 3.70) 0.01 2.05 (1.16, 3.65) 0.01 2.08 (1.16, 3.71) 0.01 1.28 (0.69, 2.36) 0.41 
Very high risk WC 5.08 (3.01, 8.57) <0.001 4.93 (2.91, 8.33) <0.001 5.15 (3.09, 8.75) <0.001 1.52 (0.74, 3.14) 0.25 
P for linear trend <0.001  <0.001  <0.001  0.25  
Note: analyses restricted to those with non-missing data for WC, type 2 diabetes and all covariates for each age. BMI=Body Mass Index; SEP=socioeconomic 
position; WC=waist circumference. *  High risk category: WC of 94-102 cm; very high risk category = WC of >102 cm; categories of WC were defined according to 
the National Institute for Health and Care Excellence (NICE) cut-offs for increased risk of type 2 diabetes (279). 
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Table 20. Associations at each age between high risk and very high risk WC categories* and type 2 diabetes between age 53 and 60-64 
among women relative to normal WC 
 Model 1  Model 2  Model 3  Model 4  
 Unadjusted 
 
As Model 1 + SEP and 
education 
As Model 2 + physical activity, 
smoking history, 
As Model 3 + BMI  
 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
36 years (N=1174)         
High risk WC 2.27 (1.33, 3.87) <0.01 2.24 (1.30, 3.85) <0.01 2.24 (1.29, 3.88) <0.01 1.62 (0.90, 2.90) 0.10 
Very high risk WC 2.65 (1.57, 4.46) <0.001 2.50 (1.47, 4.26) <0.01 2.50 (1.46, 4.28) <0.01 1.17 (0.58, 2.37) 0.64 
P for trend <0.001  <0.001  <0.001  0.50  
43 years (N=1198)         
High risk WC 3.84 (2.25, 6.55) <0.001 3.73 (2.18, 6.38) <0.001 3.66 (2.13, 6.31) <0.001 2.83 (1.56, 5.13) <0.01 
Very high risk WC 6.17 (3.65, 10.42) <0.001 5.84 (3.42, 9.96) <0.001 5.77 (3.34, 9.96) <0.001 3.16 (1.41, 7.05) <0.01 
P for trend <0.001  <0.001  <0.001  <0.01  
53 years (N=1194)         
High risk WC 5.69 (2.30, 14.10) <0.001 5.69 (2.29, 14.10) <0.001 5.70 (2.29, 14.15) <0.001 4.32 (1.75, 10.84) <0.01 
Very high risk WC 14.20 (6.15, 33.09) <0.001 13.86 (5.92, 32.42) <0.001 13.91 (5.92, 32.66) <0.001 5.54 (2.10, 14.61) <0.01 
P for trend <0.001  <0.001  <0.001  <0.01  
Note: Analyses restricted to those with non-missing data for WC, type 2 diabetes and all covariates for each age. BMI=Body Mass Index; SEP=socioeconomic 
position; WC=waist circumference. *  High risk category: WC of 80-88 cm; very high risk category = WC of >88 cm; categories of WC were defined according to the 
National Institute for Health and Care Excellence (NICE) cut-offs for increased risk of type 2 diabetes (279). 
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Table 21. Associations at each age between WC and type 2 diabetes between age 53 and 60-64 among men by BMI categories 
  Model 1  Model 2  Model 3  Model 4  
  Unadjusted 
 
As Model 1 + SEP and education As Model 2 + physical activity, 
smoking history, 
As Model 3 + BMI  
 N OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
WC at Age 36 (5 cm)          
All men  1068 1.30 (1.17, 1.43) <0.001 1.29 (1.17, 1.43) <0.001 1.28 (1.16, 1.42) <0.001 0.98 (0.82, 1.17) 0.85 
By BMI category:          
BMI <25 kg/m
2
 607 1.24 (0.98, 1.57) 0.06 1.23 (0.97, 1.56) 0.07 1.23 (0.97, 1.55) 0.06   
BMI 25 – 29.9 kg/m
2 
 411 1.24 (1.00, 1.54) 0.05 1.24 (1.00, 1.54) 0.04 1.24 (0.97, 1.52) 0.05   
BMI 30 kg/m
2 
 50 0.76 (0.52, 1.09) 0.14 0.75 (0.50, 1.11) 0.15 0.66 (0.40, 1.08) 0.10   
WC at Age 43 (5 cm)          
All men  1092 1.41 (1.28, 1.56) <0.001 1.41 (1.28, 1.56) <0.001 1.41 (1.28, 1.56) <0.001 1.16 (0.96, 1.41) 0.10 
By BMI category:          
BMI <25 kg/m
2
 498 1.50 (1.12, 2.23) <0.01 1.69 (1.21, 2.37) <0.01 1.50 (1.12, 2.23) <0.01   
BMI 25 – 29.9 kg/m
2
 486 1.19 (0.96, 1.49) 0.10 1.20 (0.96, 1.49) 0.10 1.20 (0.96, 1.51) 0.10   
BMI 30 kg/m
2 * 108 0.98 (0.77, 1.25) 0.90 0.95 (0.74, 1.25) 0.72 0.96 (0.73, 1.24) 0.74   
WC at Age 53 (5 cm)          
All men  1075 1.37 (1.26, 1.50) <0.001 1.37 (1.25, 1.49) <0.001 1.39 (1.27, 1.52) <0.001 1.01 (0.83, 1.22) 0.10 
By BMI category:          
BMI <25 kg/m
2
 170 1.70 (1.05, 2.73) 0.02 1.68 (1.04, 2.73) 0.03 1.52 (0.91, 2.53) 0.10   
BMI 25 – 29.9 kg/m
2
 544 1.23 (0.97, 1.57) 0.08 1.22 (0.95, 1.56) 0.10 1.22 (0.96, 1.56) 0.10   
BMI 30 kg/m
2  * 227 1.06 (0.91, 1.25) 0.40 1.06 (0.91, 1.25) 0.41 1.04 (0.87, 1.23) 0.62   
Note: analyses restricted to those with non-missing data for WC, type 2 diabetes and all covariates for each age; BMI=Body Mass Index; SEP=socioeconomic position; WC=waist 
circumference. * p for interaction term between BMI category and WC <0.05 
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Table 22. Associations at each age between WC and type 2 diabetes between age 53 and 60-64 among women by BMI categories 
  Model 1  Model 2  Model 3  Model 4  
  Unadjusted 
 
As Model 1 + SEP and education As Model 2 + physical activity, 
smoking history, 
As Model 3 + BMI  
 N OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
WC at Age 36 (5 cm)          
All women  1174 1.26 (1.16, 1.36) <0.001 1.24 (1.14, 1.35) <0.001 1.24 (1.14, 1.35) <0.001 1.12 (0.99, 1.27) 0.06 
By BMI category:          
BMI <25 kg/m
2
 888 1.29 (1.13, 1.48) <0.001 1.28 (1.11, 1.47) <0.001 1.27 (1.10, 1.46) <0.01   
BMI 25 – 29.9 kg/m
2 
 217 1.12 (0.89, 1.43) 0.31 1.15 (0.89, 1.47) 0.26 1.18 (0.91, 1.52) 0.19   
BMI 30 kg/m
2 
 60 1.18 (0.92, 1.50) 0.17 1.20 (0.92, 1.56) 0.16 1.08 (0.81, 1.44) 0.56   
WC at Age 43 (5 cm)          
All women  1092 1.39 (1.27, 1.51) <0.001 1.37 (1.25, 1.50) <0.001 1.37 (1.25, 1.50) <0.001 1.32 (1.12, 1.56) <0.01 
By BMI category:          
BMI <25 kg/m
2
 740 1.55 (1.17, 2.06) <0.01 1.52 (1.14, 2.02) <0.01 1.54 (1.15, 2.05) <0.01   
BMI 25 – 29.9 kg/m
2
 306 1.46 (1.13 1.87) <0.01 1.44 (1.11, 1.86) <0.01 1.41 (1.09 1.84) <0.01   
BMI 30 kg/m
2 
 152 1.17 (0.98, 1.41) 0.08 1.16 (0.96, 1.40) 0.10 1.16 (0.96, 1.41) 0.10   
WC at Age 53 (5 cm)          
All women  1194 1.40 (1.30, 1.52) <0.001 1.39 (1.29, 1.51) <0.001 1.42 (1.30, 1.54) <0.001 1.30 (1.09, 1.55) <0.01 
By BMI category:          
BMI <25 kg/m
2
 450 1.84 (1.26, 2.68) <0.01 1.85 (1.24, 2.76) <0.01 1.89 (1.26, 2.84) <0.01   
BMI 25 – 29.9 kg/m
2
 442 1.41 (1.05, 1.88) 0.01 1.38 (1.03, 1.83) 0.02 1.40 (1.04, 1.88) 0.02   
BMI 30 kg/m
2 
 302 1.28 (1.11, 1.46) <0.001 1.27 (1.11, 1.46) <0.001 1.29 (1.12, 1.49) <0.001   
Note: Analyses restricted to those with non-missing data for WC, type 2 diabetes and all covariates for each age; BMI=Body Mass Index; SEP=socioeconomic position; WC=waist 
circumference. 
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Figure 7. Mean WC at 36, 43 and 53 years by sex and type 2 diabetes diagnosis at age 53 
to 60-64 
Note: Sample restricted to those with non-missing values for WC, type 2 diabetes and all 
covariates (N=2007
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Table 23. Associations between lifecourse change in WC and type 2 diabetes between age 53 and 60-64 
  Model 1  Model 2  Model 3  Model 4  
  Unadjusted 
 
As Model 1 + SEP and 
education 
As Model 2 + physical activity, 
smoking history, 
As Model 3 + 
BMI change* 
 
 N OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Men  
 
        
WC change age 36-53 (5 cm) 947 1.34 (1.17, 1.53) <0.001 1.33 (1.16, 1.52) <0.001 1.36 (1.18, 1.57) <0.001 1.03 (0.82, 1.30) 0.74 
Tertiles of WC change:          
< 5.3 cm 317 1  1  1  1  
5.4 – 11 cm 319 0.79 (0.43, 1.43) 0.44 0.77 (0.42, 1.41) 0.41 0.79 (0.43, 1.44) 0.45 0.68 (0.36, 1.26) 0.22 
> 11 cm 311 2.64 (1.60, 4.36) <0.001 2.55 (1.54, 4.22) <0.001 2.71 (1.62, 4.53) <0.001 1.89 (1.01, 3.53) 0.04 
P for trend  <0.01  <0.01  <0.01  0.28  
Women           
WC change age 36-53 (5 cm) 1060 1.44 (1.30, 1.61) <0.001 1.44 (1.29, 1.60) <0.001 1.44 (1.29, 1.61) <0.001 1.28 (1.04, 1.57) 0.01 
Tertiles of WC change:          
< 5.4 cm 354 1  1  1  1  
5.5 – 14 cm 355 2.87 (1.38, 5.94) <0.01 2.79 (1.34, 5.79) <0.01 2.90 (1.39, 6.05) <0.01 2.01 (0.95, 4.28) 0.06 
> 14 cm 351 6.47 (3.34, 12.53) <0.001 6.18 (3.18, 11.98) <0.001 6.28 (3.21, 12.27) <0.001 2.73 (1.22, 6.11) 0.01 
P for trend  <0.001  <0.001  <0.001  0.57  
Note: analyses restricted to those with non-missing data for WC, type 2 diabetes and all covariates; all models adjusted for WC at age 36. BMI=Body Mass Index; SEP=socioeconomic 
position; WC=waist circumference. * BMI change between age 36 and 53 
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Table 24. Associations between lifecourse change in WC and type 2 diabetes between age 53 and 60-64 by categories of baseline (age 36) BMI 
  Model 1  Model 2  Model 3  Model 4  
  Unadjusted 
 
As Model 1 + SEP and education As Model 2 + physical activity, 
smoking history, 
As Model 3 + BMI 
change* 
 
 N OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Change in WC from 36 to 53 
(5 cm) by BMI categories 
         
Men  
 
        
BMI <25 kg/m
2
 545 1.39 (1.09, 1.78) <0.01 1.38 (1.08, 1.76) 0.01 1.37 (1.07, 1.75) 0.01 1.18 (0.87, 1.60) 0.27 
BMI 25 – 29.9 kg/m
2 
 358 1.37 (1.14, 1.66) <0.01 1.37 (1.13, 1.65) <0.01 1.43 (1.17, 1.74) <0.001 1.06 (0.76, 1.49) 0.79 
BMI 30 kg/m
2 
 44 0.95 (0.61, 1.49) 0.83 0.78 (0.46, 1.34) 0.45 0.79 (0.43, 1.45) 0.45 0.93 (0.42, 2.06) 0.87 
Women           
BMI <25 kg/m
2
 801 1.64 (1.40, 1.93) <0.001 1.64 (1.39, 1.92) <0.001 1.64 (1.39, 1.94) <0.001 1.44 (1.14, 1.82) 0.01 
BMI 25 – 29.9 kg/m
2 
 199 1.49 (1.20, 1.85) <0.01 1.47 (1.17, 1.83) <0.01 1.48 (1.17, 1.87) <0.01 1.32 (0.88, 1.99) 0.17 
BMI 30 kg/m
2 
 60 1.29 (0.95, 1.75) 0.09 1.25 (0.94, 1.66) 0.11 1.36 (0.96, 1.93) 0.07 1.29 (0.68, 2.44) 0.43 
Note: analyses restricted to those with non-missing data for WC, type 2 diabetes and all covariates; all models adjusted for WC at age 36. BMI=Body Mass Index; SEP=socioeconomic 
position. * BMI change between age 36 and 53 
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Figure 8. Mean WC velocity (cm per year) at different periods by sex and type 2 diabetes 
diagnosis between 53 and 60-64 years.  
Note: Sample restricted to those with non-missing values for WC, type 2 diabetes and all 
covariates 
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Table 25. Associations between conditional WC velocity at different age intervals and type 2 diabetes between age 53 and 60-64 
 Model 1 
 
Model 2  Model 3  
 Unadjusted 
 
Adjusted for SEP 
and education 
 As Model 2 + 
adjusted for physical 
activity and smoking 
history 
 
 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Period of change        
Men, n=947       
36-43 years 1.60 (1.22, 2.11) <0.01 1.59 (1.21, 2.10) <0.01 1.62 (1.23, 2.14) <0.01 
43-53 years 1.44 (1.14, 1.81) <0.01 1.42 (1.12, 1.79) <0.01 1.48 (1.16, 1.88) <0.01 
P* for difference between periods         0.55  0.55  0.61  
Women, n= 1060       
36-43 years 1.82 (1.46, 2.25) <0.001 1.77 (1.42, 2.20) <0.001 1.77 (1.42, 2.21) <0.001 
43-53 years 1.68 (1.35, 2.08) <0.001 1.69 (1.37, 2.09) <0.001 1.66 (1.36, 2.09) <0.001 
P* for difference between periods         0.69  0.77  0.75  
Note: analyses restricted to those with non-missing data for WC at age 36, 43 and 53, type 2 diabetes and all covariates. SEP=socioeconomic position, WC=waist 
circumference; OR of type 2 diabetes for a 1 SD increase in WC in each interval conditional on previous WC; P for difference between periods estimated with 
Wald’s test 
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4.4 Discussion 
4.4.1 Main findings 
The main findings of this chapter are that for both genders, at any time of the adult life course, 
having a large WC is associated with a greater risk of type 2 diabetes being diagnosed between 
age 53 to 60-64 years. The relative risk is especially high among older women with a WC 
greater than 88 cm (high risk WC category).  A high WC is a risk factor for type 2 diabetes in 
normal weight and overweight, but not obese, men and women. 
Long-term WC change, conditional on initial WC, was associated with increased risk of 
diabetes; the associations were independent of concomitant BMI change only for men and 
women in the highest tertile of WC change. Also, changes in WC are particularly important for 
people who have an initially normal BMI. There was no particular period over the adult life 
course during which WC gains were more detrimental for later diabetes risk. 
1
st
 objective: To analyse the association between WC measured at different time points in the 
adult life (age 36, 43 and 53 years) and type 2 diabetes 
It was hypothesised that WC would be independently associated with type 2 diabetes and that 
this association would be stronger for women. In support of the first hypothesis, at all ages (36, 
43 and 53 years) people with a larger WC had higher risks of type 2 diabetes compared with 
those with a normal WC. The effect of abdominal obesity was only marginally affected by 
confounding factors. In agreement with other studies (65-77) these findings suggest that having 
a very large (clinically defined) WC, at any age during the adult life course is strongly associated 
with later type 2 diabetes. The size of the association was similar between men and women at 
age 36 but became increasingly larger for women at age 43 and especially at age 53. 
Adjustment for BMI significantly weakened most of the associations for men while associations 
remained significant among women, for whom the risk was still strong at the highest category of 
WC. These results, taken together with those in chapter 3, seem to confirm that the effect of 
WC is relatively more important for women than for men, as previous studies have suggested 
(75-78), especially once the effect of overall obesity is removed. However, in two large studies 
such as the EPIC InterAct (76) and the Spanish Epic (75), WC remained significantly associated 
with diabetes among men after adjustment for BMI, a discrepancy that could be attributed to 
differences in power. 
2
nd
 objective: To assess whether the effect of WC on type 2 diabetes risk is different according 
to different levels of BMI 
It was hypothesised that the relative risk of type 2 diabetes for a raised WC would differ 
according to BMI categories. In agreement with the second hypothesis the results showed that 
in both men and women the association between abdominal obesity and diabetes was relatively 
more important among people with a lower BMI, particularly those within the normal BMI 
category. On the contrary for obese people, except obese women at age 53, there was no 
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relative increase in diabetes risk. The difference among BMI categories was stronger at age 53, 
particularly for women, although the overlapping confidence intervals suggest a non-significant 
difference. These results are in agreement with previous studies (75, 276, 277) that found an 
interaction between WC and BMI, so that the association between WC and diabetes was 
strongest among individuals with a normal BMI. It has been suggested that in people with a 
lower BMI, WC could be a better indicator of visceral fat, since these individuals have less total 
subcutaneous fat compared with those with a higher BMI. Therefore, results suggest that WC is 
a good discriminator of type 2 diabetes risk in normal BMI individuals because it is a direct 
measure of visceral fat. Whereas, among obese individuals WC is not an independent risk 
factor for diabetes because this groups is already at increased risk of diabetes due to the 
metabolic dysfunction brought about by their large total amount of adipose tissue, which seems 
to override the association between WC and diabetes. Indeed in this cohort the correlation 
between WC and BMI was higher among obese people than it was among those with a normal 
weight, suggesting that the measurement of WC would not add any additional risk information 
when total body fatness is already very high  (Appendix 7). For example, at age 53 the 
correlation between WC and BMI was 0.78 for obese men and 0.79 for obese women, while the 
corresponding correlations among individuals with a BMI<25 kg/m
2 
were 0.56 for men and 0.53 
for women. 
3
rd
 objective: To investigate whether WC changes during the adult life-course are associated 
with later risk of type 2 diabetes independently of initial WC and of concurrent BMI changes 
It was hypothesised that increases in WC over the lifecourse would be associated with type 2 
diabetes risk independently of BMI changes and that this association would be stronger for 
women. As hypothesised, long-term WC changes from age 36 to 53 years were associated with 
type 2 diabetes at age 53 to 60-64 for both genders. The size of the associations was stronger 
and the trend of increasing risk with larger WC measures was more robust among women. This 
is in line with analyses of WC and diabetes at one point in time and in accordance with the few 
studies that analysed WC change over varying lengths of time (79, 113, 117, 119). 
Importantly, the associations among the highest tertile of WC change (>11 cm for men and >14 
cm for women) were independent of concomitant BMI change. Interestingly even before 
controlling for BMI change, moderate WC changes (5.4-11 cm for men and 5.5-14 cm for 
women) were not significantly related to diabetes among men but were strongly related to risk 
among women. This result is similar to the findings from the Health Professional Follow-up 
Study (113), which found that among men only very large WC gains (14.6 cm) were related to 
diabetes risk both before and after controlling for weight change. Only one study (119) reported 
WC change separately for men and women and found that short-term (5 years) WC changes, 
independent of BMI changes, were not related to diabetes in men and only moderately related 
to risk among women. However, that study only analysed WC change as a continuous variable, 
and as this thesis has shown, this would miss important information about a group of people 
with large WC gains, who are at particular high risk of diabetes. Furthermore 5 years might not 
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be a long-enough time to assess life-course WC gains, which are likely to accumulate over a 
long period. This thesis adds to previous evidence the important finding that for women long-
term WC change is a key risk factor for metabolic disorders even at moderate levels of change 
and that large WC gains are particularly detrimental. The fact that the effect of large WC gains 
on diabetes was independent of BMI change points to the need for monitoring WC regularly to 
prevent large WC gains in the long-term, even in the absence of weight gain, particularly among 
women. 
4
th
 objective: To assess whether the effect of lifecourse WC change on type 2 diabetes risk is 
different according to levels of initial BMI 
It was hypothesised that associations between WC increases and diabetes would be stronger 
for people with an initial lower BMI. In agreement with this hypothesis, the association of WC 
changes between age 36-53 with type 2 diabetes was stronger for individuals who initially (age 
36) had a lower BMI independently of initial WC. Only one previous study (79) presented 
associations between WC and diabetes by BMI level (BMI < or 25 kg/m
2
) and found similarly 
that the risk of progression to diabetes was higher among those with an initially lower BMI. 
However, that study did not present results separately for men and women and only included 
individuals with IFG. Thus this thesis expands on previous evidence by including analyses 
stratified by sex and BMI categories in the same model. Among obese men and women, waist 
change did not make a significant difference to the risk of future diabetes. On the contrary, the 
risk was particularly increased for women with a BMI<25 even after adjustment for BMI change, 
while for men the risk estimates were of similar size for overweight and normal weight 
individuals, although these were not independent of BMI change. These findings are in line with 
those in prospective analyses and suggest that, given a certain WC, change in abdominal 
fatness is a better indicator of metabolic risk for those who start with a lower total amount of 
body fatness. Crucially, among women with an initially normal BMI a WC change in the absence 
of BMI change would still predict diabetes risk suggesting a benefit of measuring abdominal 
changes among this group. 
5
th
 objective: To investigate whether WC gain at different periods of the adult life (36 to 43 and 
43 to 53 years) has a different impact on later risk of type 2 diabetes 
This chapter also explored sensitive periods of WC gain, which to the author’s knowledge, has 
not been investigated before. At any period of the adult life WC changes were significantly 
correlated with later diabetes risk for both men and women. There was some suggestion that 
WC changes at an earlier stage of the adult life (36-43 years) were more detrimental than 
changes at a later stage (43-53 years) however these differences were not significant. 
Interestingly, results of analyses of sensitive periods of BMI velocity in chapter 3 showed that 
BMI gains between 43-53 years were more detrimental for future diabetes risk than BMI 
changes between 36-43 years. This difference suggests that BMI and WC patterns of change 
are not parallel. 
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As it can be observed in figure 8, mean WC velocity difference between those who remained 
free of diabetes and those who developed diabetes appears to be converging with age. 
However, the graph also shows that those who developed diabetes had faster WC gains from 
an early adult age; it is probable that an earlier increase will lead to a larger WC in later life, as 
is clear from figure 6. Interestingly, while for men WC velocity seems to be fairly constant, 
women had substantially faster WC gain between 43-53 years irrespectively of their diabetes 
diagnosis. This fast increase probably coincides with the hormonal changes of the peri-
menopausal stage, which facilitates abdominal fat accumulation.  
4.4.2 Strengths 
One of the main strengths of this chapter is that unlike most studies on abdominal obesity, it 
used repeated measures of WC at three ages during the adult life course. Only few studies 
have analysed WC change over time and all used only 2 time points. The availability of 
repeated WC measures allowed the exploration of sensitive periods of WC gain in relation to 
type 2 diabetes, which have not been investigated before.  
Another strength is that, unlike some studies, which used self-reported measures, 
anthropometric values were measured by trained nurses using a standardized protocol at 36, 43 
and 53. Poor agreement between self-reported and technician-measured WC has been 
reported, with self-reported measurements underestimating WC in both men and women (283, 
284); furthermore underestimation increases with higher BMI and WC (283). 
Lifecourse analyses of WC in relation to type 2 diabetes are limited in the literature; only a few 
of these studies investigated WC changes according to BMI level and assessed men and 
women separately. The findings from this chapter add to the previous literature by investigating 
long-term analyses of WC change by sex and initial BMI category in the same model, while also 
including adjustment for BMI change.  
4.4.3 Limitations 
As in the previous chapter, complete case analyses were conducted with only study participants 
having data for all WC measures and type 2 diabetes status as well as for all covariates 
included in the analyses. However, as already demonstrated in the previous chapter, Appendix 
3 shows that those with non-missing data for the outcome and all covariates were very similar to 
those in the maximum sample available for each covariate and type 2 diabetes. At all ages, 
there was no difference in mean WC between the maximum sample available and those with 
missing values. However, as shown in Appendix 3 and 4, those with missing values for 
anthropometric measurements (WC measures were taken at the same time as height and 
weight, therefore missing values for BMI and WC are essentially the same number) were less 
educated and more likely to be men, to be in a lower SEP, and to be smokers. 
A possible limitation of this chapter is the sample size used in stratified analyses, which might 
have resulted in lack of power. This was mainly an issue with analyses stratified by BMI 
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categories because of the few obese people at age 36. However, results were in agreement to 
previous large prospective studies, suggesting that if lack of power was an issue, it was 
probably limited.  
4.4.4 Conclusions 
This chapter has shown that at any age having a large WC is positively associated with later 
type 2 diabetes. A large WC is particularly detrimental for women and the relative risk is higher 
for those with a normal BMI.  
Long-term, as well short-term WC change is associated with increased diabetes risk but among 
men only large WC gains are independent of concurrent BMI changes. Women in the normal 
BMI category have the greatest relative risk of diabetes with increasing WC changes. 
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5 Chapter 5. Dietary fibre, dietary GI, dietary fat, SFA and type 2 diabetes 
5.1 Introduction 
Although age and obesity are considered the most important risk factors for type 2 diabetes, an 
increasing amount of evidence points to the role of diet as a key player in metabolic 
abnormalities, not only as a major contributor to body weight but also as a direct risk factor. 
Among the various dietary factors investigated, the evidence is strong for dietary fibre, the GI of 
foods, and dietary fats, particularly SFA.  
5.1.1 Dietary fibre 
Dietary fibre, for which wholegrain cereals, legumes, fruit and vegetables are rich sources, have 
been extensively studied in recent years; evidence supports their beneficial role in reducing 
post-prandial glycaemic response and improving insulin resistance (152, 156, 165, 166). A large 
number of prospective studies report a protective role for total dietary fibre against type 2 
diabetes (131, 137, 142, 145, 147, 162). The latest meta-analysis (285) including 12 
prospective studies up to 2013 reported a RR of 0.81 (95%CI: 0.73-0.90) for high versus low 
intake of fibre. This meta-analysis also included a dose-response analysis based on 5 studies 
showing a nonlinear association between total dietary fibre intake and type 2 diabetes; there 
was a threshold effect for fibre with the risk for the disease significantly decreased only when 
total fibre intake reached at least 25g/day (285). A number of large prospective studies that 
analysed the source of fibre in the diet showed that the strongest risk reduction for type 2 
diabetes is obtained by consumption of cereal fibre rather than fruit or vegetable fibre. A recent 
systematic review (286) including 11 reports from 9 mostly large prospective cohort studies 
showed a risk reduction of 18-40% when high intake of cereal fibre was compared to the lowest 
intake. Nearly all studies reported a linear trend of reduced risk with increasing cereal fibre 
intake. A meta-analysis (285) reported a pooled RR for type 2 diabetes for high versus low 
cereal fibre of 0.77 (95%CI: 0.69-0.85). This risk reduction was significantly greater than that 
associated with fruit fibre (0.94, 95%CI: 0.88-0.99) and vegetable fibre (0.95, 95%CI: 0.84-
1.07). As opposed to total dietary fibre, a linear relationship between cereal fibre and diabetes 
was found; the risk decreased by 6% for each 2g/day increase in cereal fibre (285). Although 
these meta-analyses are in agreement regarding the apparent protective role of fibre, 
particularly from cereal sources, reviews cannot eliminate the bias inherent in each study. For 
example, although most of the studies included were large and adjusted for major confounders, 
not all adjusted for either education or social class, which are known to be associated with 
diabetes incidence. 
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5.1.2 Glycemic Index 
A growing body of evidence indicates that diets with a high GI are associated with increasing 
risk of type 2 diabetes (131, 137-142, 144, 146). However, as outlined in chapter 1, there are 
some discrepancies in results, with a few studies not showing significant associations (145-147) 
Explanations for these divergent results include the use of different dietary assessment tools, 
some of which were not designed to assess GI, differences in the populations studied and the 
varying range of GI values (143, 287). Discrepancies in the assignment of GI values can also 
impact on the ranking of participants (287). A 2011 meta-analysis, which included 13 
prospective studies reported a 16% increased risk of diabetes for the highest dietary GI 
category compared with the lowest (140). Most major confounders were accounted for in the 
studies, however there was some unexplained heterogeneity among studies included. A more 
recent meta-analysis that included additional large cohorts (288-290) (291), also assessed the 
dose-response relationship between dietary GI and type 2 diabetes (291). Based on 15 included 
studies,  the authors reported an adjusted RR for a linear dose-response of 1.08 (95% CI: 1.02, 
1.15) per 5 GI units (291). There was some heterogeneity between studies, some of which was 
explained by length of follow-up and adjustment for covariates, especially family history of 
diabetes. 
It has been reported that the detrimental effect of dietary GI might be more pronounced among 
overweight and obese people, who are often more insulin resistant than normal weight 
individuals (292). This has been confirmed in a few prospective studies (139, 142, 144) but not 
in others (140, 141). An interaction between GI and dietary fibre has also been observed in 
cohort studies with those individuals consuming a diet with the highest GI and the lowest fibre 
density having the highest risk of diabetes (131, 137, 145). 
5.1.3 Total and saturated fats 
Epidemiological evidence from prospective cohort studies support the view that both total 
dietary fats and SFA may contribute to type 2 diabetes development (165-170). Furthermore, 
intervention trials to prevent type 2 diabetes conducted among at-risk individuals have 
demonstrated that a low-fat diet was an important determinant of reduced type 2 diabetes 
incidence (59, 121, 122, 178). For example, in the Finnish Diabetes Prevention Study those with 
the highest total fat intake had a two-fold increased risk of diabetes compared with participants 
with the lowest intake, even after adjustment for weight change (122). However, some studies 
that did not find an association between dietary fats and type 2 diabetes (51, 137). One reason 
for these discrepancies might be measurement error; fat intake is especially prone to 
underreporting given the negative image of high-fat diets portrayed by media and nutritional 
guidelines in the last decades (293).  
Despite the growing number of studies investigating the association between dietary factors and 
type 2 diabetes, only a few British studies have analysed GI, which has been primarily 
investigated in United States and Australian cohorts.  
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5.1.4 Mechanisms of action: direct and indirect pathways 
There are different plausible physiological mechanisms through which dietary fibre, GI and 
dietary fats can affect type 2 diabetes risk either independently or through the mediating effects 
of BMI and WC, most of which have explained in detail in chapter 1.  
High GI foods induce postprandial hyperglycaemia, which may have cumulative glucotoxic 
effects on pancreatic -cells, thus affecting insulin secretion (132). Postprandial hyperglycaemia 
also leads to a quicker fall in blood glucose levels, which in turn triggers a counter-regulatory 
hormonal response with consequent raised circulating FFA levels (132, 133); these have been 
linked to insulin resistance and -cells dysfunction.  
Dietary fibre has a lowering effect on the postprandial glycaemic response, thus leading to 
improved insulin sensitivity (165); dietary fibre, especially fibre that undergoes extensive 
fermentation in the gut, have strong anti-inflammatory properties (157-159, 286), helping to 
counteract the pro-inflammatory action of environmental stressors, such as obesity and over 
nutrition (15). 
Evidence shows that increased fat intake can promote insulin resistance and inflammatory 
responses (182, 183) while SFA can disrupt insulin signal pathways and promote postprandial 
hyperinsulinaemia (189, 191). SFA in particular can disrupt -cells functionality and worsen 
insulin resistance (187-189).  
Although the above-mentioned pathways are mostly independent of body weight, one of the key 
mechanisms by which these nutritional factors could be linked to diabetes is their involvement in 
energy regulation, caloric intake and abdominal fat storage. For example, the GI of a meal can 
affect food intake at the subsequent meal by modulating satiety signals; thus a low-GI diet can 
indirectly promote weight loss or maintenance (134). Dietary fibre has a similar satiety 
regulating action by affecting intestinal hormones and by directly stimulating the digestive tract 
(156); the bulk action and low energy-density of dietary fibre also promote satiation at meals 
(154). Dietary fats, on the other hand, have high energy density and a low satiating effect 
promoting overconsumption (179). Furthermore, there is some evidence that a high GI diet 
might promote preferential abdominal fat storage (135, 136) while a diet high in dietary fibre 
might reduce this (294-297). It has been suggested that the effects of GI and fibre on WC might 
be due to the higher susceptibility of visceral fat to the detrimental effects of strong insulin 
responses (135).  
Therefore, BMI and WC are important potential mediators in the association between GI, dietary 
fiber and dietary fats and type 2 diabetes. 
5.1.5 Previous findings from the MRC NSHD 
Prynne et al (298) previously investigated changes in nutrient intake over 17 years using data 
from age 36, 43 and 53 years. The percentage of energy from fat fell while that from 
carbohydrates increased by age 53. They reported that the fall in fat intake might be a 
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consequence of the shift in consumption from whole milk to semi-skimmed or skimmed milk, 
and from butter to vegetable spreads. The type of meat also changed with a shift from red meat 
to poultry. The consumption of fruit and vegetables rose while that of potatoes and bread 
decreased, substituted by other types of carbohydrates, such as pasta, rice and pizza. 
Prynne et al (299) investigated nutrient intake at age 36, 43 and 53 in relation to HbA1c at age 
53. They found that lower intakes of iron, folate and fibre at age 36 and lower consumption of 
protein and carbohydrates and a higher energy from fat at age 43 were significantly associated 
with higher HbA1c at age 53. At age 53, none of the nutrients investigated was cross-sectionally 
associated with high HbA1c. 
This chapter will build on the earlier analyses conducted in the NSHD by investigating 
associations between dietary fibre, GI (not previously derived in the NSHD) and dietary fats 
(both total and SFA) in adult life in relation to type 2 diabetes diagnosed between age 53 and 
age 60-64.  
5.1.6 Research question 
The main research question of this chapter is how dietary fibre, GI and dietary fats intake 
throughout adult life affect type 2 diabetes risk in later life. 
5.1.7 Objectives 
1. To analyse the association between dietary fibre, GI and dietary fats intake at age 36, 
43 and 53 years and type 2 diabetes diagnosed between age 53 and 64 years  
2. To assess whether the association between fibre, GI and fat is mediated by BMI and 
WC 
3. To investigate whether associations between dietary factors and type 2 diabetes are 
stringer among those with higher BMI or WC 
5.1.8 Hypotheses 
1. Low fibre intake, high GI and high fat intake are prospectively and positively associated 
with increased risk of type 2 diabetes  
2. The association between these dietary factors and type 2 diabetes will be mediated in 
part by BMI and WC, however direct associations between the above dietary factors 
and type 2 diabetes will remain 
3. A positive association between dietary GI and type 2 diabetes will be stronger among 
overweight and obese people than those with a normal BMI 
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5.2 Methods 
5.2.1 Explanatory variables  
The main explanatory variables used in this chapter are dietary fibre density (g/1000kcal), GI 
(units), total dietary fat density (g/1000kcal) and SFA density (g/1000kcal) at age 36, 43 and 53. 
The nutrient density method was adopted to account for confounding by total energy intake. 
Dietary fibre density was calculated as total daily g fibre (non starch polysaccharide) divided by 
total daily energy intake (kcal) multiplied by 1000. Fat density and SFA density (g/1000kcal) 
were calculated as total daily g fat or SFA divided by total daily energy intake (kcal) multiplied 
by 1000. This method was chosen because it can be calculated directly and it has been used in 
national dietary guidelines (300). Dietary intake was assessed using 5-day food diaries, details 
of which have been described in chapter 2. 
5.2.2 Assignment of GI values  
During the second year of this PhD the author, in collaboration with two members of the MRC 
HNR Emily Fitt and Nida Ziauddeen, undertook a project to assign GI values to the DINO food 
codes, as GI values were previously not available in the NSHD data base. Glycemic index 
values were assigned to each food using the methodology described in detail by Aston et al 
(301), which was developed to calculate the GI of diets reported in food diaries in the pan-
European Diogenes intervention study (302). Briefly, all food codes with total carbohydrate 
>0.1g per 100g were assigned a GI value, based on five levels of data confidence relating to 
source of the data used, with levels 1 being the highest. The five decreasing levels of 
confidence were: 1) Measured values; 2) Published values; 3) Equivalent values; 4) Estimated 
values; 5) Nominal values. Details of each level of confidence are given in Table 26. 
Although a few researchers have expressed some concerns regarding the use of GI in mixed 
meals (303, 304), many studies have demonstrated that GI of mixed diets can be sufficiently 
reliably calculated as the weighted mean of the GI of each food item within the meal (305-308). 
Thus, the average GI of the daily diet was calculated by assigning a GL value for each food 
item, then summing the GL values for the day and dividing this by the total daily carbohydrates. 
This method was initially proposed by Wolever et al (307) and was subsequently endorsed by 
the Food and Agriculture Organization (309). 
5.2.2.1 Missing data for dietary intake 
In Appendix 8 individuals who completed diet diaries were compared with those who did not 
provide dietary information at each age; at all ages completers were more likely to be female 
and to be more educated and less likely to be in manual employment and to be smokers. At age 
36 and 53 completers were also less likely to be obese, have a raised WC and, at age 53, to be 
inactive. 
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Table 26. Levels of confidence* used for the assignment of GI values in the NSHD 
dataset 
Levels 1: Measured values Where the GI of a specific food had been measured at one 
of the research centres taking part in the Diogenes study or 
by the product manufacturer following the published 
standardized protocol (310) 
Levels 2: Published values When the GI of a specific food was not measured directly 
but a published value (311-313), of the same item existed 
Levels 3: Equivalent values When there was no exact published value match but the 
value for a similar food had been published (311-313) 
Levels 4: Estimated values When no published value existed of a similar item an 
estimate was made to one of three values representing low 
(45), medium (63) and high GI (85) based on the mid-point 
of each category (314) 
Levels 5: Nominal values Assigned as 70, when no similar value existed and there 
was not enough information to assign an estimated value; 
this methodology had previously been used with the 
purpose of avoiding biasing the total dietary GI towards the 
null when zero is assigned to missing values (315) 
*Adapted from Aston et al (301) 
5.2.3 Outcome variable 
The outcome used in this chapter is the main outcome of this thesis, type 2 diabetes diagnosed 
between age 53 and 60-64 years. This is described in more detail in Chapter 2.  
5.2.4 Potential confounding variables 
As outlined in chapter 1 and 2, SEP, both as occupational class and as educational attainment, 
is an acknowledged risk factor for type 2 diabetes. It is well established that diet quality follows 
a socioeconomic gradient with healthier diets being associated with higher diet quality (316). 
People in higher SEP groups tend to consume more whole grains, fresh vegetables and fruit, 
fish and low-fat dairy products, while those in lower SEP groups are more likely to consume 
refined grains, potatoes, fried foods, fatty meats and added fats (317-320). These associations 
might be mediated by diet cost, social network, knowledge and attitude towards food (321-323). 
Physical inactivity and smoking were considered potential confounders as these may be related 
to both diet and type 2 diabetes risk. People who consume unhealthy diets are also more likely 
to be inactive and to smoke, since unhealthy lifestyle choices tend to correlate with each other 
(41, 44). On the other hand smoking cessation is also associated with increased energy intake 
(271).  
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BMI and WC were considered mediators since one of the mechanisms though which fibre, GI 
and fats affect diabetes risk is their role in body weight and abdominal fat accumulation. 
SEP was based on lifetime socio-economic position based on the head of the household’s 
occupational social class at age 15-53 years and highest level of educational qualification 
achieved by age 26 years. Self-reported measures of leisure time physical activity at 36, 43 and 
53 years were used as potential confounders. Three categorical variables of smoking history up 
to 36, 43 or 53 were used as measures of cumulative smoking damage.  
More detailed descriptions of the potential confounding measures used in this chapter are given 
in Chapter 2. 
5.2.5 Statistical analyses 
Descriptive analyses compared the proportions of mean and women and those with type 2 
diabetes (diagnosed between age 53 and 60-64), mean of intakes of energy, macronutrients 
(carbohydrates, protein, fat and alcohol) and of the exposure variables according to quintile of 
intake of fibre density, GI, fat density and SFA density. Mean or median (when the distribution 
was skewed) of fibre density, GI, fat density and SFA density were graphed by survey year and 
sex. Food groups with highest correlations with fibre density, GI, fat density and SFA density 
are presented. Associations of potential confounders with fibre density, GI and fat density at age 
36, 43 and 53 and the outcome were examined using linear regression or bivariate analyses. 
Multivariable logistic regression was used to examine, in separate models for each dietary 
exposure, prospective associations between fibre density, GI, total fat density and SFA density 
at 36, 43 and 53 years of age and incident type 2 diabetes between age 53 and 60-64 years.  
For all analyses associations were first presented unadjusted (Model 1). A series of models 
were then constructed to sequentially adjust for socio-economic status and educational 
attainment (Model 2), smoking history and exercise (Model 3), BMI (Model 4) and abdominal 
circumference (Model 5).  
Interactions between dietary factors and sex, BMI or WC were tested by inclusion of interaction 
terms in the model with both main effects and p values were reported. 
5.2.6 Sample 
All analyses were restricted to those participants who provided data on type 2 diabetes 
diagnosed between age 53 and 60-64, diet and for all confounders (SEP, education, smoking 
history, BMI, WC). The final number was different depending on the year of the dietary 
assessment (N=1804 for age 36; N=2267 for age 43; N=1477 for age 53). 
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5.3 Results 
5.3.1 Descriptive analyses 
Nutritional characteristics and type 2 diabetes diagnosis (age 53 to 60-64) by quintile of intake 
of fibre density, average daily GI, fat density and SFA density at age 36, 43 and 53 for 
participants included in prospective analyses are shown in Tables 27-29. At all ages the 
percentage of male participants was significantly lower in the highest quintiles of fibre intake 
and higher in the highest quintiles of average GI. At all ages, the proportion of people diagnosed 
with type 2 diabetes between age 53 and 60-64 decreased with increasing quintiles of fibre 
intake and increased with higher GI quintiles, in a clear dose-response manner. The relationship 
between fat, SFA and diabetes was less straightforward; there was no apparent pattern at age 
36, and a non-significant tendency for the proportion of diabetes to increase with higher fat 
quintiles, and to a lesser extent SFA quintiles, at age 43 and 53. At age 36 women were more 
likely to be in the highest quintiles of fat and saturated fat intake, while the opposite was true at 
age 53. At all ages high fibre density intake was associated with a lower GI and lower energy, 
total fat, SFA, and alcohol intakes and with higher carbohydrates and protein intakes (p for trend 
<0.01). Average daily GI was positively associated with energy intake and alcohol and 
negatively associated with protein and fibre (p for trend <0.001). At age 36 fat and SFA tended 
to decrease with increasing quintiles of GI, while the opposite was true at age 43 and 53. At all 
ages, those in the highest quintiles of fat and SFA intake consumed less carbohydrates, fibre 
and alcohol. 
Figure 9. Mean or median intakes by age and sex for a) fibre density b) GI c) fat density and d) 
Saturated fat density shows the mean (or median when distribution was found to be skewed) 
intakes of the explanatory variables by age and sex. The median fibre density intake was similar 
at age 36 and 43 but considerably higher at age 53 for both genders, although women had 
higher intakes at all ages. Mean GI decreased with age and was lower for women at all ages. 
Median fat density and SFA density was similar at age 36 and 43 and substantially lower at age 
53. Figure 10 shows the mean or median intakes of dietary factors by age and diabetes 
incidence between age 53 and 60-64. At all ages those who developed diabetes had a diet with 
higher GI and lower fibre density compared to those who did not develop the disease, while 
there was little difference in fat and SFA intakes. 
Table 30 shows food groups correlated with fibre, GI and dietary fats. Foods positively 
correlated with fibre density were similar at all ages and included fruit, which had the strongest 
correlation, vegetables, high-fibre breads and cereals and low-fat dairy products. White bread, 
table sugar (sucrose), butter/animal fat, red or processed meat and potatoes had the strongest 
negative correlations with fibre. Alcohol was negatively correlated with fibre intake at age 43 
and age 53. White bread, table sugar and potatoes (either fried or not) were the foods with the 
highest positive correlation with GI, while fruit, yogurt and low-fat milk had the highest negative 
correlations. At all ages butter and animal fat had the strongest correlation with fat and 
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particularly with SFA density. Full-fat dairy products and biscuits, pastry and cakes were 
positively correlated with fat and SFA at all ages while processed meat was correlated at age 43 
and 53. Low-fat dairy products as well as low-fat plant fat were negatively correlated with fat 
and SFA at all ages. At age 43 and 53 fruit and alcohol had strong negative correlations with fat 
and SFA. 
5.3.2 Investigation of potential confounders 
People from a lower socio-economic class, especially those in manual employment, and with 
lower educational attainment consumed less fibre and had a diet with a higher GI at all ages 
(Table 31-33). Fat intake was associated with education only at age 43. There was a tendency 
for people with higher BMI and WC to consume less fibre (except for BMI at age 36) and have a 
higher GI compared to those with a lower BMI and WC with associations being stronger for WC. 
Fat was inversely associated with BMI and WC at age 36 but positively associated with WC at 
age 53. Never smokers had higher fibre and lower fat (except at age 36) intake and lower GI. 
More active people had significantly higher fibre and lower fat intake and lower GI. 
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Table 27.  Nutrient intakes and diabetes status (age 53 to 60-64) by quintiles of fibre density, GI, fat density and SFA density at age 36 
N=1804 Quintile of daily intake of fibre density* Quintile of daily GI  
 Q1 Q2 Q3 Q4 Q5 P value Q1 Q2 Q3 Q4 Q5 P value 
Range <4.5 4.5-5.1 5.2-5.9 6.0-7.2 7.3-27.6  <61.3 61.3-63.6 63.7-65.6 65.7-67.8 67.9-76.8  
Median 4.1 4.8 5.6 6.5 8.6  59.2 62.6 64.7 66.8 69.4  
Male (%) 62.6 54.2 51.5 38.5 30.2 <0.001 22.8 41.1 50.1 61.3 70.1 <0.001 
Diabetes (%) 11.3 11.3 9.1 7.4 7.5 0.01 7.2 8.5 8.4 11.1 12.1 0.01 
Energy, kcal 2286 ± 605 2164 ± 591 2044 ± 572 1935 ± 614 1737 ± 556 <0.001 1735 ± 571 1970 ± 571 2064 ± 595 2193 ± 650 2182 ± 686 <0.001 
CHO density* 106.4 ± 17.5 110.4 ± 14.9 108.7 ± 14.8 110.4 ± 13.4 111.5 ± 15.3 <0.01 105.8 ± 16.8 109.3 ± 15.5 111.2 ± 14.9 110.3 ± 16.2 109.4 ± 15.4 <0.01 
Protein density* 34.0 ± 5.8 34.9 ± 5.3 36.5 ± 5.9 37.5 ± 6.5 41.6 ± 9.8 <0.001 41.0 ± 10.4 37.0 ± 6.9 36.7 ± 5.8 35.3 ± 5.5 35.9 ± 6.0 <0.001 
Alcohol, g 25.0 ± 29.4 14.1 ± 17.0 12.1 ± 15.2 9.3 ± 14.6 8.2 ± 12.5 <0.001 8.9 ± 14.1 11.0 ± 15.2 12.9 ± 16.2 18.2 ± 27.3 22.3 ± 27.2 <0.001 
Fat density* 43.4 ± 6.2 44.4 ± 5.0 44.8 ± 4.9 44.5 ± 4.5 42.2 ± 5.7 0.03 44.6 ± 6.0 44.6 ± 5.1 43.9 ± 4.9 43.2 ± 5.2 42.0 ± 5.7 <0.001 
SFA density* 18.2 ± 3.3 18.3 ± 2.8 18.6 ± 2.8 18.3 ± 2.7 17.0 ± 3.1 <0.001 18.4 ± 3.3 18.5 ± 2.9 18.2 ± 2.9 18.0 ± 3.0 17.3 ± 3.1 <0.001 
Fibre density* - - - - -  7.4 ± 3.1 6.4 ± 2.1 5.7 ± 1.7 5.2 ± 1.3 5.1 ± 1.2 <0.001 
Average GI 65.5 ± 3.7 65.4 ± 3.4 64.8 ± 3.7 63.5 ± 3.7 61.5 ± 4.1 <0.001 - - - - - - 
N=1804 Quintile of daily intake of fat density* Quintile of daily intake of SFA density*  
 Q1 Q2 Q3 Q4 Q5 P value Q1 Q2 Q3 Q4 Q5 P value 
Range <39.8 39.8-42.9 43.0-45.3 45.4-48.1 48.2-62.3  <15.6 15.6-17.4 17.5-18.8 18.9-20.6 20.7-28.9  
Median 37.2 41.5 44.2 46.5 50.4  16.5 18.1 19.7 22.0 18.0  
Male (%) 60.1 55.6 46.5 43.7 31.3 <0.001 59.2 55.1 47.3 43.2 32.4 <0.001 
Diabetes (%) 9.7 9.7 10.2 8.3 8.8 0.53 10.2 10.2 6.9 10.2 9.1 0.65 
Energy, kcal 1979. ± 704 2086 ± 593 2058 ± 613 2067 ± 578 1976 ± 661 0.83 1994 ± 702 2051 ± 596 2066 ± 620 2067 ± 570 1988 ± 586 0.95 
CHO density* 113.9 ± 19.8 114.6 ± 15.2 112.3 ± 11.9 108.1 ± 10.2 98.5 ± 11.9 <0.001 111.0 ± 19.4 113.9 ± 14.6 111.0 ± 14.0 109.5 ± 11.9 102.0 ± 13.3 <0.001 
Protein density* 38.7 ± 10.1 36.3 ± 6.9 36.1 ± 5.4 35.3 ± 6.0 37.2 ± 7.0 0.53 38.9 ± 10.7 36.3 ± 6.0 36.0 ± 5.9 36.1 ± 5.4 37.3 ± 6.8 0.74 
Alcohol, g 28.4 ± 31.4 15.3 ± 16.7 10.7 ± 13.0 8.5 ± 11.2 5.9 ± 7.6 <0.001 27.7 ± 30.9 14.5 ± 16.6 11.6 ± 14.0 8.9 ± 12.1 6.2 ± 9.0 <0.001 
Fat density* - - - - -  37.4 ± 5.0 42.1 ± 2.9 44.3 ± 3.1 46.1 ± 2.9 49.4 ± 3.4 <0.001 
SFA density* 14.6 ± 2.2 16.9 ± 1.7 18.3 ± 1.8 19.3 ± 1.9 21.4 ± 1.7 <0.001 - - - - -  
Fibre density* 6.6 ± 3.2 6.1 ± 2.0 5.9 ± 1.9 5.9 ± 1.7 5.6 ± 1.5 0.01 6.8 ± 3.2 6.1 ± 2.0 5.9 ± 1.8 5.8 ± 1.7 5.6 ± 1.6 <0.001 
Average GI 64.7 ± 4.7 64.5 ± 3.5 64.2 ± 3.7 64.0 ± 3.7 63.4 ± 4.1 <0.001 64.4 ± 4.7 64.6 ± 3.8 64.1 ± 3.5 63.9 ± 3.8 63.7 ± 4.0 0.02 
Note: analyses restricted to those with non-missing values for dietary intake, diabetes and all covariates; * = g/1000kcal; GI= Glycaemic Index; SFA= Saturated fatty acids; CHO=carbohydrates 
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Table 28.  Nutrient intakes and diabetes status (age 53 to 60-64) by quintiles of fibre density, GI, fat density and SFA at age 43 
N=2271 Quintile of daily intake of fibre density* Quintile of daily GI  
 Q1 Q2 Q3 Q4 Q5 P value Q1 Q2 Q3 Q4 Q5 P value 
Range <4.3 4.3-5.3 5.4-6.3 6.4-7.8 7.9-31.3  <59.8 59.8-62.7 62.8-65.2 65.3-68.0 68.1-82.0  
Median 3.6 4.8 5.7 6.9 9.2  57.8 61.4 64.0 66.7 69.9  
Male (%) 67.4 57.0 46.2 37.6 29.7 <0.001 28.3 42.9 48.2 53.5 65.2 <0.001 
Diabetes (%) 13.6 10.1 11.0 7.0 5.5 <0.001 5.2 7.7 9.4 11.0 13.9 <0.001 
Energy, kcal 2347 ± 758 2227 ± 574 2105 ± 539 2012 ± 559 1708 ± 507 <0.001 1827 ± 561 2086 ± 594 2114 ± 606 2170 ± 623 2203 ± 701 <0.001 
CHO density* 102.8 ± 17.7 106.2 ± 14.4 110.6 ± 14.4 112.0 ± 14.9 121.5 ± 17.1 <0.001 113.3 ± 18.6 112.8 ± 16.9 111.9 ± 16.9 110.4 ± 14.8 104.7 ± 15.9 <0.01 
Protein density* 35.2 ± 6.6 36.0 ± 5.2 36.8 ± 6.1 38.2 ± 6.4 42.0 ± 9.8 <0.001 40.0 ± 9.3 37.6 ± 6.4 37.2 ± 6.6 36.3 ± 6.4 37.0 ± 7.3 <0.001 
Alcohol, g 26.9 ± 36.1 15.0 ± 17.4 11.1 ± 14.3 9.8 ± 12.6 7.4 ± 10.4 <0.001 9.6 ± 12.9 11.9 ± 16.2 11.8 ± 15.7 14.4 ± 20.8 22.4 ± 33.3 <0.001 
Fat density* 43.9 ± 7.0 45.3 ± 5.6 44.3 ± 5.0 43.8 ± 5.2 38.2 ± 6.9 <0.001 41.7 ± 7.3 42.9 ± 6.1 43.4 ± 6.1 43.7 ± 5.6 43.4 ± 7.0 <0.001 
SFA density* 19.1 ± 4.0 19.3 ± 3.4 18.6 ± 3.1 17.9 ± 3.2 15.2 ± 3.5 <0.001 17.0 ± 3.8 17.8 ± 3.6 18.2 ± 3.5 18.6 ± 3.6 18.6 ± 4.1 <0.001 
Fibre density* - - - - -  7.8 ± 3.3 6.7 ± 2.3 6.2 ± 2.1 5.5 ± 1.8 4.9 ± 1.7 <0.001 
Average GI 66.6 ± 4.0 65.1 ± 4.3 63.9 ± 4.7 62.8 ± 4.5 60.7 ± 4.7 <0.001 - - - - - - 
N=2267 Quintile of daily intake of fat density* Quintile of daily intake of SFA density*  
 Q1 Q2 Q3 Q4 Q5 P value Q1 Q2 Q3 Q4 Q5 P value 
Range <38.2 38.2-42.0 42.1-45.0 45.1-48.1 48.2-68.0  <15.0 15.0-17.1 17.2-18.9 19.0-21.1 21.2-31.4  
Median 34.8 40.3 43.6 46.5 50.5  13.3 16.1 18.0 19.9 22.8  
Male (%) 60.1 55.6 46.5 43.7 31.3 <0.001 48.4 47.6 48.6 47.9 45.4 0.88 
Diabetes (%) 7.7 9.7 8.3 9.9 11.7 0.06 8.8 8.6 8.8 10.3 10.8 0.18 
Energy, kcal 1839 ± 679 2082 ± 627 2115 ± 536 2180 ± 601 2184 ± 643 <0.001 1828 ± 668 2041 ± 600 2129 ± 586 2200 ± 586 2200 ± 639 <0.001 
CHO density* 121.1 ± 21.8 115.0 ± 15.3 111.9 ± 12.4 106.7 ± 11.8 97.9 ± 11.5 <0.001 119.1 ± 22.6 113.2 ± 15 110.7 ± 14.1 107.8 ± 12.6 102.3 ± 13.7 <0.001 
Protein density* 40.7 ± 10.2 37.7 ± 6.9 36.8 ± 6.0 36 ± 6.6 36.4 ± 5.5 <0.001 40.7 ± 10.5 38.5 ± 6.8 37.0 ± 6.0 36.3 ± 5.9 35.7 ± 5.4 <0.001 
Alcohol, g 24.6 ± 36.1 17.0 ± 19.9 11.8 ± 13.4 10.0 ± 12.3 7.6 ± 10.5 <0.001 22.7 ± 34.9 15.9 ± 19.2 12.8 ± 16.3 10.5 ± 13.9 8.3 ± 12.1 <0.001 
Fat density* - - - - -  34.7 ± 6.0 40.8 ± 3.2 43.8 ± 3.4 46.2 ± 3.4 49.5 ± 4.0 <0.001 
SFA density* 13.4 ± 2.6 16.7 ± 1.9 18.2 ± 2.2 19.6 ± 2.3 22.2 ± 2.8 <0.001 - - - - -  
Fibre density* 7.8 ± 3.9 6.4 ± 2.2 5.9 ± 1.7 5.7 ± 1.7 5.2 ± 1.5 <0.001 7.9 ± 3.8 6.5 ± 2.2 6.0 ± 1.8 5.6 ± 1.7 5.2 ± 1.6 <0.001 
Average GI 63.1 ± 5.8 63.8 ± 4.7 63.7 ± 4.6 63.7 ± 4.7 64.7 ± 4.7 <0.001 63.0 ± 5.5 63.3 ± 4.7 63.5 ± 4.6 64.3 ± 4.7 65.0 ± 4.6 <0.001 
Note: analyses restricted to those with non-missing values for dietary intake, diabetes and all covariates; * = g/1000kcal; GI= Glycaemic Index; SFA= Saturated fatty acids; CHO=carbohydrates 
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Table 29.  Nutrient intakes and diabetes status (age 53 to 60-64) by quintiles of fibre density, GI, fat density and SFA at age 53 
N=1480 Quintile of daily intake of fibre density* Quintile of daily GI  
 Q1 Q2 Q3 Q4 Q5 P value Q1 Q2 Q3 Q4 Q5 P value 
Range <5.6 5.6-6.5 6.6-7.7 7.8-9.2 9.3-25.9  <58.4 58.4-60.9 61-63.0 63.1-65.4 65.5-74.4  
Median 4.9 6.1 7.2 8.5 10.7  56.7 59.7 62.0 64.1 67.0  
Male (%) 71.2 51.0 40.8 36.8 26.0 <0.001 29.3 40.2 40.5 51.3 64.5 <0.001 
Diabetes (%) 12.8 8.4 11.1 8.1 4.7 <0.01 4.7 4.4 10.5 14.8 10.8 <0.001 
Energy, kcal 2243 ± 530 2082 ± 456 1965 ± 470 1905 ± 427 1725 ± 414 <0.001 1862.3 ± 489 1982 ± 439 1961 ± 448 2020 ± 504 2095 ± 546 <0.001 
CHO density* 105.0 ± 19.2 114.2 ± 15.6 119.8 ± 15.1 124.4 ± 16.2 133.2 ± 17.3 <0.001 124.1 ± 20.7 121.8 ± 16.6 121.3 ± 16.1 117.7 ± 19.8 111.7 ± 20.0 <0.01 
Protein density* 37.5 ± 6.8 38.3.9 ± 5.9 39.5 ± 5.8 41.2  ± 6.2 43.1  ± 7.8 <0.001 41.3 ± 8.1 39.7 ± 6.4 40.0 ± 6.4 39.5  ± 6.5 39.1  ± 6.5 <0.001 
Alcohol, g 29.4 ± 33.6 17.1 ± 18.0 12.1 ± 14.2 11.7 ± 14.0 8.7 ± 12.1 <0.001 12.4 ± 15.3 13.7 ± 14.8 12.8 ± 14.9 17.1 ± 23.0 23.0 ± 31.2 <0.001 
Fat density* 40.9 ± 6.8 40.2 ± 5.4 39.0 ± 5.4 36.4 ± 6.0 32.7 ± 6.5 <0.001 36.0 ± 7.2 37.3 ± 6.4 38.0 ± 6.4 38.4 ± 6.1 39.4 ± 6.6 <0.001 
SFA density* 17.9 ± 4.0 16.3 ± 3.4 15.4 ± 3.2 13.8 ± 3.1 11.9 ± 3.2 <0.001 14.1 ± 3.8 14.4 ± 3.7 14.9 ± 3.7 15.0 ± 3.7 15.8 ± 3.9 <0.001 
Fibre density* - - - - - - 8.9 ± 3.0 8.3 ± 2.3 7.6 ± 2.0 6.8 ± 1.9 6.2 ± 1.8 <0.001 
Average GI 64.2 ± 3.7 62.8 ± 3.6 61.8 ± 3.8 61.0 ± 3.4 59.4 ± 3.9 <0.001 - - - - - - 
N=1480 Quintile of daily intake of fat density* Quintile of daily intake of SFA density*  
 Q1 Q2 Q3 Q4 Q5 P value Q1 Q2 Q3 Q4 Q5 P value 
Range <32.3 32.4-36.4 36.5-39.7 39.8-43.5 43.6-59.5  <15.6 15.6-17.4 17.5-18.8 18.9-20.6 20.7-28.9  
Median 29.0 34.5 38.2 41.5 46.3  16.5 18.1 19.7 22.0 18.0  
Male (%) 38.1 46.9 49.3 48.3 43.4 0.04 40.2 47.9 42.3 43.5 52.0 0.03 
Diabetes (%) 6.4 7.7 9.4 12.8 8.8 0.06 6.7 8.1 13.2 5.4 11.8 0.15 
Energy, kcal 1756 ± 513 1938 ± 454 2032 ± 444 2100 ± 504 2094 ± 460 0.83 1994 ± 702 2051 ± 596 2066 ± 620 2067 ± 570 1988 ± 586 0.95 
CHO density* 134.2 ± 21.9 123.9 ± 17.1 118.9 ± 15.3 115.5 ± 13.4 104.2 ± 13.4 <0.001 111.0 ± 19.4 113.9 ± 14.6 111.0 ± 14.0 109.5 ± 11.9 102.0 ± 13.3 <0.001 
Protein density* 43.3 ± 8.3 40.3 ± 6.8 39.5 ± 5.7 38.3 ± 5.9 38.2 ± 6.1 <0.001 38.9 ± 10.7 36.3 ± 6.0 36.0 ± 5.9 36.1 ± 5.4 37.3 ± 6.8 0.74 
Alcohol, g 20.7 ± 31.5 19.4 ± 22.2 16.0 ± 18.6 12.3 ± 14.4 10.5 ± 12.7 <0.001 27.7 ± 30.9 14.5 ± 16.6 11.6 ± 14.0 8.9 ± 12.1 6.2 ± 9.0 <0.001 
Fat density* - - - - - - 37.4 ± 5.0 42.1 ± 2.9 44.3 ± 3.1 46.1 ± 2.9 49.4 ± 3.4 <0.001 
SFA density* 10.2 ± 2.1 13.0 ± 1.6 14.9 ± 1.9 16.4 ± 2.1 19.5 ± 3.0 <0.001 18.4 ± 3.3 18.5 ± 2.9 18.2 ± 2.9 18.0 ± 3.0 17.3 ± 3.1 <0.001 
Fibre density* 9.6 ± 3.2 7.9 ± 2.2 7.1 ± 1.8 7.0 ± 1.7 6.3 ± 1.5 <0.001 6.8 ± 3.2 6.1 ± 2.0 5.9 ± 1.8 5.8 ± 1.7 5.6 ± 1.6 <0.001 
Average GI 60.4 ± 4.0 61.7 ± 4.0 62.2 ± 3.8 62.2 ± 4.0 62.6 ± 3.9 <0.001 64.4 ± 4.7 64.6 ± 3.8 64.1 ± 3.5 63.9 ± 3.8 63.7 ± 4.0 0.02 
Note: analyses restricted to those with non-missing values for dietary intake, diabetes and all covariates; * = g/1000kcal; GI= Glycaemic Index; SFA= Saturated fatty acids; CHO=carbohydrates 
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Figure 9. Mean or median intakes by age and sex for a) fibre density b) GI c) fat density 
and d) Saturated fat density  
Note: analyses restricted to those with non-missing data for dietary intake, type 2 diabetes and all 
covariates at each age; at age 36 N=1804; at age 43 N=2267, at age 53 N= 1477 
* Overweight = BMI  25 - 29.9 kg/m
2
; obesity = BMI ≥ 30 kg/m
2
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Figure 10. Mean or median intakes by age and type 2 diabetes diagnosis (age 53 to 60-64) for a) fibre density b) GI c) fat 
density and d) SFA density 
Note: analyses restricted to those with non-missing data for dietary intake, diabetes and all covariates at each age; at age 36 N=1804; at age 43 
N=2267, at age 53 N= 1477; SFA=saturated fatty acids 
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Table 30.  Food groups correlated with fibre density, GI, fat density and SFA density  
Age 36 Age 43 Age 53 
Food group  Correlation Food group  Correlation Food group  Correlation 
Fibre density      
Fruit 0.32 Fruit 0.45 Fruit 0.53 
Skimmed milk  0.24 High-fibre cereals 0.28 Vegetables 0.38 
Vegetables 0.20 Vegetables 0.28 Low-fat yogurt 0.25 
High-fibre cereals  0.16 Wholemeal bread 0.26 Wholemeal bread 0.24 
      
White bread -0.36 White bread -0.33 White bread -0.32 
Table sugar -0.30 Fried potatoes -0.32 Alcohol -0.30 
Butter/animal fat  -0.26 Table sugar -0.31 Table sugar -0.29 
Potatoes -0.23 Processed meat -0.29 Processed meat -0.28 
GI      
Potatoes 0.49 White bread 0.32 White bread 0.36 
White bread 0.39 Fried potatoes 0.32 Fried potatoes 0.32 
Table sugar 0.31 Potatoes 0.26 Table sugar 0.25 
Butter/animal fat 0.29 Table sugar 0.23 Processed meat 0.23 
      
Fruit -0.36 Fruit -0.36 Fruit -0.45 
Yogurt -0.31 Low-fat yogurt -0.31 Low-fat yogurt -0.30 
Skimmed milk -0.26 Skimmed milk -0.26 Pasta -0.21 
Fruit juice -0.18 High-fibre cereals -0.18 Wholemeal bread -0.19 
Dietary fat density      
Butter/animal fat 0.19 Butter/animal fat 0.29 Butter/animal fat 0.35 
Biscuits/pastry/cakes 0.15 Processed meat 0.22 Processed meat 0.20 
Cream 0.13 Whole milk 0.20 
Biscuits/pastry/cak
es 
0.19 
Whole milk 0.10 Red meat 0.18 Whole milk 0.18 
      
Skimmed milk -0.23 Alcohol -0.23 Fruit -0.25 
Table sugar -0.20 Skimmed milk -0.21 Low-fat yogurt -0.22 
Soup -0.11 Fruit -0.14 Low-fat plant fat -0.15 
Low-fat plant fat -0.10 Low-fat plant fat -0.13 Skimmed milk -0.14 
Saturated fat density      
Butter/animal fat 0.37 Butter/animal fat 0.50 Butter/animal fat 0.56 
Whole milk  0.21 Whole milk  0.31 Whole milk  0.23 
Cream 0.17 Cheese 0.20 Cheese 0.20 
Cheese  0.13 Processed meat 0.17 Processed meat 0.20 
      
Skimmed milk -0.22 Skimmed milk -0.24 Fruit -0.24 
Low-fat plant fat -0.14 Alcohol -0.19 Low-fat plant fat -0.20 
Plant fat -0.13 Low-fat plant fat -0.15 Low-fat yogurt -0.18 
Oils -0.11 Fruit -0.14 Vegetables -0.15 
Note: analyses restricted to those with non-missing values for dietary intake, diabetes status and all 
covariates at each age; SFA=saturated fatty acids 
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Table 31. Associations between potential confounders and mediators and selected 
dietary factors at age 36 
  Dietary factors 
  Fibre density GI Fat density 
 n Median (IQR) Mean (SD) Mean (SD) 
Socioeconomic position     
I    professional 146 5.7 (2.4) 63.7 (3.5) 43.3 (4.2) 
II   intermediate 697 5.7 (2.3) 63.5 (4.1) 43.9 (5.3) 
III  skilled (Non-Manual) 490 5.6 (2.3) 63.9 (3.9) 43.4 (5.3) 
III  skilled (Manual) 297 5.1 (1.6) 66.0 (3.8) 43.1 (5.8) 
IV   partly skilled 202 5.5 (2.0) 64.6 (4.3) 43.9 (5.6) 
V    unskilled 68 5.4 (1.8) 65.8 (3.7) 43.3 (5.8) 
P-value  (trend)  <0.001 <0.001 0.57 
Education attained by age 26     
None attempted 574 5.3 (1.6) 65.5 (3.9) 43.9 (5.7) 
Intermediate 528 5.6 (2.2) 64.3 (4.0) 43.6 (5.2) 
Highest  716 5.8 (2.4) 63.1 (3.9) 43.9 (5.2) 
P-value (trend)  <0.001 <0.001 0.80 
BMI category at age 36     
Normal (<25 kg/m
2
)  1283 5.6 (2.2) 64.2 (3.9) 44.2 (5.1) 
Overweight (25 -29.9 kg/m
2
) 510 5.4 (2.1) 65.0 (3.9) 43.2 (5.6) 
Obese (30 kg/m
2
) 92 5.7 (2.1) 64.5 (4.9) 42.7 (6.7) 
P-value (trend)  0.29 <0.001 <0.01 
Waist circumference at age 36     
Lowest tertile  635 5.9 (2.5) 62.9 (4.1) 44.7 (5.1) 
Middle tertile 629 5.4 (2.1) 65.8 (3.8) 43.8 (5.5) 
Highest tertile 629 5.3 (1.8) 65.0 (4.0) 43.1 (5.4) 
P-value (trend)  <0.001 <0.001 <0.001 
Smoking history up to age 36     
Current smoker  502 5.1 (1.6) 65.6 (3.7) 43.2 (5.5) 
Ex smoker 783 5.6 (2.3) 64.0 (4.1) 43.8 (5.4) 
Never smoker 614 5.8 (2.2) 63.3 (4.1) 44.5 (5.1) 
P-value (ANOVA)  <0.001 <0.001 <0.001 
Exercise at age 36     
Inactive 659 5.5 (1.9) 64.6 (4.0) 44.4 (5.5) 
Less active 519 5.5 (2.1) 64.4 (3.9) 44.0 (4.9) 
Most active 721 5.7 (2.5) 63.7 (4.2) 43.2 (5.5) 
P-value (trend)  <0.001 <0.001 <0.001 
Note: analyses restricted to those with non-missing data for type 2 diabetes diagnosis; maximum 
available sample size used with each indicator; educational attainment was categorised as none (none 
attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or Burnam B or 
higher); activity at 36 years was coded as inactive (no participation), moderately active (participated one 
to four times) and most active (participated five or more times) in the previous month. IQR=Interquartile 
range 
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Table 32. Associations between potential confounders and mediators and selected 
dietary factors at age 43 
  Dietary factors 
  Fibre density GI Fat density 
 n Median (IQR) Mean (SD) Mean (SD) 
Socioeconomic position     
I    professional 182 5.8 (2.6) 63.4 (4.3) 42.3 (5.5) 
II   intermediate 913 6.0 (2.6) 63.1 (4.9) 42.7 (6.4) 
III  skilled (Non-Manual) 569 5.9 (2.7) 63.4 (4.9) 43.4 (6.1) 
III  skilled (Manual) 399 4.9 (2.3) 65.5 (4.9) 43.2 (6.9) 
IV   partly skilled 266 5.6 (2.6) 64.5 (4.9) 43.3 (7.1) 
V    unskilled 93 5.1 (2.2) 64.7 (5.5) 42.6 (7.3) 
P-value  (trend)  <0.001 <0.001 0.25 
Education attained by age 26     
None attempted 772 5.3 (2.5) 65.3 (5.0) 43.6 (7.0) 
Intermediate 648 5.8 (2.5) 63.7 (4.8) 42.9 (6.5) 
Highest  874 6.2 (2.9) 62.7 (4.7) 42.5 (6.00) 
P-value (trend)  <0.001 <0.001 <0.001 
BMI category at age 43     
Normal (<25 kg/m
2
)  1314 5.9 (2.7) 63.2 (5.0) 43.1 (6.3) 
Overweight (25 -29.9 kg/m
2
) 834 5.5 (2.6) 64.4 (4.8) 43.8 (6.4) 
Obese (30 kg/m
2
) 268 5.6 (2.7) 64.6 (4.9) 43.0 (7.4) 
P-value (trend)  0.01 <0.001 0.84 
Waist circumference at age 43     
Lowest tertile  815 6.3 (2.8) 62.4 (5.0) 43.3 (6.3) 
Middle tertile 796 5.9 (2.8) 63.8 (4.8) 42.8 (6.4) 
Highest tertile 800 5.2 (2.2) 65.2 (4.6) 42.9 (6.8) 
P-value (trend)  <0.001 <0.001 0.13 
Smoking history up to age 43     
Current smoker  617 4.9 (2.3) 65.5 (4.9) 43.5 (7.1) 
Ex smoker 1050 5.9 (2.8) 63.2 (4.8) 42.7 (6.5) 
Never smoker 756 6.1 (2.8) 63.2 (4.9) 42.9 (6.0) 
P-value (ANOVA)  <0.001 <0.001 0.04 
Exercise at age 43     
Inactive 1214 5.6 (2.5) 64.3 (4.9) 43.4 (6.6) 
Less active 589 5.7 (2.5) 63.6 (5.1) 42.8 (6.2) 
Most active 625 6.2 (3.1) 63.0 (4.8) 42.3 (6.3) 
P-value (trend)  <0.001 <0.001 <0.001 
Note: analyses restricted to those with non-missing data for type 2 diabetes diagnosis; maximum 
available sample size used with each indicator; educational attainment was categorised as none (none 
attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or Burnam B or 
higher); exercise at age 43 was coded as inactive (no participation), moderately active (participated one 
to four times) and most active (participated five or more times) per month. IQR=Interquartile range 
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Table 33. Associations between potential confounders and mediators and selected 
dietary factors at age 53 
  Dietary factors 
  Fibre density GI Fat density 
 n Median (IQR) Mean (SD) Mean (SD) 
Socioeconomic position     
I    professional 128 7.4 (2.6) 61.0 (3.2) 38.2 (5.6) 
II   intermediate 585 7.2 (3.2) 61.3 (4.0) 37.7 (6.5) 
III  skilled (Non-Manual) 388 7.6 (3.0) 61.6 (3.8) 37.9 (6.4) 
III  skilled (Manual) 243 6.5 (3.0) 63.4 (4.4) 38.0 (7.5) 
IV   partly skilled 175 7.2 (3.1) 62.5 (4.3) 38.5 (7.4) 
V    unskilled 61 7.1 (2.9) 63.0 (3.8) 36.4 (6.9) 
P-value  (trend)  0.04 <0.001 0.53 
Education attained by age 26     
None attempted 435 7.0 (2.7) 63.2 (3.9) 38.3 (6.9) 
Intermediate 440 7.3 (3.0) 61.9 (3.9) 37.6 (7.3) 
Highest  616 7.4 (3.1) 60.9 (3.9) 37.7 (6.2) 
P-value (trend)  <0.01 <0.001 0.13 
BMI category at age 53     
Normal (<25 kg/m
2
)  576 7.5 (3.2) 61.3 (4.1) 38.1 (7.0) 
Overweight (25 -29.9 kg/m
2
) 673 7.0 (3.0) 62.1 (4.2) 37.5 (6.3) 
Obese (30 kg/m
2
) 323 7.0 (2.8) 62.4 (3.8) 37.1 (6.9) 
P-value (trend)  0.01 <0.001 0.71 
Waist circumference at age 53     
Lowest tertile  531 7.9 (3.0) 60.8 (4.0) 37.3 (6.9) 
Middle tertile 521 7.1 (3.1) 62.0 (4.2) 38.0 (6.8) 
Highest tertile 526 6.6 (2.7) 62.9 (3.8) 38.3 (6.4) 
P-value (trend)  <0.001 <0.001 0.01 
Smoking history up to age 53     
Current smoker  265 6.1 (2.5) 63.7 (3.9) 39.4 (6.9) 
Ex smoker 813 7.3 (3.0) 61.7 (4.0) 37.6 (6.7) 
Never smoker 505 7.5 (3.1) 61.2 (4.0) 37.7 (6.5) 
P-value (ANOVA)  <0.001 <0.001 <0.01 
Exercise at age 53     
Inactive 710 7.0 (2.9) 62.5 (4.1) 38.2 (6.8) 
Less active 315 7.0 (3.0) 61.9 (3.9) 38.7 (6.2) 
Most active 557 7.6 (3.1) 61.1 (3.9) 37.1 (6.8) 
P-value (trend)  <0.001 <0.001 <0.01 
Note: analyses restricted to those with non-missing data for type 2 diabetes diagnosis; maximum 
available sample size used with each indicator; educational attainment was categorised as none 
(none attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or 
Burnam B or higher); exercise at age 53 was coded as inactive (no participation), moderately active 
(participated one to four times) and most active (participated five or more times) in the previous 4 
weeks. IQR=Interquartile range 
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5.3.3 Prospective associations between fibre, GI, dietary fats and type 2 diabetes 
Prospective associations between dietary fibre density, GI, total fat density and SFA density at 
age 36, 43, 53 and type 2 diabetes are shown in Tables 34-37.  
5.3.3.1 Fibre density 
At all ages there was a significant negative dose-response relationship across quintiles of 
dietary fibre density and type 2 diabetes in later adulthood (Table 34, Model 1-2, p for trend 
<0.05). Those in the highest quintile of intake had significantly lower type 2 diabetes incidence 
than people in the lowest (at age 36 associations were borderline significant). After adjustment 
for social and lifestyle confounders associations at age 36 were eliminated. After further 
adjustment for BMI and WC, the associations at age 53 were weakened and were borderline 
significant when comparing extreme quintiles of intake; at age 43 the associations remained 
strong (OR for the highest versus the lowest quintile of fibre density: 0.50, 95%CI: 0.29, 0.88).  
5.3.3.2 Dietary Glycaemic Index 
the risk of type 2 diabetes increased with increasing quintiles of dietary GI at age 43 and 53 
years (Table 35) with significant linear trends in all models; participants in the highest quintile of 
GI had a more than two-fold increased risk of diabetes compared to those in the lowest quintile. 
These associations were not considerably changed by adjustment for SEP, education, smoking 
and physical activity (Model 2 and 3). After further adjustment for BMI and WC the associations 
were attenuated, but remained significant at age 43 (highest compared to lowest quintile: 
OR=1.90, 95% CI, 1.11, 3.25) and 53 (fourth compared to lowest quintile: OR=2.65, 95% CI, 
1.36, 5.17). Although in the same direction as for age 43 and 53, the associations at age 36 
years were not statistically significant. 
5.3.3.3 Fat density 
Unlike dietary fibre density and GI, significant interactions were observed between total fat and 
sex; therefore analyses were subsequently presented by sex (Table 36). While there was no 
association between fat density and type 2 diabetes among men, total fat density significantly 
increased the risk of diabetes among women in a dose-response manner (p for trend <0.05) 
except at age 36. After adjustment for SEP, education, smoking and exercise the risk was 
increased three-fold for the highest compared to the lowest quintile of intake; further adjustment 
for BMI and WC did not appreciably affect the associations (age 43 OR: 2.96, 95%CI: 1.27, 
6.87; age 53 OR: 3.35, 95%CI: 1.05, 10.68). There was a similar interaction between SFA 
intake and sex (although only significant at age 53), therefore results were presented by sex 
(Table 37). As with total fat, no association was found for men but there was a significant 
positive association among women, although only at age 53, which remained significant after 
adjustment for all considered confounders. Those in the highest quintile of intake had a 4-time 
increased risk of type 2 diabetes, although there was no linear trend across quintiles of SFA 
intake. 
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5.3.4 Investigation of interactions between dietary factors and BMI and WC 
Associations between dietary factors and type 2 diabetes risk were further analysed according 
to BMI and WC categories (Tables 38-39) to test the hypothesis that these dietary factors might 
be more important for those at higher risk of type 2 diabetes. This was confirmed for fibre 
density and BMI at 36 and 53 years (p value for interaction = 0.02) and dietary GI and BMI at 36 
years (p value for interaction = 0.02). In models adjusted for all social and lifestyle confounders, 
the protective association with dietary fibre was more pronounced among the overweight and 
obese than among people with a BMI<25 (Table 38). 
Although interactions between categories of WC and fibre density were non-significant, 
consumption of high dietary fibre (highest tertile) was significantly associated with lower 
diabetes risk only among participants in the very high risk WC category (Table 38). Similarly, no 
significant interaction between categories of WC and GI was found; however dietary GI was 
positively associated with diabetes only among the very high risk WC category at age 43 and 53 
(Table 39). 
At all ages, the association with fibre was stronger in participants with a larger WC, whereas 
associations among those with a normal WC tended to be weak and not significant 
Similarly, there were significant interactions between GI and BMI (at age 36 p<0.05). While 
weak associations were found among those with a BMI<25, GI was significantly associated with 
type 2 diabetes among overweight and obese people (Table 39). A similar pattern was 
observed for WC with the effect of GI being stronger for participants with a higher WC. 
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Table 34. Associations at each age between dietary fibre density intake and type 2 diabetes between age 53 and 60-64 
 Model 1  Model 2  Model 3  Model 4  Model 5  
 Adjusted for kcal 
intake and sex  
Adjusted for SEP and 
education 
As Model 2 + physical 
activity, smoking history 
As Model 3 + BMI  As Model 4 + 
WC 
 
Quintiles of fibre 
density intake OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Age 36 (N=1804)          
Q2 1.00 (0.63, 1.53) 0.99 1.00 (0.63, 1.60) 0.97 1.03 (0.64, 1.63) 0.90 1.06 (0.66, 1.70) 0.79 1.06 (0.66, 1.70) 0.79 
Q3 0.76 (0.47, 1.25) 0.28 0.76 (0.47, 1.25) 0.29 0.79 (0.48, 1.30) 0.36 0.82 (0.50, 1.36) 0.46 0.82 (0.49, 1.35) 0.44 
Q4 0.63 (0.37, 1.07) 0.09 0.64 (0.38, 1.09) 0.10 0.66 (0.39, 1.13) 0.13 0.64 (0.37, 1.10) 0.01 0.64 (0.37, 1.10) 0.11 
Q5 0.62 (0.36, 1.00) 0.05 0.64 (0.36, 1.10) 0.10 0.70 (0.40, 1.21) 0.20 0.71 (0.40, 1.24) 0.23 0.73 (0.42, 1.29) 0.28 
P for trend 0.02  0.03  0.06  0.06  0.07  
Age 43 (N=2267)          
Q2 0.72 (0.48, 1.08) 0.12 0.73 (0.48, 1.10) 0.14 0.80 (0.52, 1.21) 0.29 0.76 (0.49, 1.17) 0.20 0.76 (0.49, 1.18) 0.23 
Q3 0.80 (0.53, 1.20) 0.29 0.83 (0.55, 1.24) 0.37 0.92 (0.61, 1.40) 0.72 0.97 (0.63, 1.49) 0.91 0.98 (0.64, 1.51) 0.94 
Q4 0.50 (0.31, 0.79) <0.01 0.52 (0.32, 0.83) <0.01 0.58 (0.36, 0.94) 0.02 0.63 (0.38, 1.02) 0.06 0.64 (0.39, 1.05) 0.08 
Q5 0.36 (0.22, 0.61) <0.001 0.38 (0.22, 0.64) <0.001 0.45 (0.26, 0.78) <0.01 0.47 (0.27, 0.82) <0.01 0.50 (0.29, 0.88) 0.01 
P for trend <0.001  <0.001  <0.01  0.01  0.02  
Age 53 (N=1477)          
Q2 0.67 (0.39, 1.15) 0.15 0.67 (0.39, 1.63) 0.15 0.68 (0.39, 1.18) 0.17 0.77 (0.44, 1.36) 0.37 0.74 (0.42, 1.30) 0.30 
Q3 0.95 (0.57, 1.60) 0.87 0.96 (0.57, 1.62) 0.90 0.97 (0.57, 1.64) 0.92 1.12 (0.65, 1.93) 0.67 1.09 (0.65, 1.89) 0.73 
Q4 0.68 (0.39, 1.20) 0.19 0.71 (0.40, 1.25) 0.24 0.71 (0.40, 1.27) 0.25 0.79 (0.44, 1.44) 0.46 0.78 (0.43, 1.43) 0.43 
Q5 0.41 (0.21, 0.80) 0.01 0.42 (0.21, 0.84) 0.01 0.44 (0.22, 0.88) 0.02 0.49 (0.24, 1.02) 0.05 0.48 (0.23, 1.00) 0.05 
P for trend 0.02  0.04  0.05  0.13  0.13  
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes and all covariates; BMI= body mass index; WC=waist circumference; for 
all associations the reference category was Q1 
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Table 35. Associations at each age between average daily glycaemic index and type 2 diabetes between age 53 and 60-64 
 Model 1  Model 2  Model 3  Model 4  Model 5  
 Adjusted for kcal 
intake and sex 
 
Adjusted for SEP and 
education 
As Model 2 + physical 
activity, smoking history 
As Model 3 + BMI  As Model 4 + WC 
Quintiles of GI OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Age 36 (N=1804)          
Q2 1.11 (0.65, 1.88) 0.68 1.20 (0.70, 2.06) 0.49 1.20 (0.70, 2.06) 0.49 1.32 (0.76, 2.29) 0.32 1.30 (0.75, 2.26) 0.34 
Q3 1.10 (0.65, 1.86) 0.71 1.14 (0.66, 1.96) 0.62 1.14 (0.66, 2.96) 0.62 1.14 (0.65, 1.99) 0.64 1.11 (0.63, 1.94) 0.70 
Q4 1.44 (0.86, 2.42) 0.16 1.49 (0.86, 2.58) 0.14 1.49 (0.86, 2.58) 0.14 1.61 (0.91, 2.85) 0.09 1.58 (0.89, 2.78) 0.11 
Q5 1.58 (0.94, 2.66) 0.08 1.61 (0.92, 2.81) 0.09 1.61 (0.92, 2.81) 0.09 1.46 (0.82, 2.62) 0.19 1.43 (0.80, 2.55) 0.22 
P for trend 0.05  0.09  0.18  0.17  0.18  
Age 43 (N=2267)          
Q2 1.48 (0.86, 2.54) 0.15 1.49 (0.86, 2.56) 0.14 1.44 (0.84, 2.49) 0.18 1.42 (0.81, 2.48) 0.20 1.38 (0.79, 2.41) 0.25 
Q3 1.82 (1.07, 3.07) 0.02 1.80 (1.06, 3.04) 0.02 1.72 (1.01, 2.91) 0.04 1.64 (0.96, 2.81) 0.06 1.60 (0.93, 2.74) 0.08 
Q4 2.13 (1.27, 3.57) <0.01 2.09 (1.24, 3.51) <0.01 2.91 (1.13, 3.22) 0.01 1.71 (1.00, 2.93) 0.04 1.67 (0.98, 2.85) 0.05 
Q5 2.66 (1.61, 4.40) <0.001 2.54 (1.52, 4.25) <0.001 2.28 (1.35, 3.83) <0.01 1.98 (1.16, 3.38) 0.01 1.90 (1.11, 3.25) 0.01 
P for trend <0.001  <0.001  <0.01  0.01  0.01  
Age 53 (N=1477)          
Q2 0.87 (0.40, 1.90) 0.74 0.86 (0.40, 1.88) 0.72 0.86 (0.39, 1.87) 0.71 0.83 (0.37, 1.85) 0.66 0.82 (0.37, 1.82) 0.63 
Q3 2.25 (1.17, 4.35) 0.01 2.24 (1.16, 4.33) 0.01 2.22 (1.15, 4.30) 0.01 1.83 (0.92, 3.65) 0.08 1.70 (0.90, 3.59) 0.09 
Q4 3.26 (1.73, 6.12) <0.001 3.18 (1.68, 6.03) <0.001 3.13 (1.64, 5.95) <0.001 2.73 (1.40, 5.32) <0.01 2.65 (1.36, 5.17) <0.01 
Q5 2.16 (1.11, 4.20) 0.02 2.09 (1.06, 4.14) 0.03 2.04 (1.02, 4.07) 0.04 1.65 (0.81, 3.37) 0.16 1.65 (0.81, 3.37) 0.16 
P for trend <0.001  <0.001  <0.01  <0.01  <0.01  
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes and all covariates; GI=glycaemic index; BMI= body mass index; 
WC=waist circumference; for all associations the reference category was Q1 
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Table 36. Associations between total dietary fat density intake and type 2 diabetes at age 53 to 60-64 by sex at each age 
 Men*   Women**   
 Model a  Model b   Model a  Model b   
Quintiles of fat density 
intake OR (95% CI) P value OR (95% CI) P value 
 
OR (95% CI) P value OR (95% CI) P value 
P value for 
interaction 
Age 36 (N=1804)          
Q2 1.00 (0.55, 1.81) 0.99 1.11 (0.60, 2.03) 0.73  1.19 (0.46, 3.07) 0.71 1.29 (0.49, 3.41) 0.59 
0.30 
Q3 0.96 (0.50, 1.82) 0.90 0.98 (0.50, 1.90) 0.96  1.81 (0.77, 4.25) 0.17 1.91 (0.80, 4.68) 0.14 
Q4 0.65 (0.31, 1.33) 0.24 0.68 (0.33, 1.42) 0.31  1.68 (0.70, 3.98) 0.23 1.82 (0.75, 4.41) 0.18 
Q5 0.91 (0.44, 1.88) 0.81 0.96 (0.46, 2.03) 0.93  1.59 (0.68, 3.71) 0.28 1.81 (0.75, 4.32) 0.18 
P for trend 0.43  0.48   0.23  0.15   
Age 43 (N=2267)          
Q2 0.97 (0.53, 1.75) 0.92 1.06 (0.57, 1.95) 0.84  2.42 (1.05, 5.61) 0.03 2.52 (1.06, 5.97) 0.03  
Q3 0.96 (0.52, 1.75) 0.89 0.99 (0.53, 1.86) 0.99  1.69 (0.69, 4.11) 0.18 1.84 (0.74, 4.57) 0.18  
Q4 0.98 (0.53, 1.82) 0.96 1.02 (0.54, 1.92) 0.94  2.78 (1.20, 6.42) 0.02 2.73 (1.15, 6.49) 0.02 0.04 
Q5 1.12 (0.61, 2.07) 0.69 1.09 (0.58, 2.04) 0.78  3.10 (1.37, 7.00) 0.01 2.96 (1.27, 6.87) 0.01  
P for trend 0.71  0.85   <0.01  0.02   
Age 53 (N=1477)          
Q2 0.79 (0.36, 1.75) 0.56 0.89 (0.38, 2.07) 0.79  1.90 (0.61, 5.87) 0.26 2.50 (0.74, 8.41) 0.13 
<0.01 
Q3 0.91 (0.42, 1.97) 0.81 0.77 (0.33, 1.75) 0.55  2.34 (0.77, 7.10) 0.13 2.82 (0.86, 9.26) 0.18 
Q4 1.00 (0.46, 2.14) 1.00 0.89 (0.39, 2.03) 0.78  4.06 (1.42, 11.6) <0.01 4.85 (1.55, 15.17) <0.01 
Q5 0.48 (0.19, 1.20) 0.12 0.54 (0.21, 1.41) 0.21  3.18 (1.09, 9.24) 0.03 3.35 (1.05, 10.68) 0.04 
P for trend 0.29  0.28   0.01  0.02   
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes and all covariates; for all associations the reference category was 
Q1; Model a: adjusted for kcals, social class, education, physical activity, smoking history; Model b= as Model a + adjusted for BMI and waist circumference. 
* At age 36 n=856, at age43 n=1080, at age 53 n=668; ** At age 36 n=946, at age 43 n=1187, at age 53 n=809 
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Table 37. Associations between saturated fat density intake and type 2 diabetes at age 53 to 60-64 by sex at each age 
 Men*  
 
Women**  
 
 Model a  Model b   Model a  Model b   
Quintiles of SFA 
density intake OR (95% CI) P value OR (95% CI) P value 
 
OR (95% CI) P value OR (95% CI) P value 
P value for 
interaction 
Age 36 (N=1804)          
Q2 0.91 (0.50, 1.67) 0.77 1.05 (0.57, 1.95) 0.85  1.42 (0.60, 3.37) 0.41 1.68 (0.69, 4.08) 0.24 
0.48 
Q3 0.65 (0.33, 1.29) 0.22 0.70 (0.35, 1.40) 0.32  0.87 (0.34, 2.21) 0.77 1.10 (0.42, 2.85) 0.84 
Q4 0.86 (0.44, 1.67) 0.65 0.89 (0.45, 1.77) 0.75  1.73 (0.76, 3.96) 0.18 2.16 (0.92, 5.07) 0.07 
Q5 0.92 (0.45, 1.88) 0.83 0.91 (0.44, 1.89) 0.81  1.41 (0.62, 3.22) 0.40 1.74 (0.74, 4.07) 0.19 
P for trend 0.66  0.60   0.32  0.16   
Age 43 (N=2267)          
Q2 1.06 (0.57, 1.94) 0.84 1.27 (0.67, 2.37) 0.45  1.12 (0.52, 2.42) 0.76 0.93 (0.42, 2.09) 0.87  
Q3 0.93 (0.51, 1.71) 0.83 0.98 (0.53, 1.83) 0.96  1.15 (0.53, 2.50) 0.70 1.19 (0.54, 2.64) 0.66  
Q4 0.86 (0.46, 1.62) 0.65 1.11 (0.57, 2.13) 0.75  1.91 (0.93, 3.95) 0.07 1.77 (0.83, 3.74) 0.13 0.33 
Q5 1.27 (0.70, 2.13) 0.41 1.33 (0.72, 2.45) 0.35  1.29 (0.60, 2.75) 0.50 1.30 (0.59, 2.85) 0.50  
P for trend 0.64  0.50   0.23  0.18   
Age 53 (N=1477)          
Q2 0.64 (0.28, 1.45) 0.29 0.60 (0.25, 1.44) 0.25  2.60 (0.88, 7.70) 0.08 3.08 (0.97, 9.82) 0.05 
0.01 
Q3 1.34 (0.64, 2.79) 0.43 1.06 (0.48, 2.35) 0.87  3.39 (1.19, 9.60) 0.02 3.89 (1.27, 11.9) 0.01 
Q4 0.55 (0.23, 1.31) 0.18 0.53 (0.21, 1.31) 0.17  0.94 (0.27, 3.29) 0.93 1.16 (0.31, 4.29) 0.82 
Q5 0.67 (0.31, 1.48) 0.33 0.63 (0.28, 1.49) 0.31  4.40 (1.54, 12.5) <0.01 4.73 (1.53, 14.64) <0.01 
P for trend 0.32  0.32   0.05  0.07   
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes and all covariates; SFA= saturated fatty acids; for all associations the 
reference category was Q1; Model a: adjusted for kcals, social class, education, physical activity, smoking history; Model b= as Model a + adjusted for BMI and waist 
circumference. * At age 36 n=856, at age43 n=1080, at age 53 n=668; ** At age 36 n=946, at age 43 n=1187, at age 53 n=809 
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Table 38. Associations between fibre density intake and type 2 diabetes at age 53 to 60-64 by BMI and WC at each age 
 BMI  
  
WC  
 
 <25  ≥25  
  
Low risk*  High risk**  
 
Tertile of fibre 
density intake  OR (95% CI) P value OR (95% CI) P value 
P value for 
interaction 
 
OR (95% CI) P value OR (95% CI) P value 
P value for 
interaction 
Age 36 (N=1804) n=1224  n=580    n=1289  n=515   
<4.9 1  1    1  1   
4.9-6.2 0.89 (0.50, 1.58) 0.76 0.53 (0.30, 0.93) 0.02 
0.02 
 0.67 (0.39, 1.11) 0.14 0.69 (0.38, 1.24) 0.22 
0.82 
>6.2 0.81 (0.43, 1.50) 0.55 0.44 (0.23, 0.83) 0.01 
 
0.63 (0.35, 1.13) 0.12 0.50 (0.25, 0.99) 0.04 
Age 43 (N=2267) n=1225  n=1042    n=1497  n=770   
<5.0 1  1    1  1   
5.0-6.6 0.81 (0.41, 1.61) 0.55 0.94 (0.62, 1.43) 0.79 
0.79 
 1,02 (0.52, 1.84) 0.92 0.83 (0.53, 1.29) 0.42 
0.47 
>6.6 0.72 (0.34 1.53) 0.40 0.61 (0.37, 1.00) 0.05 
 
0.88 (0.46, 1.69) 0.71 0.53 (0.30, 0.92) 0.02 
Age 53 (N=1477) n=541  n=936    n=598  n=879   
<6.2 1  1    1  1   
6.3-8.2 3.61 (0.97, 13.42) 0.05 0.89 (0.55, 1.45) 0.66 
0.02 
 2.09 (0.57, 7.59) 0.26 1.02 (0.63, 1.64) 0.92 
0.33 
>8.2 2.75 (0.64, 11.77) 0.17 0.39 (0.21, 0.73) <0.01  2.09 (0.47, 9.30) 0.33 0.46 (0.25, 0.84) 0.01 
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes and all covariates; all analyses adjusted for sex, kcals, social class, 
education, physical activity, smoking history; BMI and waist circumference. BMI=Body Mass Index; WC=waist circumference. 
* Low risk category = Men: WC <94 cm; women: WC <80 cm; ** High risk category = Men: WC 94 cm; women: WC  80 cm (includes Very high risk category. Categories 
of WC were defined according to the National Institute for Health and Care Excellence (NICE) cut-offs for increased risk of type 2 diabetes (279). 
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Table 39. Associations between glycaemic index and type 2 diabetes at age 53 to 60-64 by BMI and WC at each age 
 BMI  
  
WC  
 
 <25  ≥25    Low*  High**   
Tertile of mean 
daily GI  OR (95% CI) P value OR (95% CI) P value 
P value for 
interaction 
 
OR (95% CI) P value OR (95% CI) P value 
P value for 
interaction 
Age 36 (N=1804) n=1224  n=580    n=1282  n=515   
<62.7 1  1    1  1   
62.7-66.0 1.05 (0.60, 1.84) 0.84 1.05 (0.54, 2.03) 0.87 
0.02 
 1.14 (0.65, 1.98) 0.63 0.97 (0.50, 1.88) 0.93 
0.27 
<66.0 0.68 (0.34, 1.35) 0.27 1.94 (1.01, 3.64) 0.04 
 
0.92 (0.49, 1.73) 0.80 1.77 (0.92, 3.38) 0.08 
Age 43 (N=2267) n=1225  n=1042    n=1497  n=770   
<61.8 1  1    1  1   
>61.8-66.2 0.91 (0.43, 1.93) 0.81 1.87 (1.14, 3.08) 0.01 
0.18 
 1.09 (0.60, 1.98) 0.75 1.94 (1.11, 3.40) 0.01 
0.31 
>66.2 1.75 (0.87, 3.50) 0.11 1.51 (0.90, 2.51) 0.11 
 
1.07 (0.57, 2.01) 0.81 2.01 (1.14, 3.52) 0.01 
Age 53 (N=1477) n=541  n=936    n=598  n=741   
<60.1 1  1    1  1   
60.1-63.7 1.10 (0.38, 3.20) 0.85 3.03 (1.73, 5.30) <0.001 
0.49 
 0.26 (0.05, 1.37) 0.11 3.22 (1.87, 5.54) <0.001 
0.46 
>63.7 1.57 (0.40, 6.16) 0.65 2.03 (1.03, 3.97) 0.03 
 3.05 (0.84, 
11.01) 
0.08 1.64 (0.83, 3.23) 0.14 
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes and all covariates; all analyses adjusted for sex, kcals, social class, 
education, physical activity, smoking history, BMI and waist circumference; BMI and waist circumference. BMI=Body Mass Index; WC=waist circumference, GI= glycaemic 
index. 
* Low risk category = Men: WC <94 cm; women: WC <80 cm; ** High risk category = Men: WC 94 cm; women: WC  80 cm (includes Very high risk category. Categories 
of WC were defined according to the National Institute for Health and Care Excellence (NICE) cut-offs for increased risk of type 2 diabetes (279). 
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5.4 Discussion 
5.4.1 Main findings 
The main findings of this chapter are that dietary fibre and GI were associated with lower and 
higher later risk of type 2 diabetes (respectively), particularly in middle age. Greater dietary fat 
density, especially total fat rather than SFA was positively associated with type 2 diabetes risk, 
more so for women than for men. 
The associations between dietary fibre and GI persisted after controlling for BMI and WC; 
however the effects of low fibre and high GI were stronger among overweight people and those 
with a raised WC. 
1
st
 and 2
nd
 objective: To analyse the association between dietary fibre, GI and dietary fat 
intake at age 36, 43 and 53 years and to assess whether these association are mediated by 
BMI and WC. 
It was hypothesised that low fibre intake, high GI and high fat and SFA intakes would be 
associated with increased risk of type 2 diabetes (1
st
 hypothesis) and that associations would be 
partly meditated by BMI and WC, although direct associations would remain (2
nd
 hypothesis). In 
support of the first hypothesis, at age 43 and 53 people who consumed more dietary fibre and 
had a low-GI diet were at reduced risk of type 2 diabetes incidence, with a significant dose-
response trend across quintiles of intake for both fibre density and GI. Although weaker and 
mostly non-significant, associations for all dietary factors at age 36 followed a similar direction.  
An interaction was found between dietary fats and sex, with the effect of both total fat density 
and SFA density being present only among women at age 43 and 53. A linear trend was 
observed across total fat quintiles while associations between SFA and diabetes were more 
inconsistent with no apparent trend. However, the confidence intervals in these associations 
were quite large, indicating lack of precision in the estimate. The difference in association 
between men and women is not readily explained. It might be the results of different eating 
patterns or it may be a consequence of the higher number of women in the sample at age 43 
and particularly at age 53 (men 45.2%, women 54.8%). 
For all dietary factors the associations were robust to adjustment for SEP, education, smoking 
and physical activity indicating minimal confounding. The associations were weakened by 
adjustment for BMI and WC, indicating a possible mediating effect of body weight and 
abdominal fat, as suggested in the literature. However, in agreement with the second 
hypothesis a direct association between fibre density, GI and fat (for women) and diabetes 
remained, especially when comparing extreme quintiles of intakes at age 43 and 53.  
Thus, dietary factors seem to have a stronger association with type 2 diabetes during middle 
and late adulthood rather than during early adulthood. The weak association between fibre, GI 
and fats intake at age 36 and later diabetes is difficult to compare with previous studies since 
the majority of these analyses had a follow-up time of 10 years or less and used a sample of 
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middle-aged adults. It is possible that a 17-year follow-up might be too long to detect a diet-
disease association since people are likely to change their diet during this period, especially in 
conjunction with important life events, such as starting a family or retirement. Indeed, as is clear 
from Figure 9, both men and women in the NSHD, on average, changed their dietary intakes 
with diet overall becoming healthier at age 53. Figure 10 suggests that while diet became 
healthier for the whole population, those who developed type 2 diabetes had less marked 
improvements. However, Figure 10 also shows that intakes of fibre density were already lower 
and GI was already higher at age 36 for those who did developed diabetes compared with those 
who did not, with the gap widening with age, especially between age 36 and 43. This suggests 
an accumulation pattern so that the effects of an adult life-long lower-fibre and higher-GI diet 
track and accumulate over time and become apparent from middle-age when diabetes starts to 
manifest as a clinical outcome, mainly because of the rising adiposity levels. Indeed this 
apparent pattern of accumulation seems to parallel those in chapters 3 and 4, with the negative 
effects of obesity and WC accumulating over time. It is also plausible that people improved their 
diet around age 53 to avert the negative consequences of overweight (partly fed by the high-GI, 
high-fat and low-fibre diet). 
These findings are in agreement with several prospective studies reporting a strong inverse 
association between fibre intake and type 2 diabetes, independently of body weight (131, 137, 
142, 145, 147, 162). These studies used mainly middle-aged white populations, thus paralleling 
the associations found in this chapter between diet at 43 or 53 years old and later diabetes 
incidence. As in most of these studies, in this chapter a linear trend was found across 
categories of fibre density; however, only the highest intake (the fourth, and once the mediating 
effects of BMI and WC were accounted for, only the fifth quintile) were significantly associated 
with diabetes. The median daily intake of dietary fibre in the highest quintile was 15.4g at age 
36, 16g at age and 18.5g at age 53. The dietary reference value for the population using NSP 
as defined by the Englyst method (the same method used in this thesis) is 18g/day. Thus only 
the highest fifth of the population and only at age 53 reached adequate levels of intake for 
optimal disease prevention. This finding suggests that dietary fibre needs to be consumed in 
relatively large quantities to be significantly protective. This is in agreement with a dose-
response meta-analysis (285) reporting a threshold effect for total dietary fibre, with only high 
intakes being significantly protective.  
Consistent with this chapter, previous prospective studies and systematic reviews reported that 
people consuming high GI diets are at increased risk of type 2 diabetes (131, 137-142, 144, 
146). However, in disagreement with these results some studies did not find a significant 
association (145-147). This could be due to differences in the sample age, sex and ethnicity as 
well as on carbohydrates and GI range of intakes. Furthermore, assignment of GI values differs 
according to the references used. The majority of studies used various forms of FFQs to 
measure diet. These questionnaires might not be appropriate to assess GI as they are not 
detailed enough to account for differences among subtypes of food items, which might belong to 
the same food category but have very different GI value.  
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A gender difference has not been demonstrated in other prospective studies reporting a positive 
association between dietary fat and diabetes (172-174). However, it is known that men and 
women metabolize and store dietary fat differently (324) and that men tend to oxidize more 
dietary fat than women (325). It is also possible that the lack of an association between fat and 
diabetes could be due to inaccurate dietary assessment as selective underreporting of dietary 
fat has been reported among obese men (175). 
3
rd
 objective: To investigate whether BMI and WC modifies the association between dietary 
factors and type 2 diabetes.  
It was hypothesised that the positive association between GI and type 2 diabetes and the 
inverse relationship between fibre and diabetes would be stronger among overweight and 
obese people. In agreement with the third hypothesis the positive association between GI and 
incident type 2 diabetes was stronger among overweight and obese people than those with a 
normal BMI. This was particularly evident at age 36 and age 53. Indeed, for age 36 while non-
stratified associations (Table 34) showed a weak effect of GI, when associations were stratified 
by BMI (Table 38) there was a 2-fold increased risk for the highest tertile compared with the 
lowest among overweight people. Similarly, the effect of GI was stronger among people with a 
raised WC, although no significant interactions were found. Among the high-risk WC category, 
even those in the second tertile of GI intake had significantly raised diabetes risk compared with 
the lowest tertile. It has been suggested that the adverse effect of a high-GI diet might increase 
with the level of insulin resistance, which is presumably higher in obese individuals and those 
with a larger WC (129, 282), although this could not be proved since insulin resistance was not 
measured directly.  
Similarly, fibre density showed a stronger inverse association with incident type 2 diabetes in 
the overweight category than in those with normal BMI, with significant interactions at age 36 
and 53. Among the high-risk WC category at age 43 and 53, those in the highest tertile of fibre 
intake had a significantly lower risk of diabetes compared with the lowest tertile, while no 
association was found among the low-WC group. These findings suggest that a low-GI, high-
fibre diet has an important independent effect on type 2 diabetes incidence and might bring the 
greatest benefits to overweight individuals and those with a raised WC, who are more 
susceptible to type 2 diabetes because of their adiposity levels. Alternatively it could be possible 
that high BMI and WC were a consequence of a low-GI, high-fibre diet in the first place, since 
dietary choices tend to track over the life course; it is often difficult to untangle patterns of 
associations among variables that correlated and track simultaneously. These results are in 
agreement with some studies reporting a stronger effect of GI among overweight people (139, 
142, 144), but in disagreement with others, that did not find a similar modifying effect of BMI 
(140, 141). In disagreement with the results in this chapter, one study (138) has reported that 
dietary fibre is more protective for type 2 diabetes among people with a BMI <25. These 
discrepancies are difficult to explain. They might be due to differences in age and ethnicity of 
the participants, although chance findings cannot be excluded.  
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5.4.2 Strengths 
This chapter adds to the available literature a comprehensive analysis of key dietary factors that 
might be important contributors to increased type 2 diabetes risk, using data from a 
representative white British population. 
One strength of this chapter is that, unlike most other prospective cohort studies, it uses diet 
diaries to assess dietary intake. Nearly all other studies rely on FFQ to assess dietary intake. 
The FFQ has been the preferred method in large-scale epidemiological studies because it is 
easy to administer, relatively inexpensive and less burdensome for study participants (289). 
However, FFQs are subject to significant measurement error that can affect the validity of diet-
disease associations (234, 290). Over-reporting of certain foods, especially healthy foods, and 
recall bias can further reduce the validity of FFQs (234, 290). More detailed dietary assessment 
tools, such as prospectively recorded diet diaries, correlate significantly better with actual 
intakes as measured by biomarkers and are subject to substantially less regression dilution 
compared to FFQs (233, 291). Diet diaries are able to include individual’s portion sizes, cooking 
methods and recipes, making them more precise than FFQs, which utilise ‘generic’ portion 
sizes, foods and recipes. To avoid misclassification and consequent attenuation of diet-disease 
associations, it is crucial to measure dietary exposure accurately; currently the use of diet 
records, although relatively expensive, is considered by some researchers as one of the most 
accurate tools for epidemiological studies.  
Another strength of these analyses is that GI values were assigned based on a rigorous 
methodology, which was developed to calculate the GI of diets reported in food diaries of 
European study members taking part in the recently initiated Diogenes study (297). Where 
possible data sources were selected from the UK or from European studies. This ensured that 
the GI values in the NSHD were country-specific and as accurate as possible, which might 
explain the robust associations between GI and diabetes found in this chapter. 
5.4.3 Limitations 
Uncontrolled residual confounding remains a concern in all observational studies. Although 
more precise than FFQs, diet diaries can also be subject to measurement error and under- or 
over-reporting. Random error in dietary analyses usually tends to underestimate relative risk 
estimates and reduce power (310). This might have cause attenuation of some results, such as 
in fat-diabetes associations, as dietary fats are more likely to be underestimated. 
Although effort was taken to ensure GI values were assigned in as a rigorous manner as 
possible, there remains some variability in the GI of many foods. GI is affected by many factors, 
such as the physical form of the food (i.e. the particle size), the methods of processing and 
preparation or the ripeness of fruit (311). The concomitant ingestion of protein and fat will also 
affect to some degree the GI of the meal, although studies have shown that the GI of mixed 
meals can be reliably calculated (298-301). Also for some foods there was no information 
available on their GI, therefore only estimates could be used. Nevertheless, the validity of the GI 
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values was relatively high: for more than 40% of foods the GI of an equivalent or similar item 
had been measured and only for 18% of the foods a nominal value had to be assigned.  
As in previous chapters the analyses in this chapter were restricted to those with valid data for 
potential confounders (lifetime social class, educational attainment, smoking history, physical 
activity, BMI and WC). The number of participants with valid diet diaries was relatively low at 
age 53, a factor that might have decreased the power of the analyses, particularly stratified 
ones. However, significant associations were found for most dietary factors.  
In addition to contributing to loss of power, the use of complete case analyses in this chapter 
might have resulted in bias. As is shown in Appendix 6 the sample with valid data for dietary 
intake was a healthier (i.e. less likely to be smoker and inactive) and more educated; this is not 
surprising considering the relatively high compliance necessary to compile diet diaries. 
5.4.4 Conclusions 
In conclusion, high dietary GI and low dietary fibre density were prospectively associated with 
increased type 2 diabetes risk independently of BMI and WC, supporting the view that these 
dietary factors have direct effects on type 2 diabetes incidence as well as indirect effects via 
body weight. The associations for dietary fibre density and dietary GI was more pronounced 
among overweight people and those with a larger WC, indicating that a low-fibre, high-GI diet 
might be particularly detrimental to those at greater risk of type 2 diabetes due to excess 
adiposity. Dietary fat and SFA seemed to be a more important risk factor for women. The next 
chapter will expand these results by using dietary pattern analyses to investigate the combined 
effect of dietary fibre, GI and dietary fat on incident type 2 diabetes and to identify food based 
guidance for reducing type 2 diabetes risk.   
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6 Chapter 6. Dietary patterns and type 2 diabetes 
6.1 Introduction 
Over the past decade, dietary pattern analyses have increasingly been used as an alternative 
method of studying associations between diet and disease risk. As stated in Chapter 1, dietary 
patterns may better describe the ‘real world’ eating habits of free-living people, where foods 
(and nutrients) are consumed together, and not in isolation (206). Separating the individual 
effects of single nutrients analyses is challenging, owing to the natural collinearity between 
dietary variables and their likely biologic interactions; looking at whole diets can help solve 
these problems, since potential synergistic effects of different nutrients are incorporated into the 
dietary pattern (210). Also, food-based dietary guidance is easier to interpret for the consumer 
than advice based on nutrients; therefore results from dietary patterns analyses might be more 
useful for public health recommendations.  
Overall the literature suggests that dietary patterns defined as ‘healthy’ are associated with 
reduced type 2 diabetes risk (216-218, 220-229). These ‘healthy’ patterns have common 
characteristics: high intake of fruits, vegetables and wholegrain foods, and low consumption of 
red meat, added sugar and fried foods. Most of the evidence comes from studies that have 
used exploratory dietary pattern methods:  either factor or cluster analyses (216, 223, 225-229) 
or diet quality scores (217, 218, 220-222, 224) and their limitations have been discussed in 
Chapter 1. The mechanisms or pathways between ‘healthy’ dietary patterns and type 2 diabetes 
risk are as yet, uncertain. Unlike factor and cluster analysis, RRR is a hypothesis-driven 
empirical method that allows exploration of possible biological pathways. Compared to 
exploratory methods, RRR has the advantage of combining a data-driven methodology with 
prior knowledge of the diet-disease relationship. The few studies that have so far applied RRR 
to examine diet and type 2 diabetes risk have mainly investigated dietary patterns related to 
inflammatory pathways (209, 230-232, 234). No study has used RRR to investigate dietary 
patterns characterised by dietary GI, fibre and fat intake, yet separately, these dietary factors 
have been linked with diabetes risk.  
In chapter 5, the associations between type 2 diabetes risk and GI, fat and fibre intakes were 
analysed separately. These nutritional elements were hypothesised to be important 
determinants of later diabetes risk, both through their effect on body weight and independently 
through other pathways. However, as mentioned earlier, it is important to consider the 
synergistic effects of nutrients in the whole diet and to be able to give food-based rather than 
nutrient-based guidance to the public. Therefore, using RRR analyses, this chapter will 
investigate how the sum and interaction of these nutrients, as part of a dietary pattern, predict 
type 2 diabetes risk. Combinations of foods in dietary patterns studies have revealed stronger 
associations than single foods or nutrients studies (208). Therefore it is expected that dietary 
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patterns will show more robust and consistent associations with later type 2 diabetes risk than 
those presented in chapter 5.  
Despite the increasing popularity of dietary patterns, most cohort studies use only a single 
measure of dietary intake at baseline. Only a few studies have used repeated dietary 
measurements to analyse individual changes in diet over time. These studies have investigated 
dietary patterns longitudinally either to assess stability of diet over time (326, 327) or to study 
the association between changes in dietary patterns and disease risk (328-331). Changes in 
diet over time may be due to alterations of dietary advice or food supply or they might be a 
consequence of major changes to life circumstances, such as pregnancy, altered health status 
or aging (332). It is important to study how these changes affect disease risk and to what extent 
changing diet at specific times in life will subsequently decrease or increase disease risk. So far 
most studies have focused on how diet affects change in BMI and obesity risk; to the author’s 
knowledge no study has investigated how longitudinal changes in dietary patterns affect type 2 
diabetes risk. This chapter will attempt to model how changes over adult life in the consumption 
of a high fat, high GI, low fibre dietary pattern affect the risk of type 2 diabetes and whether 
specific times of change are more important than others. 
6.1.1 Research question 
The main research question of this chapter is whether the consumption throughout adult life of a 
dietary pattern characterised by high GI, low fibre and high fat predicts type 2 diabetes risk in 
later life and how changes in scores for this pattern affect disease risk. 
6.1.2 Objectives 
1. To identify a dietary pattern characterised by high GI, low dietary fibre and high dietary 
fat 
2. To assess how scores for this dietary pattern at age 36, 43 and 53 years predict type 2 
diabetes incidence later in life 
3. To ascertain to what extent the relationship between the derived dietary pattern and 
type 2 diabetes is mediated by BMI and WC 
4. To investigate whether scores for the derived dietary pattern over the adult life course 
increase or decrease the risk of type 2 diabetes 
6.1.3 Hypotheses 
1. A higher score for a dietary pattern characterized by high GI, low dietary fibre, and high 
dietary fat is prospectively associated with higher odds of type 2 diabetes. 
2. The association between the derived dietary pattern and type 2 diabetes will be 
mediated in part by BMI and waist circumference, since GI, fibre and fat can affect 
caloric intake, energy density and therefore body weight, which is a leading cause of 
type 2 diabetes. However, the association will not be entirely attenuated, since GI, fibre 
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and fat are hypothesised to affect type 2 diabetes through alternative biological 
pathways. 
3. The risk of type 2 diabetes between age 53 and 64 years will be greater with greater 
increases in scores for the high fat, high GI, low fibre dietary pattern throughout adult 
life (from age 36 to age 53 years). 
 
6.2 Methods 
6.2.1 Explanatory variables  
The main explanatory variables used in this chapter are z-scores quantifying intakes of a high 
fat, high GI, low fat dietary pattern at 36, 43 and 53 years. Details of how the dietary pattern and 
z-scores were derived are presented in section 6.2.4.1. A categorical variable converting score 
in quintiles of dietary pattern intake is used in prospective associations of dietary pattern and 
type 2 diabetes. Details of the dietary assessment method are given in chapter 2.  
6.2.2 Outcome variables 
The main outcome used in this chapter is the main outcome of this thesis, risk of type 2 
diabetes between age 53 and 60-64 years. This is described in more detail in Chapter 2 
6.2.3 Potential confounding variables 
The potential confounders variables included in this chapter were the same as for chapter 5: 
SEP, education, smoking history and physical activity. The justification for each of these factors 
parallel that for confounding factors in the dietary factors-type 2 diabetes associations, details of 
which have been given in chapter 5. As in the previous chapter, BMI and WC were considered 
as mediators, since one of the objectives of this chapter was to assess the extent to which 
dietary patterns affect diabetes risk through body weight and abdominal fat accumulation.  
SEP was based on lifetime socio-economic position based on the head of the household’s 
occupational social class at age 15-53 years and highest level of educational qualification 
achieved by age 26 years. Self-reported measures of leisure time physical activity at 36, 43 and 
53 years were used as potential confounders. Three categorical variables of smoking history up 
to 36, 43 or 53 were used as measures of cumulative smoking damage. More detailed 
descriptions of the potential confounding measures used in this chapter are given in Chapter 2. 
6.2.4 Statistical analyses 
6.2.4.1 Deriving dietary patterns 
RRR was applied to identify a dietary pattern characterised by dietary GI, fibre density and fat 
density. RRR is a statistical method that derives dietary patterns by extracting successive linear 
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combinations of predictor variables (food groups) that explain as much variation as possible in 
another set of response variables. The response variables are hypothesised to be on the 
pathway between the predictor variables (food intake) and the outcome of interest (type 2 
diabetes). Dietary GI, fibre density and fat density were chosen as the response variables 
because they are hypothesised to be important determinants of the risk of type 2 diabetes 
(explained in more detail in Chapter 1 and explored in Chapter 5). The function PROC PLS in 
the software SAS was used to conduct all RRR analyses.  
The RRR model included 45 food groups (Table 40) as predictor variables (coded as g 
consumed per day) and dietary GI, fibre density and fat density as response variables. The 
procedure for calculating the GI for each food is explained in more details in Chapter 5.  
Because there were some differences in the intakes of the response variables between men 
and women the dietary patterns were initially created for men and women separately. The 
patterns derived were substantially similar. Therefore a dietary pattern based on men and 
women combined was subsequently used.  
Initially exploratory RRR analyses were conducted separately at each age. RRR derives as 
many dietary patterns as there are response variables, which in this case were three. 
Characteristics of the three dietary patterns first derived at age 36, 43 and 53 are outlined in 
Table 41. At all ages the first dietary pattern derived from RRR analyses explained the greatest 
variation in all three response variables (total variation accounted for was 29.8% at age 36, 
31.8% at age 43 and 37.9% at age 53) compared with the second and third patterns, which 
explained around 12-15% and 5% respectively. Therefore, only the first dietary pattern was 
analysed further. This dietary pattern was very similar at all ages: at age 43 and 53 it was 
negatively associated with dietary fibre density (r=-0.73 at age 43, r=-0.70 at age 53) and 
positively associated with fat density (r=0.37 at age 43, r=0.44 at age 53) and GI (r=0.56 at age 
43, r=0.55 at age 53). At age 36 the correlations were similar but in the opposite direction (high 
fibre and low GI). Factors loadings for the first dietary pattern extracted at age 36, 43 and 53 are 
shown in Appendix 9 and 10 and Figure 11. 
To assess longitudinal associations between dietary patterns and type 2 diabetes a score for 
exactly the same dietary pattern (based on the same covariance matrix) at 36, 43 and 53 years 
was required. To achieve this confirmatory RRR analyses (236) were used to calculate dietary 
pattern scores at 36 and 43 years of age using scoring weights from the first dietary pattern 
identified at 53 years (which explained the greater variation in response variables). Each study 
member received a score calculating the degree to which their dietary intake reflected this 
dietary pattern at age 36, 43 and 53.  
6.2.4.2 Descriptive and regression analyses 
Descriptive analyses compared proportion of people diagnosed with type 2 diabetes between 
age 53 and 60-64 and selected nutrients intakes according to quintiles of the dietary pattern 
score. Associations of potential confounders with dietary pattern scores and outcome were then 
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examined using tests for trend and t test. 
Multivariable logistic regression models were used to examine prospective associations 
between quintiles of dietary pattern scores and type 2 diabetes risk between age 53 and 64 
years. There was no interaction between the dietary pattern score and gender at age 36 
(p=0.85) and 53 (p=0.14) but a significant interaction at age 43 (p=0.01). The data were then 
analysed together for all ages and subsequently stratified by sex at age 43. Sequential 
adjustments were made for caloric intake, sex, socio-economic status, educational attainment, 
smoking and exercise. Additional models were adjusted for BMI and WC. 
Changes in dietary pattern scores over the period between age 36 and 53 were obtained by 
subtracting the score at age 36 from the score at 53. These steps were repeated to obtain the 
change in score between age 36 and 43 and between age 43 and 53. These change score 
were plotted graphically to allow visual inspection. A conditional model of change (272) was 
used to estimate the association between periods of changes in dietary pattern scores and the 
odds of type 2 diabetes. Dietary pattern scores change for the periods 36–53, 36–43 and 43–53 
years were calculated conditional on earlier score using the residual method, which has been 
described in chapter 3. These residuals were fitted in the same models, adjusting for energy 
intake, socio-economic status, educational attainment, smoking and physical activity. Additional 
models were adjusted for conditional BMI and conditional WC change. Interactions between sex 
and dietary pattern change were tested. There was a significant interaction between the dietary 
pattern score change at age 36-43 and 36-53 and sex (p=0.01) therefore analyses were 
presented separately for men and women. 
6.2.5 Study population 
All analyses were restricted to those with valid information for type 2 diabetes status. In 
prospective analyses the dietary pattern and type 2 diabetes, models were restricted to study 
members with valid data for dietary intake and for all confounders and mediators (SEP, 
education, smoking, exercise, BMI, WC). The final number was different depending on the year 
of the dietary assessment (N=1804 for age 36; N=2267 for age 43; N=1478 for age 53). For 
longitudinal analyses of changes in dietary pattern score, analyses were restricted to those with 
valid data for all three dietary collection years and all confounders (N=1180). 
6.3 Results 
6.3.1 Descriptive analyses of dietary patterns 
Dietary patterns analyses were initially identified in the 1760 study members for whom diet 
diaries were available at age 53 years. Factor loadings for the high fat, high GI, low-fibre dietary 
pattern identified at age 53 are shown in Figure 11. A positive factor loading indicated that as 
the intake of that food increased, so did the dietary pattern score; whereas, foods with a 
negative factor loading decreased the score. The dietary pattern was characterised by low 
intake of fruit, vegetables, low-fat yogurt, wholemeal bread, high-fibre cereals and high intakes 
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of white bread, processed meat, fried potatoes, butter and animal fat and added sugar (Figure 
11). A detailed description of the foods groups included in the dietary pattern is given in Table 
40. Fifty-seven percent of the variation in dietary pattern score was explained by the top five 
and bottom five factor loadings, with fresh fruit explaining the most variation (23%), then white 
bread (8%), vegetables (6%), low-fat yogurt (5%), and processed meat (4%). 
Confirmatory dietary pattern analyses were applied to the diet diaries completed at age 36 
(n=2441) and 43 years (n=3187) of age. Table 42 shows the proportion of people diagnosed 
with type 2 diabetes between age 53 and 60-64 and the nutritional characteristics of the dietary 
pattern at age 36, 43 and 53 years.  At all ages those with higher scores for the high fat, high 
GI, low fibre dietary pattern had higher intakes of energy (kcal), total fat and protein density, a 
greater average daily GI and lower intakes of dietary fibre density. Those with higher scores for 
the dietary pattern also consumed less carbohydrates density and more alcohol except for age 
36. The distributions of fat, fibre and GI, to some extent, changed with age. The diet of the 
NSHD population appears to be becoming healthier on average. For example, those in the top 
quintile for the dietary pattern had a median daily fibre density of 4.3g (SD=1.6), an average 
daily fat density of 45.1g (SD=4.9) and an average daily GI of 66.5 (SD=2.9) at age 36 
compared to respectively 5.5g (SD=1.5), 42.3g (SD=5.9) and 64.9 (SD=3.5) at age 53 (Table 
42). 
6.3.2 Investigation of potential confounders/mediators 
Table 43 shows associations between possible confounding variables and dietary patterns z-
scores at age 36, 43 and 53. A negative score signifies a ‘healthier’ diet. Men and those from a 
lower socio-economic class and with lower educational attainments had higher scores for the 
high fat, high GI, low fibre dietary pattern at all ages. Lifetime smokers and less active people 
had all significantly higher dietary pattern scores at all ages. There was a significant trend for z-
scores at all ages to increase with higher WC tertiles. The association between BMI categories 
and dietary patterns was less clear; at all ages obese individuals had the lowest z-score for 
dietary pattern at age 36; those within the normal BMI category at age 43 and 53 had the lowest 
negative scores at age 43 and 53, but overweight people tended to have higher z-scores than 
the obese at age 43. This could be due to underreporting among the severely obese or it could 
be due to the smaller number of obese people compared with overweight, especially at age 36. 
Alternatively it could be possible that those people who were obese from a younger age had 
already modified their diet as a consequence of their weight. 
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Table 40. Description of food groups included in the dietary pattern analyses 
Food group name Foods included 
Pizza Pizza 
Pasta Pasta & pasta dishes 
Rice Rice & rice dishes 
Cereals_other Cereals other than pasta, bread and rice 
High-fibre cereals Breakfast/oat cereals with fibre content equal or >3g/40g portion;  
Low-fibre cereals Low-fibre cereals and breakfast bars 
White bread White bread 
Wholemeal bread Wholemeal, granary and brown bread 
Crisp & other bread Crisp bread (e.g. Rivita, grissini) and other bread 
Biscuit, pastry, cakes Biscuits, pastries, buns, pies and cakes 
Whole milk Whole milk (cow or goat) 
Skimmed milk Skimmed milk, semi-skimmed milk and milk 1% 
Low-fat dairy desserts Low fat dairy desserts, low-fat ice-cream and flavoured milk 
Full-fat yogurt Full-fat yogurt 
Low-fat yogurt Low-fat yogurt 
Full fat dairy dessert Full fat dairy desserts, ice-cream and milk pudding 
Cream Cream 
Butter and animal fat Butter and animal fat 
Cheese Cheese 
Eggs Eggs 
Oils Oils 
Plant fat solid Plant based fats (solid) 
Plant fat solid low fat Plant based fats (solid) reduced-fat and low-fat 
Fish White fish, oily fish and shellfish 
Red meat, offal Beef, lamb, pork and other red meat (including dishes) 
White meat Chicken, turkey and other game birds (including dishes) 
Processed meat Bacon, ham, meat pies, sausages and other processed meats 
Vegetables Raw and cooked vegetables 
Pulses Pulses, lentils and baked beans 
Fruit Fresh, canned and dried fruits 
Potatoes Potatoes (not fried or roasted) 
Fried potatoes Fried and roasted potatoes 
Nuts and seeds Nuts and seeds (including peanut butter) 
Soups Canned, fresh and dried soup 
Dressing & sauces Dressings, mayonnaise, cooking sauces and other sauces  
Jam and chutney Jam, marmalade, chutney and pickles 
Table sugar Sucrose 
Honey and syrup Honey, syrup and other sugars (not pure sugar) 
Confectionery Chocolate products, sugar-based products, sorbets and lollies 
Savoury snacks 
Savoury biscuits, crackers, potato-, cereal- and vegetable-based 
snacks 
Alcoholic drinks Wine, beer, spirits, Alco pops 
Squashes & juices Squashes & fruit concentrate, fruit juice drinks 
Pure fruit juice Pure fruit juice and smoothies 
Soft drinks Carbonated soft drinks 
Coffee & tea Coffee, tea, powdered beverages (e.g. ovaltine) 
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Table 41. Characteristics of the 3 RRR-derived exploratory dietary patterns at age 36, 
43 and 53  
Dietary patterns at age 36  
Per cent Variation Accounted for in the response variables 
Dietary pattern Fibre Density* Fat Density* GI 
Total variation 
accounted for 
1 38.2 1.9 49.4 29.8 
2 40.8 47.3 49.4 15.9 
3 50.1 47.9 57.4 5.9 
Correlation coefficients for Response variables  
Dietary pattern Fibre Density* Fat Density* GI 
 1 0.65 0.14 -0.74  
2 -0.23 0.97 -0.01  
3 0.72 0.18 0.66  
Dietary patterns at age 43  
Per cent Variation Accounted for in the response variables 
Dietary pattern Fibre Density* Fat Density* GI 
Total variation 
accounted for 
1 51.7 13.7 29.9 31.8 
2 53.4 48.0 35.2 13.7 
3 59.1 48.3 42.9 4.5 
Correlation coefficients for Response variables  
Dietary pattern Fibre Density* Fat Density* GI 
 1 -0.73 0.37 0.56  
2 0.19 0.91 -0.35  
3 0.64 0.15 0.74  
Dietary patterns at age 53  
Per cent Variation Accounted for in the response variables 
Dietary pattern Fibre Density* Fat Density* GI 
Total variation 
accounted for 
1 56.2 22.2 35.2 37.9 
2 56.7 48.7 45.4 12.3 
3 64.9 50.2 52.3 5.5 
Correlation coefficients for Response variables  
Dietary pattern Fibre Density* Fat Density* GI 
 1 -0.70 0.44 0.55  
2 0.11 0.84 -0.52  
3 0.70 0.30 0.64  
*= g/1000kcal; GI= glycaemic index 
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Figure 11. Factor loadings for the high-fat, high-GI, low-fibre dietary pattern at age 53 
used in confirmatory dietary pattern analyses 
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Table 42. Mean (SD) or median (IQR) nutrient intakes by quintile of high-fat, high-GI, low-
fibre dietary pattern z-score  
Quintile of dietary patterns z-score 
 1 2 4 3 5 
p-
value 
Age 36       
n 361 489 489 488 488  
Diabetes
a
 (%) 7.7 9.7 8.8 10.2 10.2 0.24 
Energy, kcal  1785  569 1940  574 2004  550 2065  551 2373  679 <0.001 
Fat density* 41.6  5.9 43.7  5.4 44.3  5.9 44.6  5.2 45.1  4.9 <0.001 
CHO density* 110.8  16.1 107.5  16.1 109.0  15.5 109.6  14.7 110.6  14.3 0.47 
Protein density* 41.3  10.2 37.5  6.8 36.2  6.5 35.9  5.4 33.7  4.5 <0.001 
Alcohol 
(MedianIQR)  
5.5  15.3 6.7  17.7 7.5  18.0 8.2  21.4 6.2  21.3 0.34 
Fibre density* 
(MedianIQR) 
8.4  3.4  6.6  2.3  5.7  2.0  5.1  2.  4.3  1.6  <0.001 
GI 61.3  10.0 63.1  3.8 64.4  3.3 65.5  3.6 66.5  2.9 <0.001 
Age 43       
n 454 453 454 453 453  
Diabetes
a
 (%) 7.9 6.6 10.5 10.1 12.1 <0.01 
Energy, kcal  1833  567 1934  568 2078  571 2129  569 2424  708 <0.001 
Fat density* 38.6  7.3 41.7  5.6 43.3  5.6 44.9  5.7 46.5  5.1 <0.001 
CHO density* 118.2  19.4 112.1  15.4 109.7  16.7 106.5  15.3 106.6  14.7 <0.001 
Protein density* 41.6  9.6 38.7  7.1 37.2  6.6 36.2  5.6 34.4  5.1 <0.001 
Alcohol 
(MedianIQR)  
5.4  15.9 7.7  18.0 6.4  17.6 6.1  17.3 6.8  15.9 0.04 
Fibre density* 
(MedianIQR) 
7.6  2.8  6.0  2.0  5.6  1.6  5.1  1.2  4.6  1.1  <0.001 
GI 60.4  4.8 63.0  4.7 63.8  4.5 65.1  4.2 66.8  3.8 <0.001 
Age 53       
n 296 296 295 296 295  
Diabetes
a
 (%) 5.7 7.4 7.4 11.4 13.2 <0.001 
Energy, kcal  1867  476 1913  456 1999  474 2031  501 2117  514 <0.001 
Fat density* 32.6  6.8 36.1  5.6 38.8  5.7 39.4  5.4 42.3  5.9 <0.001 
CHO density* 131.7  19.7 123.5  14.7 118.1  17.6 114.1  16.9 109.3  19.1 <0.001 
Protein density* 42.1  7.7 41.5  6.6 39.4  6.4 38.6  6.2 37.9  6.4 <0.001 
Alcohol 
(MedianIQR)  
7.5  17.4 8.1  17.5 9.7  21.9 12.3  25.6 9.2  26.6 <0.001 
Fibre density* 
(MedianIQR) 
9.8  3.3  8.2  2.3  7.0  2.1  6.4  1.9  5.5  1.5  <0.001 
GI 58.8  3.5 60.3  3.2 61.6  3.3 63.5  3.3 64.9  3.5 <0.001 
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes 
and all covariates. Values are mean (SD) unless specified; p-value for trend across quintiles of dietary 
pattern score; a= type 2 diabetes diagnosed between age 53 and 60-64; *= g/1000kcal; 
CHO=carbohydrates; GI= glycaemic index;  
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Table 43. Associations between potential confounders/mediators and dietary patterns 
z-scores at age 36, 43 and 53 
 
  Dietary pattern z-score 
 n 36 year 43 year 53 years 
Sex     
Male 632 0.29 (0.9) 0.26 (1.0) 0.25 (0.9) 
Female 765 -0.39 (0.8) -0.36 (0.8) -0.36 (0.9) 
P-value   <0.001 <0.001 <0.001 
Socioeconomic position     
I    professional 112 -0.39 (0.9) -0.31 (0.8) -0.18 (0.9) 
II   intermediate 514 -0.22 (0.9) -0.20 (0.9) -0.20 (0.9) 
III  skilled (Non-Manual) 351 0.14 (0.9) 0.09 (0.9) -0.22 (0.9) 
III  skilled (Manual) 206 0.24 (0.9) 0.22 (1.0) 0.37 (1.0) 
IV   partly skilled 149 0.07 (1.0) 0.08 (1.0) 0.05 (1.0) 
V    unskilled 59 0.22 (0.9) 0.34 (0.9) 0.02 (0.9) 
P-value  (trend)  <0.001 <0.001 <0.001 
Education attained by age 26     
None attempted 379 0.32 (0.9) 0.27 (0.9) 0.19 (0.9) 
Intermediate 394 0.30 (0.9) 0.09 (0.9)  -0.15 (1.0) 
Highest  562 -0.27 (0.9) -0.31 (0.9) -0.23 1.0) 
P-value (trend)  <0.001 <0.001 <0.001 
BMI (kg/m2) at age 36     
Underweight or normal  983 -0.12 (0.9)   
Overweight  340 0.08 (1.0)   
Obese  60 -0.40 (0.9)   
P-value (trend)  0.24   
BMI (kg/m2) at age 43     
Underweight or normal  806 -0.12 (0.9) -0.17 (0.9)  
Overweight  448 0.09 (0.9) 0.10 (0.9)  
Obese  133 -0.40 (1.0) -0.11 (1.0)  
P-value (trend)  0.85 <0.01  
BMI (kg/m2) at age 53     
Underweight or normal  511 -0.13 (0.9) -0.18 (0.9) -0.20 (1.0) 
Overweight  597 0.01 (0.9) 0.01 (1.0) -0.02 (1.0) 
Obese  276 -0.21 (1.0) -0.07 (0.9) 0.00 (0.9) 
 P-value (trend)  0.71 0.05 <0.01 
Waist circumference age 36      
Lowest tertile  538 -0.34 (0.8)   
Middle tertile 446 0.07 (0.9)   
Highest tertile 387 0.11 (1.0)   
P-value (trend)  <0.001   
Waist circumference age 43     
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Lowest tertile  568 -0.30 (0.8) -0.36 (0.8)  
Middle tertile 423 -0.00 (0.9) 0.05 (1.0)  
Highest tertile 355 0.15 (1.0) 0.20 (1.0)  
P-value (trend)  <0.001 <0.001  
Waist circumference age 53     
Lowest tertile  537 -0.28 (0.8) -0.33 (0.9) -0.37 (1.0) 
Middle tertile 464 -0.01 (0.9) -0.00 (0.9) -0.02 (0.9) 
Highest tertile 389 0.11 (1.0) 0.18 (1.0) 0.23 (0.9) 
P-value (trend)  <0.001 <0.001 <0.001 
Lifetime smoking trajectory     
Never smoker 442 -0.27 (0.8) -0.22 (0.9) -0.29 (0.9) 
Predominantly non-smoker 528 -0.18 (0.9) -0.17 (1.0) -0.20 (1.0) 
Predominantly smoker 257 0.21 (0.9) 0.12 (0.9) 0.15 (0.9) 
Lifelong smoker 145 0.32 (0.9) 0.34 (0.9) 0.59 (0.9) 
P-value (trend)  <0.001 <0.001 <0.001 
Exercise at age 36     
Inactive 475 -0.00 (0.9)   
Less active 358 0.04 (0.9)   
Most active 563 -0.22 (0.9)   
P-value (trend)  <0.001   
Exercise at age 43     
Inactive 674  0.05 (0.9)  
Less active 364  -0.16 (1.0)  
Most active 359  -0.23 (1.0)  
P-value (trend)   <0.001  
Exercise at age 53     
Inactive 643   0.07 (1.0) 
Less active 279   -0.07 (0.9) 
Most active 473   -0.30 (1.0) 
P-value (trend)    <0.001 
Note: analyses restricted to those with non-missing data for dietary patterns scores at age 36, age 43 
and age 53; maximum available sample size used with each indicator; educational attainment was 
categorised as none (none attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest 
(GCE A level or Burnam B or higher); exercise at age 43 was coded as inactive (no participation), 
moderately active (participated one to four times) and most active (participated five or more times) per 
month. P-value=t test or ANOVA 
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6.3.3 Prospective associations between dietary patterns and type 2 diabetes  
Prospective associations between dietary pattern scores at age 36, 43 and 53 and type 2 
diabetes diagnosed between 53 and 60-64 years are shown in Table 44. In models only 
adjusted for energy intake and sex, at all ages there was an increasing trend in type 2 diabetes 
risk observed with increasing quintile of the high fat, high GI, low fibre dietary pattern score 
(Model 1, p for trend <0.05 at age 36, <0.001 at age 43 and <0.01 at age 53). Following 
adjustments for lifestyle and social confounders associations were no longer significant at age 
36 (Model 3). After adjustment for BMI associations between the highest quintile of intake and 
diabetes were no longer significant at age 43 but significant trends across quintiles persisted 
(Model 4). After further adjustment for WC associations were weakened but remained 
significant at age 53 (OR=2.35, 95% CI 1.14, 4.87, p=0.02) (Model 5).  
Modification by sex was investigated and significant interactions were observed between dietary 
pattern score and sex on diabetes but only at age 43 (p=0.01); therefore analyses were also 
presented by sex (Table 45).  While no effect for the high-fat low-fibre high-GI dietary pattern 
was observed among men at age 43, among women there was a strong relationship between 
higher scores and type 2 diabetes incidence, which persisted after adjustment for BMI and WC 
(p for trend <0.01). 
6.3.4 Longitudinal changes in dietary pattern scores and type 2 diabetes 
Table 46 shows the mean change in scores for the high fat, high GI, low fibre dietary pattern 
during the follow-up period. On average, dietary pattern scores for the whole population 
decreased between age 36 and 53 years. There were no significant differences in average 
score change between men and women, although men tended to decrease their scores for the 
dietary pattern steadily, while on average, women increased it between 36 and 43 years and 
decreased it between 43 and 53 years. People who developed type 2 diabetes between age 53 
and 60-64 increased their dietary pattern scores (on average) during both periods, with an 
overall change between age 36 and 53 of 0.26, compared to a change of -0.06 for the rest of 
the sample (p <0.01). Figure 12 shows that the difference in mean dietary pattern score change 
from age 36 to 43 (and consequently from age 36 to 53) between those who later developed 
diabetes and those who did not, was stronger in women than men.  
A significant interaction was observed between dietary pattern score change from age 36-43 
years and sex on diabetes (p=0.01) therefore analyses were presented by sex. Multivariable 
regression models (Table 45) showed that changes in dietary pattern scores between age 36 
and 43 and between age 43 and 53 were significantly associated with type 2 diabetes risk 
among women but not men. After adjustment for BMI change, dietary pattern change at age 43-
53 was no longer significant while change at age 36-43 remained borderline significant. 
However, long-term change between age 36 and 53 remained significantly associated with type 
2 diabetes in all models among women: for a 1 SD unit increase in score between age 36 and 
53, the OR for type 2 diabetes 1.62 (95% CI: 1.10, 2.39).  
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Table 44. Associations at each age between a high fat, high GI, low fibre dietary pattern z-score and type 2 diabetes between age 53 and 60-64 
 Model 1  Model 2  Model 3  Model 4  Model 5  
 Adjusted for kcal 
intake and sex 
 
As Model 1 + SEP and 
education 
As Model 2 + physical 
activity, smoking history 
As Model 3 + BMI  As Model 4 + 
WC 
 
Quintiles of 
dietary pattern 
intake 
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Age 36 (N=1804)          
Q2 1.24 (0.72, 2.12) 0.43 1.24 (0.72, 2.12) 0.43 1.24 (0.72, 2.13) 0.43 1.43 (0.82, 2.50) 0.43 1.41 (0.81, 2.47) 0.22 
Q3 1.08 (0.61, 1.90) 0.77 1.07 (0.61, 1.89) 0.79 1.03 (0.58, 1.82) 0.90 1.11 (0.62, 1.99) 0.90 1.09 (0.61, 1.96) 0.75 
Q4 1.52 (0.88, 2.61) 0.12 1.51 (0.87, 2.61) 0.13 1.44 (0.83, 2.51) 0.18 1.55 (0.88, 2.73) 0.18 1.51 (0.85, 2.66) 0.15 
Q5 1.84 (1.03, 3.22) 0.03 1.79 (0.98, 3.27) 0.05 1.62 (0.88, 2.98) 0.11 1.75 (0.93, 3.29) 0.11 1.72 (0.91, 3.22) 0.09 
P for trend 0.03  0.04  0.10  0.09  0.10  
Age 43 (N=2267)          
Q2 0.92 (0.56, 1.50) 0.74 0.91 (0.55, 1.49) 0.71 0.85 (0.51, 1.40) 0.53 0.87 (0.52, 1.46) 0.61 0.88 (0.53, 1.47) 0.63 
Q3 1.46 (0.92, 2.33) 0.10 1.44 (0.91, 2.30) 0.11 1.35 (0.84, 2.16) 0.20 1.33 (0.82, 2.16) 0.23 1.29 (0.80, 2.10) 0.28 
Q4 1.52 (0.94, 2.43) 0.08 1.47 (0.91, 2.38) 0.11 1.34 (0.82, 2.18) 0.23 1.36 (0.83, 2.25) 0.21 1.33 (0.80, 2.20) 0.25 
Q5 2.09 (1.30, 3.37) <0.01 1.93 (1.21, 3.24) <0.01 1.67 (1.00, 2.77) 0.04 1.55 (0.92, 2.62) 0.09 1.52 (0.90, 2.57) 0.11 
P for trend <0.001  <0.01  0.01  0.03  0.04  
Age 53 (N=1477)          
Q2 1.47 (0.74, 2.92) 0.26 1.45 (0.73, 2.89) 0.28 1.46 (0.73, 2.91) 0.27 1.62 (0.79, 3.38) 0.18 1.60 (0.77, 3.30) 0.20 
Q3 1.98 (1.03, 3.82) 0.03 1.94 (1.01, 3.75) 0.04 1.94 (1.00, 3.75) 0.04 1.68 (0.83, 3.35) 0.14 1.67 (0.83, 3.37) 0.14 
Q4 2.32 (1.21, 4.43) 0.01 2.25 (1.17, 4.31) 0.01 2.23 (1.16, 4.31) 0.01 2.21 (1.10, 4.44) 0.02 2.15 (1.06, 4.32) 0.03 
Q5 2.81 (1.46, 5.44) <0.01  2.67 (1.36, 5.24) <0.01 2.68 (1.35, 5.34) <0.01 2.42 (1.17, 4.88) 0.01 2.36 (1.14, 4.87) 0.02 
P for trend <0.01  <0.01  <0.01  0.01  0.01  
Note: analyses restricted to those with non-missing data for dietary intake at each age, type 2 diabetes and all covariates; SEP=socioeconomic position; BMI= body mass index; 
WC=waist circumference; for all associations the reference category was Q1 
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Table 45. Associations between dietary pattern z-score at age 43 and type 2 diabetes at age 53 to 60-64 by sex 
Age 43 (N=2267)    
 
    
 
 Model a  Model b   Model a  Model b   
Quintiles of dietary 
pattern z-score  OR (95% CI) P value OR (95% CI) P value 
 
OR (95% CI) P value OR (95% CI) P value 
P value for 
interaction 
 Men (n=1080)   Women (n=1187)   
Q2 0.61 (0.33, 1.13) 0.17 0.64 (0.34, 1.22) 0.18  1.33 (0.51, 3.47) 0.55 1.31 (0.49, 3.48) 0.58  
Q3 0.88 (0.49, 1.60) 0.58 0.89 (0.48, 1.65) 0.73  2.99 (1.28, 7.01) 0.01 2.63 (1.10, 6.38) 0.02  
Q4 0.91 (0.49, 1.71) 0.99 0.87 (0.45, 1.66) 0.68  2.81 (1.18, 6.66) 0.01 2.81 (1.16, 6.79) 0.02 0.01 
Q5 0.89 (0.45, 1.73) 0.87 0.91 (0.46, 1.80) 0.79  4.03 (1.64, 9.85) <0.01 3.36 (1.32, 8.52) 0.01  
P for trend 0.88  0.94   <0.01  <0.01   
Note: analyses restricted to those with non-missing data for dietary intake, type 2 diabetes and all covariates; for all associations the reference category was Q1; Model a: 
adjusted for kcals, occupational class, education, physical activity, smoking history; Model b= as Model a + adjusted for BMI and waist circumference. 
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Table 46. Mean change (95%CI) in dietary pattern z-score according to sex and type 2 diabetes diagnosed between age 53 and 60-64 
  Change in dietary pattern z-score 
  36 to 43 years 43 to 53 years 36 to 53 years 
 N Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Whole sample 1180 -0.006 (-0.066 – 0.052) -0.022 (-0.082 – 0.037) -0.029 (-0.092 – 0.037) 
By sex     
Men 525 -0.036 (-0134 – 0.061) -0.046 (-0.143 – 0.050) -0.082 (-0.182 – 0.017) 
Women 655 0.015 (-0.059 – 0.090) -0.003 (-0.079 – 0.072) 0.011 (-0.069 – 0.093) 
P-value  0.40 0.49 0.14 
 By type 2 diabetes     
Not diabetic 1074 -0.025 (-0.087 – 0.036) -0.034 (-0.097 – 0.028) -0.060 (-0.125 – 0.005) 
Diabetic 106 0.170 (-0.052 – 0.393) 0.096 (-0.109 – 0.301) 0.266 (0.036 – 0.496) 
P-value  0.05 0.21 <0.01 
Note: analyses restricted to those with non-missing data for dietary intake, type 2 diabetes and all covariates; CI=confidence interval 
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Figure 12. Mean change in dietary pattern score (SD) by sex and type 2 diabetes 
diagnosis 
Note: analyses restricted to those with non-missing data for dietary intake, type 2 diabetes and all 
covariates (N=1180); DP= dietary pattern 
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Table 47. Associations between change in dietary pattern z-score and type 2 diabetes between age 53 and 60-64 
 Model 1  Model 2 
 
Model 3 
 
Model 3  
 Adjusted for, SEP, education, 
energy intake 
As Model 1 + smoking and exercise As Model 2 + BMI change* As Model 3 + WC 
change** 
 
 
OR (95% CI) 
P  
value 
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Change in dietary pattern 
z-score  
 
   
 
 
 
 
Men, N=525         
   Age 36 to 43 1.08 (0.77, 1.53) 0.63 1.07 (0.76, 1.51) 0.67 1.09 (0.76, 1.59) 0.61 1.11 (0.77, 1.60) 0.56 
   Age 43 to 53 1.10 (0.79, 1.54) 0.53 1.07 (0.77, 1.50) 0.66 1.13 (0.81, 1.59) 0.45 1.05 (0.74, 1.48) 0.76 
   Age 36 to 53 1.12 (10.82, 1.53) 0.46 1.09 (0.79, 1.49) 0.59 1.17 (0.83, 1.63) 0.35 1.16 (0.83, 1.62) 0.37 
Women, N=655         
   Age 36 to 43 1.82 (1.22, 2.71) <0.01 1.84 (1.23, 2.75) <0.01 1.49 (0.99, 2.24) 0.05 1.50 (1.00, 2.27) 0.04 
   Age 43 to 53 1.55 (1.07, 2.25) 0.01 1.55 (1.06, 2.26) 0.02 1.43 (0.96, 2.13) 0.07 1.45 (0.98, 1.65) 0.06 
   Age 36 to 53 1.75 (1.23, 2.49) <0.01 1.78 (1.24, 2.55) <0.01 1.56 (1.07, 2.26) 0.01 1.62 (1.10, 2.39) 0.01 
Note: analyses restricted to those with non-missing values for all covariates at all ages. OR of type 2 diabetes for a 1 SD increase in dietary patterns z-score in each interval 
conditional on previous dietary pattern z-score; 
* conditional Body Mass Index change at age 36-43 and 43-53;  ** conditional waist circumference change at age 36-43 and 43-53 waist circumference  
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6.4 Discussion 
6.4.1 Main findings 
A higher score for a dietary pattern characterised by high fat, high GI, low fibre at age 53 was 
associated with a greater type 2 diabetes risk in men and women; higher scores at age 43 were 
associated with diabetes among women but not men. These associations were independent of 
BMI and WC. Gradually increasing the score for this dietary pattern over the life course (36 to 
53 years) is particularly detrimental for type 2 diabetes among women. 
1
st
 and 2
nd
 objectives: To identify a dietary pattern characterised by high GI, low dietary fibre 
and high dietary fat and to investigate the association between this dietary pattern at age 36, 43 
and 53 and type 2 diabetes incidence between age 53 and 60-64. It was hypothesised that a 
higher score for this dietary pattern would be prospectively associated with higher odds of type 
2 diabetes. 
Using RRR in this chapter, a high fat, high GI, low fibre dietary pattern was identified that was 
characterised by a high consumption of white bread, processed meat, fried potatoes, butter, 
animal fats and added sugar, and a low intake of fruits, vegetables, low-fat yogurt and high-fibre 
cereals. In agreement with the first hypothesis higher scores for this dietary pattern at age 53 
were associated with an increased risk of type 2 diabetes diagnosed between age 53 and 60-
64. This association was robust to adjustment for education, SEP, smoking, exercise, BMI and 
WC. At age 43 there was a significant sex interaction such that the dietary pattern was strongly 
associated with diabetes among women, for whom the association was independent of BMI and 
WC; however no association was observed among men. The associations between the dietary 
patterns at age 36 and diabetes were weaker and mostly non-significant. Therefore, it appears 
that this dietary pattern became more important for type 2 diabetes risk in middle and late 
adulthood and significantly more so in later adulthood. These results, in parallel with those in 
chapters 3-5, suggest a pattern of accumulation of lifestyle risk factors for type 2 diabetes 
across the adult life.  
The results from this chapter are in agreement with the majority of previous findings from 
studies on type 2 diabetes and dietary patterns. Both the AHEI and the DASH diets, two diet 
quality scores that include fruits, vegetables, low-fat dairy and whole grains were protective 
against type 2 diabetes in White populations (218, 221). The Mediterranean diet, rich in 
vegetables and fruits and low in red meat, has also been linked with lower risk of type 2 
diabetes (222, 224). Protective dietary patterns identified with factor and cluster analyses, often 
labelled ‘healthy’ or ‘prudent’, have also tended to include fruits, vegetables, whole grains, 
whole bread and low-fat dairy products, whereas, dietary patterns associated with increased 
type 2 diabetes risk have tended to be high in red and processed meat, refined grains, fried 
foods, high-fat dairy products and sweets (216, 225-228). Most of these protective and 
detrimental food groups loaded strongly on the high fat, high GI and low fibre dietary pattern 
identified in this chapter.  
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The results from this chapter build on previous findings by providing insight into the possible 
biological pathways that link these food groups with type 2 diabetes, as discussed in detail 
below. A few studies have attempted to do this by using RRR methodologies to examine 
pathways between food, inflammatory markers and type 2 diabetes (230-232, 234). Another 
study applied RRR to examine a dietary pattern based on fibre, alcohol, magnesium and a high 
ratio of PUFA to SFA in relation to type 2 diabetes risk (209). To the author’s knowledge, no 
previous studies have used RRR to examine a dietary pattern characterised by fat density, GI 
and fibre density, for which, as outlined in chapter 1 and 5, there is some supporting evidence of 
a link with type 2 diabetes. 
The stronger association between the dietary pattern at age 43 and diabetes among women 
could be due to several reasons. In chapter 5 a similar gender difference was observed for the 
association between fat (and SFA) and type 2 diabetes. Thus, there might be biological gender 
differences in the responses to certain nutrients, particularly fatty acids, and the way these are 
disposed of and stored in the postprandial state. For example it is known that sex-specific 
hormones can influence insulin receptors and lipid removal (324) and that men oxidise a higher 
percentage of ingested fat than women (325). However, the gender difference could also be 
due to different food choices; it is possible that this particularly dietary pattern explained greater 
variation in nutrients among women than men and that other food combinations might be more 
important for men. However, when dietary patterns were initially identified separately for men 
and women there were no major differences in the main foods characterizing the dietary 
patterns. Finally, accuracy in reporting dietary intake may also vary by sex (333).  
Few studies have investigated men and women separately in the same cohort. In the 
Melbourne Collaborative Cohort Study (225) the association between a dietary pattern 
characterized by meats and fatty fried foods, and diabetes was significantly stronger among 
women, whose risk was in the highest quintile was nearly 4-fold compared to the lowest quintile. 
Conversely among men the risk was 2-fold and borderline significant. Other studies did not find 
significant interactions. However, in the Nurses’ Health Studies the relative risks comparing 
quintiles of intakes of a RRR-derived dietary pattern high in processed meat, refined grains and 
soft drinks were particularly high (RR: 2.56, 95% CI: 2.10, 3.12 in the Nurses' Health Study and 
2.93, 95% CI: 2.18, 3.92 in the Nurses' Health Study II) (234); on the contrary a similarly 
characterised dietary pattern had comparatively weaker associations in the Health 
Professionals Follow up Study (RR comparing quintiles: 1.59, 95%CI: 1.32 to 1.93) (228). 
3
rd
 objective: To ascertain whether the relationship between the derived dietary pattern and 
type 2 diabetes is mediated by BMI and WC. It was hypothesised that, since GI, dietary fibre 
and dietary fat can affect caloric intake and energy balance, the association would be partly 
mediated by BMI, but that an independent association between dietary pattern and diabetes 
would remain. The results in this chapter support this hypothesis. This was mainly true for the 
dietary pattern at age 43 (among women) and 53. Excess body weight, especially around the 
waist, is an established risk for type 2 diabetes; GI and fibre act on satiety signals while foods 
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high in fat are very energy-dense therefore affecting energy intake. Thus, it was expected that a 
dietary pattern high in fat and GI and low in fibre would act partly through its effect on energy 
intake and weight gain. The fact that an independent association remained after adjustment for 
BMI and WC (for dietary patterns at age 53) suggests that this dietary pattern might also act 
through alternative pathways. These pathways are discussed in more details in chapter 1 and 5. 
The postprandial hyperglycaemia induced by high GI foods can affect -cells functions and 
insulin resistance both directly and indirectly by inducing a counter-regulatory hormone 
response, which increases circulating levels of free fatty acids (132, 133). Dietary fibre might 
reduce type 2 diabetes risk though its anti-inflammatory properties (157). Free fatty acids, which 
are elevated when excess calories and fat are consumed, increase insulin resistance by 
disrupting insulin signals in the gut and promote -cells dysfunction though their lipotoxic effect 
in the pancreas (11). All these pathways are independent of excess body weight, although free 
fatty acids are particularly elevated in overweight individuals 
Because RRR attempts to explain only the variation in chosen response variables, it is also 
possible that other nutrients and biological pathways might be important in the association 
between dietary patterns and type 2 diabetes.  
4
th
 objective: To investigate whether changes in the consumption of the high fat high GI low 
fibre dietary pattern over the adult life course are associated with type 2 diabetes incidence. It 
was hypothesised that the risk of type 2 diabetes would be greater with higher increases in 
dietary pattern score throughout adult life (from age 36 to age 53 years). The results from 
longitudinal analyses support this hypothesis, at least for women. Although, on average, the 
NSHD population decreased their scores over the entire follow up, thus improving their diet, 
those who developed type 2 diabetes between age 53 and 60-64 tended to increase their 
scores. The largest average increase was between age 36 and 43, when those who developed 
diabetes increased their score by 0.17 SD on average, compared to -0.02 SD for non-diabetics. 
This increase was mainly due to the large change observed among women in that period. 
Among women, results from regression analyses showed that long-term deterioration of the diet 
(increase in the dietary pattern score) from age 36 to 53 was particularly detrimental for type 2 
diabetes risk rather than change at any particular time. This suggests that the cumulative 
influence of an unhealthy diet (as well as other lifestyle factors e.g. decreased physical activity) 
on body fatness and metabolic functions comes into play at an older age, which is when women 
become more susceptible to chronic diseases associated with aging. These findings parallel 
those in chapter 3 and 4, where it was shown that the detrimental effects of excess body weight 
and abdominal fat accumulate over the life course and that accumulation of excess weight 
around the waist is particularly detrimental for women. 
6.4.2 Strengths 
Because RRR incorporates hypothesised knowledge about pathways to disease, dietary 
patterns derived with this method may be more specific to the disease being analysed. This 
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allowed the author to investigate the synergistic action of dietary fibre, GI and dietary fat, key 
nutritional components hypothesised in the aetiology of type 2 diabetes. In this way our 
knowledge of the nutritional pathways linking dietary patterns and diabetes can be advanced. 
Furthermore, food-based public health recommendations based on key diabetes-relevant 
nutrients can be provided. 
All the analyses accounted for a range of confounders (measures of SEP, education, smoking 
and physical activity) and results were similar after taking these into account. The mediating 
actions of BMI and WC were investigated and accounted for in separate models. 
Another strength of these analyses is that repeated measures of dietary intake over the adult 
life were used to analyse longitudinal changes in diet in relation to type 2 diabetes. Although 
changes in diet might happen for different reasons, these are not commonly investigated. Most 
epidemiological studies of dietary patterns use only one measure of diet assuming eating 
behaviours remain stable over the adult life course.  
6.4.3 Limitations 
Although RRR is a more hypothesis-driven method than other exploratory dietary pattern 
methods, it requires previous knowledge of the biological pathways linking diet and disease. 
Based on the available evidence GI, fibre and fat were chosen as response variable for the 
RRR model. However, other nutritional components that were not included might have been 
important. Some of these, such antioxidants or polyphenols, are not easily recorded and are not 
listed in nutrition databases. For others there might not be enough evidence, but their biological 
role might still be important. Also, as with other dietary pattern methods, subjectivity can 
influence the RRR process at different stages, for example when deciding how to group foods 
and how to adjust for energy intake.  
Although confirmatory RRR can be used to apply the same dietary pattern to other samples, the 
patterns derived with RRR, like other data-driven techniques, cannot be exactly reproduced in 
other cohorts. The food groups used in each cohort might be different or the foods consumed 
might vary according to season or country. In the NSHD sample, reproducibility of the high fat, 
high GI low fibre dietary pattern at age 36 had some limitations. Some foods commonly 
consumed in 1999 when the cohort was 53 did not exist in 1982 when the cohort was 36 e.g. 
skimmed milk and cereal bars were not consumed in 1982. Food formulation, meat fat content 
and portion sizes are also likely to have changed. In 1982 there was also a limited year-round 
supply of tropical and subtropical fruits and vegetables, the import of which only started in 
subsequent years. This might have contributed to greater seasonal variation in food consumed 
at age 36 (298). These factors might explain the weak associations found with type 2 diabetes 
in prospective analyses.  
Although it is important to recognise the potential measurement error associated with dietary 
assessment, the use of food diaries generally provides more reliable estimates of food intakes 
(334) compared to food frequency questionnaires, which predominate in epidemiological 
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studies.  
The analyses in this chapter were restricted to those with valid data for potential confounders 
(lifetime social class, educational attainment, smoking trajectory, physical activity, BMI and 
WC). Although this could have introduced bias, this restriction resulted in relatively small 
numbers of participants being excluded. However, loss to follow-up in NSHD might have 
introduced some bias and reduce the power of the associations, in particular in longitudinal 
analyses. The number of participants with valid diet diaries for all ages was 1397. However, we 
have no reason to suppose that this would have altered the pattern of results obtained. 
Nevertheless, as shown in Appendix 8, those providing dietary data were healthier and more 
likely to be women compared to those who did not complete diet diaries. Therefore results from 
these analyses might not be generalizable to all populations. 
6.4.4 Conclusions 
In conclusion, a dietary pattern characterised by high fat, high GI, low fibre is prospectively 
associated with type 2 diabetes risk especially among women and this association is partially 
independent of BMI and WC, indicating that this dietary pattern might be acting via alternative 
pathways as well as via body weight.  Among women, this association was robust when the 
dietary pattern was examined longitudinally over the life course (36 to 53 years) suggesting that 
the cumulative effects of changes in diet over a long-term period are particularly important for 
type 2 diabetes for women. 
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7 Chapter 7 - Discussion 
7.1 Research questions 
This PhD project aimed to address the following research questions: 
 How do longitudinal patterns of BMI throughout adult life affect type 2 diabetes 
incidence? (Chapter 3) 
 How does WC throughout the adult life course affect type 2 diabetes incidence? 
(Chapter 4) 
 Does consumption of dietary fibre, GI and dietary fats at different times of the adult life 
affect type 2 diabetes incidence? (Chapter 5) 
 Is the consumption throughout the adult life of a dietary pattern characterised by high 
GI, low fibre and high fat associated with type 2 diabetes incidence and is this 
association mediated by BMI and WC? (Chapter 6) 
7.2 Summary of main findings 
The findings presented across this thesis consistently show that accumulating excess body 
weight and having a large WC, as well as eating an unhealthy diet (for women), throughout the 
adult life course increase the risk of developing type 2 diabetes later in life (53 to 60-64 years). 
Chapter 3 showed that at any stage of the adult life course, overweight and obesity, as well as 
weight gain, were associated with later risk of type 2 diabetes. Early (26-36 years) and late 
adulthood (43-53 years) BMI gains were more important for men whereas gains in late 
adulthood had stronger associations for women. Chapter 3 also found evidence of the 
detrimental effect of accumulating weight across the life course, with those being overweight for 
longer durations reaching higher attained BMI and having the highest type 2 diabetes risk. 
Chapter 4 expanded the results of chapter 3 by analysing abdominal obesity and its relationship 
with BMI. At any time of the adult life course, having a large WC was associated with type 2 
diabetes incidence. The relative risk was particularly strong among women for whom the effect 
of having a large WC was independent of BMI. Chapter 4 also showed that long-term changes 
in WC (36-53) were associated with increased type 2 diabetes incidence, although only very 
large WC changes were independent of concomitant BMI change. Unlike BMI gains there was 
no period when WC gains were especially detrimental for later diabetes risk, although changes 
at age 36-43 were marginally more strongly associated with type 2 diabetes than later changes. 
Both abdominal obesity and changes in WC were particularly important for people with a normal 
BMI. 
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Chapter 5 and 6 showed that dietary choices across the adult life course are important for the 
prevention of type 2 diabetes, both through their effect on body weight and independently 
through other pathways. Chapter 5 found that dietary fibre, and GI, particularly at 43 and 53 
years, was significantly associated with type 2 diabetes incidence (43 and 53 years), among 
whom the association persisted after controlling for BMI and WC. Excess dietary fat, especially 
total fat rather than SFA, had a stronger impact on women, and this association was 
independent of body weight and abdominal obesity. Chapter 5 also found that the effects of low 
fibre and high GI were stronger among overweight people and those with a raised WC 
suggesting that people already at risk might be more susceptible to the effects of an unhealthy 
diet. 
Chapter 6 identified a high fat, high GI, low fibre dietary pattern that was characterised by high 
consumption of white bread, processed meat, fried potatoes, animal fats and added sugar, and 
a low intake of fruits, vegetables, low-fat dairy products and whole grain cereals. Higher scores 
for this dietary pattern at age 53 were associated with an increased type 2 diabetes incidence 
while at age 43 associations were strong for women but null for men. This association was only 
partly driven by the effect of diet on body weight and WC and was robust when the dietary 
pattern was examined longitudinally over the life course. In women, but not men, larger 
increases in this dietary patterns from age 36 to 53 years were associated with a higher risk of 
diabetes later in life independently of changes in BMI and WC over the same period. 
All analyses were adjusted for adult social class, educational attainment, physical activity and 
smoking history, suggesting these results were unlikely to be confounded by these factors. Most 
of the analyses presented in this thesis extended previous work on obesity, diet and type 2 
diabetes. However, few previous studies have analysed longitudinal patterns of excess body 
weight, WC and their association with type 2 diabetes risk and even fewer have examined 
longitudinal changes in dietary patterns over time. Indeed, a key strength of this thesis is the 
exploitation of repeated anthropometric and dietary measures to assess the interplay of these 
lifestyle factors and their effect on type 2 diabetes over the life course.  
7.3 Implications of findings 
As outlined in chapter 1, type 2 diabetes is a burdensome chronic disease, the prevalence of 
which is increasing worldwide. Diabetes complications are a major cause of morbidity and 
mortality and are extremely costly to handle, therefore prevention of the disease has become a 
public health priority. The findings from this thesis have a number of important implications for 
the prevention or delay of type 2 diabetes at the population level. 
This thesis provided evidence that accumulating weight, especially around the waist, as well as 
consuming a diet increasingly characterised by high fat, high GI and low fibre, across adulthood 
is associated with higher type 2 diabetes incidence, particularly among women. Using a life 
course perspective this thesis showed that not only are these risk factors important individually, 
but that they are also deeply interconnected and should be approached jointly when planning 
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prevention strategies. To date, no other study has looked at concurrent longitudinal changes in 
BMI, WC and dietary patterns in relation to type 2 diabetes, therefore these findings provide 
meaningful new insights into the interrelated pathways of these risk factors in the development 
of diabetes. 
Overall findings from this thesis point to a pattern of accumulation of metabolic insults brought 
about by repeated unhealthy life style choices over the life course.  Results from chapter 3 and 
4 underscore the importance of preventing weight gain as early as possible to avoid reaching a 
critically high body weight and WC peak in later life especially given that weight loss, or even 
weight maintenances, are rarely accomplished, as demonstrated by the NSHD cohort. Similarly, 
findings from chapters 5 and 6 indicate that a gradual worsening of the diet through the adult life 
is associated with type 2 diabetes. This is despite the fact that diet on average tended to 
improve for the NSHD cohort. The implications of these results are particularly relevant in the 
context of current obesity trends with people becoming overweight at increasingly younger ages 
and being exposed to longer durations of obesity than in previous decades (335). If, as argued 
by behavioural models of food choice (336), the most important dietary habits are those formed 
during the childhood years, which tend to track over the adult years, prevention should start as 
early as childhood. Furthermore, interventions to reduce even relatively small amounts of weight 
in later life tend to be costly, and maintenance of weight loss is typically poor. Shifting the focus 
from interventions solely aimed at at-risk individuals to a broader approach aimed at improving 
population lifestyle behaviours would probably be the most effective strategy to prevent 
diabetes and obesity in the future. The theory that effective prevention requires changes that 
involve the whole population, as initially proposed by Geoffrey Rose in its ‘Strategy of 
Preventive Medicine’ (337) and subsequently developed by the Marmot Reviews (25), is now a 
key focus of any public health policy. 
Chapter 5 and 6 suggest that promoting a dietary pattern rich in fruit, vegetable and whole-grain 
cereals as well as choosing low-fat versions of diary products would help prevent type 2 
diabetes, especially among women. Limiting processed and fried foods and reducing the 
consumption of added sugar and animal fat should also be encouraged. This is in agreement 
with findings from other studies. However, unlike other studies, this thesis has shed light on the 
nutritional pathways linking these food choices with diabetes development. By using a 
hypothesis-driven methodology it was found that dietary fibre, GI and dietary fats are key 
nutritional components underlying the metabolic effects of the above-mentioned food choices.  
Furthermore, this thesis has helped elucidate whether the association between dietary factors 
and diabetes is mediated by BMI and WC both prospectively and longitudinally. The BMI-
mediated pathways probably act through the high-energy density of fat-rich foods and low-
satiating effect of diets poor in fibre and high in GI. There is also increasing evidence that high 
GI low fibre diets could preferentially facilitate visceral fat storage in the abdominal area (135, 
136, 294-297). However, one important implication of this thesis is that consumption of a high-
GI, low-fibre, high-fat dietary pattern can increase the risk of type 2 diabetes through alternative 
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biological mechanisms, independent of BMI and WC. The elevated postprandial insulin and 
glycaemic response brought about by a high GI-diet (i.e. one rich in refined carbohydrate) could 
lead to -cells dysfunction if consumed for a long time (132); furthermore, high GI foods, after 
the initial glucose peak, lead to a quicker drop in blood glucose and a subsequent rise in FFA 
triggered by counter-regulatory hormones (132, 133). Raised FFA have been linked to insulin 
resistance and -cell dysfunction. Two important mechanisms of dietary fibre, independent of 
body weight, are its strong anti-inflammatory action (157-159, 286), and its acute lowering effect 
on postprandial glycaemia (165); conversely, dietary fats when consumed in excess, increase 
inflammation and insulin resistance (182, 183). The results also suggest that the associations 
between these factors and diabetes might partly depend on gender differences in metabolism 
and food choices. 
7.4 Overall strengths and limitations 
Strengths and limitations specific to chapters 3-6 have already been discussed within each 
chapter. Only strengths and limitations common to the whole thesis will be discussed in this 
section. 
7.4.1 Strengths 
An important strength of this thesis was the use of a socially representative sample of the British 
population. The NSHD, with its longitudinal birth cohort study design, comprises a rich data set 
encompassing more than 65 years of life. Detailed information on prospectively obtained 
anthropometric measures, lifestyle behaviours, SEP and diabetes outcome enabled analyses to 
be adjusted for multiple potential confounder factors. The prospective nature of the study 
ensured that the temporal sequence of exposure and outcome in all analyses limited the risk of 
reverse causation.  
A key strength of this thesis was the use of a life course perspective, which was essential to the 
identification of patterns of body weight, dietary choices and diabetes. Repeated measures of 
body weight, WC and diet were used in this thesis to address specific research questions, which 
would not have been possible using single measures. For example, repeated anthropometric 
measures were measures were used to identify periods of the adult life course when changes in 
BMI and WC were more detrimental for diabetes incidence and to investigate the cumulative 
damage of weight gain across the years. Repeated dietary measures were used to show the 
deleterious effects of adult changes in dietary patterns on diabetes risk, which have been rarely 
addressed in epidemiological studies. Furthermore, by modeling both anthropometric and 
dietary changes in one model the independent effect of dietary pattern on diabetes was shown. 
By addressing these issues, this thesis significantly contributes to the limited evidence on the 
longitudinal effects of diet and body weight on the risk of type 2 diabetes. 
Another strength of this thesis was the use of a comprehensively measured diabetes outcome, 
which was ascertained by analyses of fasting blood glucose and HbA1c as well as by self-
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report. Furthermore, the accuracy of participant-reported diabetes was validated using general 
practitioner information, which was collected by the author and used in a validation study (241). 
7.4.2 Limitations 
One of the main limitations of this thesis, as for many longitudinal studies, is represented by 
missing values due to loss to follow-up. In this thesis, the method chosen to address this 
problem was complete case analyses, with analyses restricted to those with valid data for all 
explanatory and confounding variables and the outcome. This method led to a reduced sample 
size with consequent reduction in statistical power. It may also have introduced bias if the 
excluded people differed substantially from those included with regards to the outcome and the 
main explanatory variables. However, as shown in Appendix 3, 4 and 6 this was not the case for 
analyses presented in chapter 3 and 4. However, as shown in Appendix 8, individuals providing 
dietary data were different from those not completing diet diaries with respect to social and 
lifestyle characteristics. In particular, the sample used for analyses in chapter 5 and 6 was a 
healthier one compared to the general population, making generalizations about findings more 
difficult.  
The use of multiple imputation would have led to a larger sample size with consequent higher 
statistical power. However, multiple imputation assumes that data are missing at random, which 
happens when the difference between measured and missing values can be explained by 
differences within the observed data (338). However, when data are missing not at random 
(when the difference between measured and missing values depend on unmeasured variables), 
multiple imputation may give misleading results, resulting in potentially greater bias than 
complete case analyses (338).  
Another potential limitation of this thesis is the use of self-reported measures of dietary intake, 
smoking and physical activity. Over reporting of healthy behaviours, such as fruit and vegetable 
intake and high-intensity exercise, and underreporting of unhealthy behaviours, such as 
smoking and fat intake, might have biased some results. However, if misreporting did happen 
this was likely to have resulted in bias towards the null and underestimation of relative risks. 
A further limitation is the fact that some of the explanatory variables of interest, especially WC 
and dietary intakes, were collected only during the adult years limiting the scope of life course 
analyses. For example, it would have been of interest to explore at what time during an 
individual lifecourse unhealthy food choices associated with diabetes incidence start to develop; 
or whether they are influenced by specific life events in adolescence and early adulthood. 
Analysis of one-day recall diet records of 4-year olds in the NSHD (339) showed that compared 
with younger generations, the NSHD children were a healthier cohort mainly due to the 
availability of food items during the post war period. Availability of dietary data for later 
childhood and adolescence would have helped identify periods when dietary habits start to 
change and factors associated with this transition.  
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The generalisability of findings from this thesis to younger cohorts is questionable. Particularly, 
the prevalence of obesity in younger cohorts is higher than in the NSHD, while excess weight 
gain is increasingly starting earlier in life (261, 340). In the NSHD only few people were obese in 
childhood and adolescence, which prevented analyses of patterns of weight gain during these 
periods. It is possible that in younger cohorts significant weight gain in childhood might 
represent a sensitive period for the development of type 2 diabetes rather than accumulation of 
weight through the adult life course. 
Reflecting the ethnic make-up of Britain in the 1940s, the NSHD is comprised exclusively of 
Caucasians. Therefore, the findings from this thesis might not be generalizable to cohorts of 
different ethnic groups. For example, the prevalence of type 2 diabetes is significantly higher 
among people of South Asian descent (1). Furthermore, because of the different body weight 
distribution and genetic background of these populations (341), the relative importance of BMI, 
WC and diet in modulating diabetes risk might differ from that of Caucasians. 
7.5 Policy implications 
Type 2 diabetes has reached epidemic proportions and will continue to rise worldwide, 
particularly among low-income countries. In an aging society, the older groups of the 
populations, those aged 65 years and more, are predicted to experience the greatest increase 
in type 2 diabetes (1), leading to a major public health impact on individuals’ lives and 
governments spending. 
As outlined in this thesis obesity and unhealthy diets are major determinants of this epidemic. 
These factors are highly interrelated and deeply imbedded in the culture of modern society. As 
illustrated by the social model of health of Dahlgren & Whitehead (342) health is determined not 
only by individuals choices but by a multitude of socio-economic, cultural and environmental 
factors, such as housing, employment and education. Targeting these wider determinants of 
health is a key priority for policies aiming at reducing obesity and diabetes. In fact, as noted in 
the Foresight report ‘Tackling Obesities: Future Choices’ (261), although individual responsibility 
plays a role in weight gain, the influence of the current ‘obesogenic environment’ with its 
abundant energy-dense foods and facilitation of sedentary life, has led to a state of near 
‘passive obesity’. This suggests that unhealthy lifestyles cannot be changed by policies solely 
aimed at the individual. Instead if policies are to be effective they need to involve various 
government departments and external stakeholders in an integrated fashion. These policies 
should target all opportunities for actions, including education, availability of food, food pricing 
and urban planning. 
As suggested by the government’s ‘Healthy Lives, Healthy People: A call to action on obesity in 
England’ (343), policy actions to reduce obesity and improve diets should involve the whole of 
society, including individuals, businesses and governments. The North Karelia Project in 
Finland (344), a 20-year long community-based programme aimed at reducing heart disease, 
provides evidence that such a whole-society approach would bring substantial population health 
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benefits. The Fleurbaix Laventie Ville Santé Study is a similar long-term community-based 
intervention started in two towns in France, which led to significant reductions in childhood 
obesity after 10 years. Based on the success of this study, the community-based project 
EPODE (345) (Ensemble prevenons l’obesite des enfants) aimed at preventing childhood 
obesity, was started in 2004 in 10 towns in France and is now implemented in 293 towns across 
Europe. These encouraging results demonstrated that a programme involving the whole town 
and based on political commitment, mobilization of resources, sustainability and continuous 
evaluation can successfully reverse the obesity trend (346). Similar progarmmes have not as 
yet been implemented in the UK. However, recently, government actions have been taken to 
involve various stakeholders to share the responsibility in reducing obesity levels, by for 
example encouraging food businesses to adopt the new government front of pack labeling 
system and to put calorie information on restaurant menus. On the other hand, awareness 
campaigns, such as the recently Change4Life programme (347), which uses social marketing to 
provides advice on healthy diet and physical activity aimed at families, have so far made little 
difference to people’ behaviour (348). A better understanding of why people change their 
behaviour, as argued by social cognition theories, such as the Health Belief Model (349), might 
also be needed if such campaigns are to be more effective. However, ultimately, more research 
into the wider economic and social determinants of lifestyle behaviours is needed as well as 
more evaluations of the effectiveness of on-going interventions to support cost-effective 
decision-making. Finally, more emphasis needs to be placed on the importance of primary 
prevention of chronic diseases if policies are to be truly effective, since as demonstrated by this 
thesis, weight loss in adult life is rarely achieved and the negative effects of unhealthy choices 
accumulate over time.  
7.6 Future research 
This thesis has found that accumulation of body weight over the adult life course is a key 
determinant of type 2 diabetes and that weight and WC gains at any time are detrimental. Few 
studies have examined long durations of overweight or obesity and even fewer have looked at 
sensitive periods of weight and WC gains; thus replication of findings from this thesis would 
strengthen the conclusions from chapter 3 and 4. The replication of findings using longer life 
course trajectories and shorter time intervals between anthropometric measurements would be 
particularly informative. The use of data from cohorts with higher obesity prevalence in younger 
years would also allow more powerful analyses.  
This thesis found that changes in dietary patterns are linked to type 2 diabetes, especially 
among women. Few studies have assessed diet longitudinally, therefore replicating results of 
dietary patterns analyses, particularly focusing on longitudinal changes of diet scores, either in 
Caucasians or in cohorts from different ethnic backgrounds would provide further insight on the 
link between diet and type 2 diabetes. More analyses of gender differences in the association 
between dietary patterns and diabetes could be conducted to ascertain the nature of this 
differential effect. 
171 
Future research could expand the findings from this thesis by exploring the combined effects of 
physical activity and diet in modulating the risk of type 2 diabetes, both directly though energy 
dynamics and independently via other pathways. The use of objectives measures of physical 
exertion would greatly advance research on exercise and metabolic outcomes.    
Further investigations on the link between diet and diabetes could include genetic information to 
investigate genetic and nutritional interactions. Research on the interaction between dietary 
factors and genetic traits is a growing area of research, which would enhance the understanding 
of the interplay between environmental and genetic factors in modulating diabetes risk.  
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Appendices 
Appendix 1. Descriptive statistics of the main explanatory variables used in this thesis 
      Centiles   
 N Mean  SD Min Max 10 25 75 90 Median IQR 
Body Mass Index (BMI) 1860
a
           
BMI at age 26  22.8 3 13.8 50.4 19.6 20.8 24.4 26.4 22.3 3.6 
BMI at age 36  23.9 3.4 14.1 44.3 20.1 21.5 25.8 28.2 23.5 4.3 
BMI at age 43  25.2 3.9 17.0 49.3 21 22.5 27.9 30.3 24.6 4.7 
BMI at age 53  27.3 4.6 17.1 57.1 22.3 24.1 29.7 33.2 26.5 5.6 
Waist circumference (WC) 2007
b
           
WC at age 36  82.2 11.8 51.5 132.5 67 73 90.5 97.4 82 17.5 
WC at age 43  83.9 12.2 54.5 130.1 68.6 74.2 92.5 100 83.5 18.3 
WC at age 53  91.1 12.9 58.6 159.9 74.2 81.7 99.6 107.3 91 17.9 
Dietary fibre density            
Dietary fibre at age 36 1804
c
 6 2.2 2 27.6 4.1 4.6 6.9 8.6 5.5 2.3 
Dietary fibre at age 43 2267
d
 6.2 2.5 0.9 31.3 3.6 4.6 7.3 9.2 5.7 2.7 
Dietary fibre at age 53 1477
e
 7.6 2.4 1.5 25.9 4.9 5.8 8.9 10.7 7.2 3 
Glycaemic Index (GI)            
GI at age 36 1804
c
 64.2 4 41.5 75.8 58.7 61.8 67 69 64.5 5.2 
GI at age 43 2267
d
 63.8 4.9 43.6 82 57.7 60.5 67.3 69.9 63.9 6.7 
GI at age 53 1477
e
 61.8 4 45.1 74.4 56.6 59 64.5 66.9 61.9 5.5 
Dietary fat density            
Dietary fat at age 36 1804
c
 43.9 5.3 4.7 62.3 37.2 40.7 47.3 50.4 44.2 6.6 
Dietary fat at age 43 2267
d
 43 6.5 7.6 68 34.8 39.4 47.3 50.5 43.6 7.9 
Dietary fat at age 53 1477
e
 378 6.7 10,7 59.5 29 33.4 42.6 46.3 38.2 9.1 
a= sample used in chapter 3;  b= sample used in chapter 4; c,d,e= samples used in chapter 5 and 6; IQR= interquartile range 
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Appendix 2. Descriptive statistics for the confounders variables used in this thesis 
 Sample used in chapter 3 Sample used in chapter 4  Samples used in chapter 5 and 6 
 N=1860 N=2007  N=1804 N=2267 N=1477 
 Frequency Percent Frequency Percent  Frequency Percent Frequency Percent Frequency Percent 
Sex            
Male 883 47.5 947 47.2  856 47.4 1080 47.6 668 45.2 
Female 977 52.5 1060 52.8  948 52.5 1187 52.4 809 54.8 
Socioeconomic position            
I    professional 139 7.5 151 7.5  136 7.5 170 7.5 118 8 
II   intermediate 701 37.7 755 37.6  667 37.0 854 37.7 551 37.3 
III  skilled (Non-Manual) 460 24.7 488 24.3  464 25.7 534 23.6 365 24.7 
III  skilled (Manual) 300 16.1 327 16.3  282 15.6 374 16.5 226 15.3 
IV   partly skilled 187 10.1 206 10.3  188 10.4 246 10.8 158 10.7 
V    unskilled 73 3.9 80 4.0  67 3.7 89 3.9 59 4 
Education attained  
by age 26 
    
 
  
  
  
None attempted 603 32.4 661 32.9  571 31.6 768 33.9 430 29.1 
Intermediate 533 28.7 577 28.8  525 29.1 634 28 436 29.5 
     Highest 724 38.9 769 38.3  708 39.3 865 38.1 611 41.4 
Smoking history up to age 
36, 43 or 53 
    
 
  
    
Current smoker       478 26.5 582 25.7 247 16.7 
Ex smoker      745 41.3 982 43.3 761 51.5 
Never smoker      581 32.2 703 31 469 31.8 
Lifetime smoking trajectory            
Never smoker 587 31.6 624 31.1        
Predominantly non-
smoker 
672 36.1 727 36.2 
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Predominantly smoker 372 20.0 405 20.2        
Lifelong smoker 229 12.3 251 12.5  229 12.3     
Exercise at age 36            
Inactive 640 34.4 700 34.9  621 34.4     
Less active 495 26.6 528 26.3  493 27.4     
Most active 725 39.0 779 38.8  690 38.2     
Exercise at age 43            
Inactive 933 50.1 995 49.6    1126 49.7   
Less active 446 24.0 90 24.4    556 24.5   
Most active 481 26.9 522 26.0    585 25.8   
Exercise at age 53            
Inactive 843 45.3 910 45.4      655 44.4 
Less active 266 19.7 393 19.6      299 20.2 
Most active 650 35.0 703 35.0      523 35.4 
Educational attainment categorised as none (none attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or Burnam B or higher); exercise was 
coded as inactive (no participation), moderately active (participated one to four times) and most active (participated five or more times) in the previous 4 weeks/ one month 
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Appendix 3. Comparison between study members with missing data on BMI and those 
with available data at age 26 and 36 
 Age 26  Age 36  
 Missing Non-missing Missing Non-missing 
 n  % n % P value n  % n % P value 
Sex           
Male 993 56.4 1822 50.5 <0.001 1183 56.2 1633 49.7 <0.001 
Type 2 diabetes            
age 53 to 60- 64 29 8.3 230 10 0.32 34 12.2 225 9.5 0.15 
SEP            
Manual 255 40.7 1276 35.7 0.01 394 42.1 1137 34.8 <0.001 
Education (by age 26)           
None attempted 434 45.9 1331 38.3  578 44.4 1187 38.0  
Intermediate 278 29.4 938 26.9 <0.001 341 26.2 875 28 <0.001 
Highest  233 24.6 1206 34.7  382 29.3 1057 33.8  
Lifetime smoking            
Never smoker 81 24.8 869 28.3 
<0.001 
65 28.6 885 28 
0.02 
Predominantly  
non-smoker 
89 27.3 1012 33 54 23.7 1047 33.1 
Predominantly  
smoker 
78 23.9 543 20.8 57 25.1 658 20.8 
Lifelong smoker 78 23.9 543 17.7 51 22.4 570 18 
BMI category*           
Overweight  
(25 -29.9 kg/m
2
) 
 -    132 18.7 534 18.4 
0.86 
Obese  
(30 kg/m
2
) 
     17 2.4 80 2.7 
WC category*           
High risk   -     -    
Very high risk            
Physical activity*           
Inactive           
Less active           
Most active           
BMI= body mass index; WC= waist circumference; educational attainment was categorised as none (none 
attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or Burnam B or 
higher); exercise was coded as inactive (no participation), moderately active (participated one to four times) 
and most active (participated five or more times) in the previous 4 weeks/ one month; * high risk category: 
WC of 94-102 cm for men, WC of 80-88 cm for women; very high risk category: WC>102 for men, WC>88 
cm for women. * information from previous data collection used 
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Appendix 4. Comparison between study members with missing data on BMI and those with 
available data at age 43 and 53 
 Age 43  Age 53  
 Missing Non-missing Missing Non-missing 
 n  % n % P value n  % n % P value 
Sex           
Male 1198 56.0 1617 50.1 <0.001 1363 56.4 1452 49.2 <0.001 
Type 2 diabetes            
age 53 to 60- 64 28 14.2 231 9.4 0.03 27 12 232 9.5 0.23 
SEP            
Manual 422 42.3 1109 34.6 <0.001 536 42 995 34 <0.001 
Education (by age 26)          
None attempted 641 46.2 1124 37  741 45 1024 36.8  
Intermediate 365 26.3 851 28.0 <0.001 444 27 772 27.8 <0.001 
Highest  380 27.4 1059 34.9  459 27.9 980 35.3  
Lifetime smoking            
Never smoker 78 23.5 872 28.5 
<0.001 
140 22.6 810 29.2 
<0.001 
Predominantly  
non-smoker 
69 20.8 1032 33.7 152 24.6 949 34.2 
Predominantly  
smoker 
72 21.7 643 21 136 22 579 20.9 
Lifelong smoker 112 33.8 509 16.6 190 30.7 431 15.5 
BMI category*           
Overweight  
(25 -29.9 kg/m
2
) 
100 28.7 830 28.3 0.16 179 37.5 960 34.9 
0.37 
 Obese  
(30 kg/m
2
) 
31 8.9 185 6.3  62 13 333 12.1 
WC category*           
High risk  80 22.6 570 19.3 0.04 108 22.5 601 21.9 0.08 
Very high risk  51 14.4 337 11.4  78 16.3 352 12.8  
Physical activity*           
Inactive 151 42.3 1068 36.1  275 56.1 1424 51.3  
Less active 91 25.4 746 25.2 0.03 108 22 645 23.2 0.12 
Most active 115 32.2 1138 38.5  107 21.8 703 25.3  
BMI= body mass index; WC= waist circumference; educational attainment was categorised as none (none 
attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE A level or Burnam B or 
higher); exercise was coded as inactive (no participation), moderately active (participated one to four times) 
and most active (participated five or more times) in the previous 4 weeks/ one month; * high risk category: 
WC of 94-102 cm for men, WC of 80-88 cm for women; very high risk category: WC>102 for men, WC>88 
cm for women. * information from previous data collection used 
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Appendix 5. Associations between conditional BMI changes at different age intervals and type 2 diabetes between age 
53 and 60-64 
 Model 1  Model 2  Model 3  
 Unadjusted 
 
Adjusted for SEP 
and education 
 As Model 2 + 
adjusted for 
physical activity and 
smoking history 
 
 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Period of change        
Men, n=889       
26-43 years 1.48 (1.19, 1.83) <0.001 1.46 (1.18, 1.81) <0.001 1.50 (1.21, 1.87) <0.001 
43-53 years 1.57 (1.27, 1.94) <0.001 1.56 (1.26, 1.93) <0.001 1.64 (1.32, 2.05) <0.001 
P* for difference between periods 0.15  0.68  0.58  
Women, n= 984       
26-43 years 1.60 (1.28, 2.01) <0.001 1.59 (1.27, 1.99) <0.001 1.59 (1.26, 2.00) <0.001 
43-53 years 1.85 (1.46, 2.34) <0.001 1.85 (1.46, 2.34) <0.001 1.84 (1.45, 2.34) <0.001 
P* for difference between periods 0.42  0.39  0.41  
Note: analyses restricted to those with non-missing data for BMI at age 26, 36, 43 and 53, type 2 diabetes and all covariates. OR of type 2 
diabetes for a 1 SD increase in BMI in each interval conditional on previous BMI;P for difference between periods estimated with Wald’s test 
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Appendix 6. Comparison between subjects with information about type 2 diabetes 
between age 53 and 64 and those with non-missing data for all covariates 
 Maximum sample Complete cases 
  (n= 1872) 
 
Maximum 
N available 
n  % n (%) 
Male (N=2642) 1,279  48.4 889 47.4 
Type 2 diabetes status  (N=2642)     
Diagnosed between age 53 
and 64 
 259 9.7 182 9.7 
Socioeconomic position  (N=2618)     
Manual 827 31.5 562 30.0 
Education attained by age 26 (N= 2467)     
None attempted 841 34.0 603 32.2 
Intermediate 694 28.1 538 28.7 
Highest  932 37.2 731 39.0 
Lifetime smoking trajectory (N=2462)     
Never smoker  747 30.3 594 31.7 
Predominantly non-smoker  866 35.1 677 36.1 
Predominantly smoker  511 20.7 372 19.8 
Lifelong smoker  338 13.7 230 12.2 
BMI Mean (95%CI)      
BMI at age 26 (N=2294) 22.7 (22.65, 22.90) 22.7 (22.65, 22.92) 
BMI at age 36 (N=2364) 24.01 (23.87, 24.15) 23.9 (23.80, 24.11) 
BMI at age 43 (N=2445) 25.2 (25.10, 25.41) 25.2 (25.07, 25.42) 
BMI at age 53 (N=2418) 27.3 (27.17, 27.54) 27.3 (27.12, 27.54) 
WC Mean (95%CI)      
WC at age 36 (N=2375) 82.5 (82.03, 82.98) 82.2 (81.73, 82.80) 
WC at age 43 (N=2438) 84.0 (83.58, 84.56) 83.9 (83.39, 84.51) 
WC at age 53 (N=2429) 91.1 90.64, 91,68) 91.1 (90.52, 91,70) 
BMI= body mass index; WC= waist circumference 
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Appendix 7. Correlation between WC and BMI measures by BMI category 
a) Males (n=947) a) Females (n=1060) 
Correlation between BMI and WC at age 36 
BMI <25 kg/m
2
 0.55 BMI <25 kg/m
2
 0.41 
BMI 25 – 29.9 kg/m
2
 0.53 BMI 25 – 29.9 kg/m
2
 0.36 
BMI 30 kg/m
2
 0.67 BMI 30 kg/m
2
 0.58 
Correlation between BMI and WC at age 43 
BMI <25 kg/m
2
 0.50 BMI <25 kg/m
2
 0.55 
BMI 25 – 29.9 kg/m
2
 0.56 BMI 25 – 29.9 kg/m
2
 0.47 
BMI 30 kg/m
2
 0.70 BMI 30 kg/m
2
 0.59 
Correlation between BMI and WC at age 53 
BMI <25 kg/m
2
 0.53 BMI <25 kg/m
2
 0.74 
BMI 25 – 29.9 kg/m
2
 0.57 BMI 25 – 29.9 kg/m
2
 0.69 
BMI 30 kg/m
2
 0.78 BMI 30 kg/m
2
 0.78 
Note: Analyses restricted to those with non-missing data for WC and BMI at age 36, 43 and 53, 
type 2 diabetes and all covariates 
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Appendix 8. Comparison between study members who completed diet diaries and those who did not at each age  
 Age 36  Age 43  Age 53  
 Non completers Completers  Non completers Completers  Non completers Completers  
 n  % n % P value n  % n  % P value n % n % P value 
Male 1617 55.3 1198 49 <0.001 1229 56.5 1586 49.7 <0.001 1988 55.4 827 46.5 <0.001 
Type 2 diabetes diagnosis                 
age 53 to 60- 64 83 11.2 176 9.2 0.11 30 14 229 9.4 0.03 122 11.5 137 8.6 0.01 
Socioeconomic position                 
Manual 718 40.5 813 33.4 <0.001 436 42.1 1095 34.6 <0.001 983 40.2 548 31.1 <0.001 
Education attained by age 26                
None attempted 959 45.8 806 34.6  653 45.9 1112 37  1249 45.3 516 30.9  
Intermediate 544 25.9 672 28.8 <0.001 379 26.6 837 27.9 <0.001 737 26.7 479 28.7 <0.001 
Highest  591 28.2 848 36.4  390 27.4 1049 34.9  767 27.8 672 40.3  
Lifetime smoking trajectory                
Never smoker 249 24.6 701 29.5 
<0.001 
91 24.5 859 28.4 
<0.001 
427 25 523 31.1 
<0.001 
Predominantly non-smoker 251 24.8 850 35.7 76 20.5 1025 33.9 475 27.8 626 37.2 
Predominantly smoker 258 25.4 457 19.2 78 21 637 21.1 382 22.3 333 19.8 
Lifelong smoker 254 25.1 367 15.4 125 24.8 496 16.4 424 24.8 197 11.7 
BMI category                
Overweight (25 -29.9 kg/m
2
) 275 31.8 655 27.1 <0.001 23 37.1 1116 35.2 0.32 508 42.5 749 42.6 <0.001 
Obese (30 kg/m
2
) 72 8.3 144 5.9  11 17.7 384 12.1  352 29.5 362 20.6  
WC category                
High risk  183 21 467 19.2 0.01 12 20.3 697 22.0 0.48 380 31.7 559 31.6 <0.001 
Very high risk  123 24.1 265 10.9  11 18.6 419 13.2   445 37.1 487 27.6  
Physical activity                
Inactive 345 39.6 874 35.8  42 56 1657 51.9  660 54.3 817 46.1  
Less active 199 22.8 638 26.1 0.07 13 17.3 740 23.2 0.48 179 14.7 339 19.1 <0.001 
Most active 327 37.5 926 37.9  20 26.6 790 24.7  376 30.9 615 34.7  
BMI= body mass index; WC= waist circumference; educational attainment categorised as none (none attempted), intermediate (GCE 'O' level or Burnam C or lower) or highest (GCE 
A level or Burnam B or higher); exercise was coded as inactive (no participation), moderately active (participated one to four times) and most active (participated five or more times) in 
the previous 4 weeks/ one month; * high risk category: WC of 94-102 cm for men, WC of 80-88 cm for women; very high risk category: WC>102 for men, WC>88 cm for women 
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Appendix 9. Factor loadings for the first dietary pattern (high-fibre, low-fat, low-GI) 
extracted at age 36 using exploratory RRR analyses.  
 
 
 
potatoes 
white bread 
table sugar 
alcoholic drinks 
butter, animal fat 
processec meat 
oils 
red meat, offal 
low fibre cereals 
other cereals 
plant fat solid 
coffee, tea 
Soft drinks 
savoury snacks 
white meat 
eggs 
dressing sauces 
fish 
pulses/baked beans 
roasted/fried potato 
confectionery 
full fat milk 
full fat dairy desserts 
jam, chutney 
rice 
low fat dairy desserts 
soups 
biscuits, pastry, cakes 
cream 
honey, syrup 
pure fruit juice 
pasta 
pizza 
cheese 
nuts and seeds 
vegetables 
plant fat solid low fat 
other/crisp bread 
juices, squashes 
high fibre/oat cereal 
wholemeal bread 
low fat yogurt 
skimmed milk 
fruit 
-0.5 -0.4 -0.3 -0.2 -0.1 0 0.1 0.2 0.3 0.4 0.5
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Appendix 10. Factor loadings for the first dietary pattern (low-fibre, high-fat, high-GI) 
extracted at age 43 using exploratory RRR analyses.  
 
 
fruit 
low fat yogurt 
skimmedmilk 
high fibre /oat cereal 
wholemeal bread 
vegetables 
pulses 
plantfat, solid low fat 
honey, syrup 
soup 
pasta 
full fat yogurt 
other breads 
oils 
white meat 
jam, chutney 
rice 
pure fruit juice 
low fibre cereal 
pizza 
low fat dairy desserts 
nuts, seeds 
cream 
Full fat dairy desserts 
juices, squashes 
fish 
biscuits, cakes 
confectioneryl 
soft drinks 
coffee, tea, 
cheese 
dressing sauces 
cereals_other 
savoury snacks 
eggs 
plantfat solid 
red meat, offal 
potatoes 
alcoholic drinks 
whole milk 
added sugar 
processec meat 
butter, animal fat 
fried potatoes 
white bread 
-0.5 -0.4 -0.3 -0.2 -0.1 0 0.1 0.2 0.3 0.4 0.5
